Name,Direction.PXD023778,FDR.PXD023778,PValue.PXD023778,NGenes.PXD023778,MeanAbsT0.PXD023778,MeanWeightT0.PXD023778,av_foldchange.PXD023778,sig.PXD023778,Direction.PXD008934,FDR.PXD008934,PValue.PXD008934,NGenes.PXD008934,MeanAbsT0.PXD008934,MeanWeightT0.PXD008934,av_foldchange.PXD008934,sig.PXD008934
Glycogen breakdown (glycogenolysis),Up,0.004333694,1.08342E-05,4,4.017705844,4.378484271,0.348974029,TRUE,Down,0.26,0.192,5,0.484894642,0.385630941,-0.257157195,FALSE
Glucuronidation,Up,0.003250271,0.001083424,1,3.156648108,3.381570248,0.382208973,TRUE,Down,0.665,0.597,1,-0.721915396,-0.665089384,-0.149766609,FALSE
"Formation of the active cofactor, UDP-glucuronate",Up,0.003250271,0.001083424,1,3.156648108,3.381570248,0.382208973,TRUE,Down,0.665,0.597,1,-0.721915396,-0.665089384,-0.149766609,FALSE
Signal transduction by L1,Up,0.001083424,0.001083424,2,4.507099112,4.53213236,0.479722776,TRUE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
Cell-extracellular matrix interactions,Up,0.001083424,0.001083424,9,2.560725664,2.703238754,0.170169513,TRUE,Up,0.601,0.521,8,-0.34829067,-0.277492359,0.2852639,FALSE
Cell-Cell communication,Up,0.001083424,0.003250271,20,3.468643942,3.8161718,0.110939248,TRUE,Up,0.457,0.364,17,0.057013049,0.162579286,0.235649429,FALSE
Cell junction organization,Up,0.003250271,0.003250271,15,3.210118003,3.48299613,0.091855921,TRUE,Up,0.777,0.717,12,-1.015023667,-0.905754527,0.182773775,FALSE
Interferon gamma signaling,Up,0.013001083,0.008667389,3,1.986365918,2.078182883,0.22564526,FALSE,,,,,,,,
Norepinephrine Neurotransmitter Release Cycle,Up,0.007583965,0.009750813,1,3.359491124,3.46983835,0.379829187,TRUE,Down,0.511,0.438,1,-0.198683115,-0.153099977,-0.341901734,FALSE
Enzymatic degradation of dopamine by COMT,Up,0.007583965,0.009750813,1,3.359491124,3.46983835,0.379829187,TRUE,Down,0.511,0.438,1,-0.198683115,-0.153099977,-0.341901734,FALSE
Enzymatic degradation of Dopamine by monoamine oxidase,Up,0.007583965,0.009750813,1,3.359491124,3.46983835,0.379829187,TRUE,Down,0.511,0.438,1,-0.198683115,-0.153099977,-0.341901734,FALSE
Dopamine clearance from the synaptic cleft,Up,0.007583965,0.009750813,1,3.359491124,3.46983835,0.379829187,TRUE,Down,0.511,0.438,1,-0.198683115,-0.153099977,-0.341901734,FALSE
Defective MAOA causes BRUNS,Up,0.007583965,0.009750813,1,3.359491124,3.46983835,0.379829187,TRUE,Down,0.511,0.438,1,-0.198683115,-0.153099977,-0.341901734,FALSE
Metabolic disorders of biological oxidation enzymes,Up,0.007583965,0.009750813,1,3.359491124,3.46983835,0.379829187,TRUE,Down,0.745,0.687,2,-0.942945113,-0.879578834,-0.181885142,FALSE
Meiotic synapsis,Up,0.048754063,0.01191766,3,0.855948936,0.972545709,0.123928872,FALSE,Up,0.019,0.014,2,3.127855414,3.250153307,1.372985739,FALSE
OAS antiviral response,Up,0.020585049,0.01191766,1,3.011614674,3.153910428,0.378245942,FALSE,Up,0.486,0.393,1,-0.20101068,-0.146312031,0.144962143,FALSE
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Up,0.019501625,0.015167931,4,3.506061585,3.441485901,0.383875661,FALSE,Up,0.229,0.182,2,0.608241049,0.595032533,0.485379164,FALSE
Inflammasomes,Up,0.018418202,0.016251354,2,2.160867934,2.116506516,0.001685345,FALSE,Down,0.665,0.611,2,-0.702834014,-0.67080467,-0.255587297,FALSE
The NLRP3 inflammasome,Up,0.018418202,0.016251354,2,2.160867934,2.116506516,0.001685345,FALSE,Down,0.665,0.611,2,-0.702834014,-0.67080467,-0.255587297,FALSE
Trafficking and processing of endosomal TLR,Up,0.013001083,0.017334778,1,2.079374605,2.188182733,0.249138792,FALSE,Down,0.725,0.645,1,-0.923262841,-0.877792533,-0.039167001,FALSE
Aryl hydrocarbon receptor signalling,Up,0.016251354,0.018418202,1,2.013240233,1.906907846,0.230525831,FALSE,Down,0.586,0.497,1,-0.570798124,-0.56321777,-0.091032296,FALSE
Purinergic signaling in leishmaniasis infection,Down,0.020585049,0.018418202,3,2.372716555,2.366511827,-0.135488704,FALSE,Down,0.49,0.392,3,-0.213994846,-0.166025779,-0.079212311,FALSE
Cell recruitment (pro-inflammatory response),Down,0.020585049,0.018418202,3,2.372716555,2.366511827,-0.135488704,FALSE,Down,0.49,0.392,3,-0.213994846,-0.166025779,-0.079212311,FALSE
Apoptosis induced DNA fragmentation,Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.579,0.494,1,-0.443629677,-0.43078284,0.28816333,FALSE
Regulation of cholesterol biosynthesis by SREBP (SREBF),Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.564,0.461,2,-0.299549956,-0.269087987,0.255993523,FALSE
Immune System,Up,0.046587216,0.020585049,112,1.438849491,1.560613042,0.098995157,FALSE,Down,0.046,0.043,136,1.305180446,1.107014891,-0.08185063,FALSE
Transport of Ribonucleoproteins into the Host Nucleus,Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.579,0.494,1,-0.443629677,-0.43078284,0.28816333,FALSE
NS1 Mediated Effects on Host Pathways,Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.579,0.494,1,-0.443629677,-0.43078284,0.28816333,FALSE
Interferon alpha/beta signaling,Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.579,0.494,1,-0.443629677,-0.43078284,0.28816333,FALSE
Postmitotic nuclear pore complex (NPC) reformation,Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.564,0.461,2,-0.299549956,-0.269087987,0.255993523,FALSE
Inhibition of nitric oxide production,Up,0.016251354,0.020585049,1,2.212886341,2.154842239,0.200434891,FALSE,Up,0.579,0.494,1,-0.443629677,-0.43078284,0.28816333,FALSE
HSF1-dependent transactivation,Up,0.024918743,0.02383532,8,2.203660309,2.346210053,0.155862454,FALSE,Up,0.018,0.013,4,2.030268419,2.145447609,0.415873769,FALSE
Glycogen metabolism,Up,0.013001083,0.02383532,11,2.031506745,2.191606149,0.203605089,FALSE,Down,0.5,0.604,12,-0.679186375,-0.874987561,-0.091829385,FALSE
Adherens junctions interactions,Down,0.026002167,0.026002167,7,1.86618666,2.070044728,-0.056091723,FALSE,Down,0.839,0.805,6,-1.309610956,-1.27228831,-0.143870671,FALSE
Cell-cell junction organization,Down,0.026002167,0.026002167,7,1.86618666,2.070044728,-0.056091723,FALSE,Down,0.839,0.805,6,-1.309610956,-1.27228831,-0.143870671,FALSE
Attenuation phase,Up,0.022751896,0.029252438,4,2.911601668,3.013686672,0.32556135,FALSE,Up,0.017,0.01,3,2.169796334,2.246218582,0.617887429,FALSE
Other semaphorin interactions,Up,0.024918743,0.029252438,1,2.120556639,1.966943133,0.245374658,FALSE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
Platelet Adhesion to exposed collagen,Up,0.029252438,0.029252438,3,3.440075925,3.33549413,0.648446482,FALSE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
MET interacts with TNS proteins,Up,0.024918743,0.029252438,1,2.120556639,1.966943133,0.245374658,FALSE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
Neurotransmitter release cycle,Up,0.05092091,0.031419285,4,2.056571593,2.212886393,0.263221556,FALSE,Up,0.237,0.162,4,0.648769694,0.750805475,0.226382093,FALSE
Scavenging of heme from plasma,Down,0.032502709,0.034669556,4,2.641210217,2.741368809,-0.921221216,FALSE,Up,0.03,0.019,4,2.912241024,2.966339797,0.311020716,FALSE
Nephrin family interactions,Up,0.02708559,0.035752979,6,2.107759411,2.352821965,0.214814174,FALSE,Up,0.103,0.053,6,1.634591776,1.680168581,0.47982948,FALSE
Uptake and function of diphtheria toxin,Up,0.076923077,0.035752979,2,1.087517107,1.042438906,0.084741524,FALSE,Down,0.367,0.28,3,0.145842272,0.233282434,-0.200591884,FALSE
Metabolism of carbohydrates,Up,0.037919827,0.037919827,42,3.18820471,3.615416636,0.229829982,FALSE,Down,0.246,0.233,40,0.032635282,0.24461355,-0.031934219,FALSE
GP1b-IX-V activation signalling,Up,0.055254605,0.040086674,4,3.300027097,3.351592954,0.55560128,FALSE,Up,0.539,0.457,2,-0.23647079,-0.209895773,0.309888876,FALSE
Pre-NOTCH Processing in Golgi,Down,0.045503792,0.041170098,1,2.135589487,2.276011869,-0.481348073,FALSE,Down,0.256,0.18,1,0.524817367,0.600724353,-0.204556708,FALSE
Chondroitin sulfate biosynthesis,Up,0.048754063,0.047670639,3,2.907403806,3.038542078,0.546989379,FALSE,Down,0.334,0.262,1,0.281122953,0.33082861,-0.573180366,FALSE
Dermatan sulfate biosynthesis,Up,0.048754063,0.047670639,3,2.907403806,3.038542078,0.546989379,FALSE,Down,0.334,0.262,1,0.281122953,0.33082861,-0.573180366,FALSE
CS/DS degradation,Up,0.048754063,0.047670639,3,2.907403806,3.038542078,0.546989379,FALSE,Down,0.334,0.262,1,0.281122953,0.33082861,-0.573180366,FALSE
Defective CHST3 causes SEDCJD,Up,0.048754063,0.047670639,3,2.907403806,3.038542078,0.546989379,FALSE,Down,0.334,0.262,1,0.281122953,0.33082861,-0.573180366,FALSE
"Defective CHST14 causes EDS, musculocontractural type",Up,0.048754063,0.047670639,3,2.907403806,3.038542078,0.546989379,FALSE,Down,0.334,0.262,1,0.281122953,0.33082861,-0.573180366,FALSE
Defective CHSY1 causes TPBS,Up,0.048754063,0.047670639,3,2.907403806,3.038542078,0.546989379,FALSE,Down,0.334,0.262,1,0.281122953,0.33082861,-0.573180366,FALSE
Sema3A PAK dependent Axon repulsion,Up,0.070422535,0.048754063,2,0.936087807,0.880728198,0.186125505,FALSE,Down,0.586,0.497,1,-0.570798124,-0.56321777,-0.091032296,FALSE
Syndecan interactions,Up,0.048754063,0.05092091,5,3.542936919,3.500329808,0.515188917,FALSE,Up,0.338,0.27,2,0.346181896,0.34507201,0.881721277,FALSE
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,Up,0.057421452,0.053087757,14,1.852453252,1.922236384,0.142485412,FALSE,Down,0.298,0.276,12,0.23405422,0.238328235,-0.045979596,FALSE
Heme signaling,Down,0.058504875,0.058504875,2,2.827597871,2.892126592,-1.288636189,FALSE,Up,0.029,0.018,2,3.093621969,3.094860083,0.743055072,FALSE
Cellular response to heat stress,Up,0.068255688,0.061755146,15,1.848517209,2.039937445,0.152336208,FALSE,Up,0.024,0.015,10,1.833663527,1.939246256,0.33697254,FALSE
HDL remodeling,Down,0.069339112,0.06283857,2,2.011025876,2.017420972,-0.964749388,FALSE,Up,0.04,0.03,3,2.711028081,2.676551577,0.706282557,FALSE
Amine Oxidase reactions,Up,0.083423619,0.063921993,2,2.187994227,2.311648734,0.234131078,FALSE,Down,0.593,0.513,2,-0.424154283,-0.341999622,-0.091131323,FALSE
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,Up,0.083423619,0.063921993,2,2.187994227,2.311648734,0.234131078,FALSE,Down,0.593,0.513,2,-0.424154283,-0.341999622,-0.091131323,FALSE
Maturation of spike protein,Up,0.066088841,0.063921993,2,1.47331057,1.577252304,0.235797095,FALSE,Up,0.884,0.859,2,-1.3456295,-1.285831589,0.117397326,FALSE
Heparan sulfate/heparin (HS-GAG) metabolism,Up,0.085590466,0.066088841,5,2.201542805,2.318834341,0.402497435,FALSE,Up,0.288,0.229,2,0.52462383,0.571205922,0.114262893,FALSE
Chondroitin sulfate/dermatan sulfate metabolism,Up,0.085590466,0.066088841,5,2.201542805,2.318834341,0.402497435,FALSE,Up,0.288,0.229,2,0.52462383,0.571205922,0.114262893,FALSE
A tetrasaccharide linker sequence is required for GAG synthesis,Up,0.085590466,0.066088841,5,2.201542805,2.318834341,0.402497435,FALSE,Up,0.288,0.229,2,0.52462383,0.571205922,0.114262893,FALSE
Phase I - Functionalization of compounds,Up,0.092091008,0.066088841,8,1.885778059,2.056825435,0.171564938,FALSE,Up,0.827,0.76,9,-1.086594606,-0.906387657,0.139196754,FALSE
"Defective B4GALT7 causes EDS, progeroid type",Up,0.085590466,0.066088841,5,2.201542805,2.318834341,0.402497435,FALSE,Up,0.288,0.229,2,0.52462383,0.571205922,0.114262893,FALSE
Defective B3GAT3 causes JDSSDHD,Up,0.085590466,0.066088841,5,2.201542805,2.318834341,0.402497435,FALSE,Up,0.288,0.229,2,0.52462383,0.571205922,0.114262893,FALSE
Defective B3GALT6 causes EDSP2 and SEMDJL1,Up,0.085590466,0.066088841,5,2.201542805,2.318834341,0.402497435,FALSE,Up,0.288,0.229,2,0.52462383,0.571205922,0.114262893,FALSE
Plasma lipoprotein remodeling,Down,0.080173348,0.067172264,3,1.514856437,1.536840243,-0.590515142,FALSE,Up,0.059,0.037,4,2.183576802,2.171450515,0.582755134,FALSE
Defective HK1 causes hexokinase deficiency (HK deficiency),Up,0.104008667,0.069339112,1,1.324468907,1.461201005,0.271194632,FALSE,Up,0.046,0.028,1,1.992487893,2.130727696,0.338967635,FALSE
Cell surface interactions at the vascular wall,Up,0.083423619,0.070422535,7,2.336501731,2.330152961,0.400977178,FALSE,Up,0.369,0.294,3,0.255864196,0.243269991,0.400879866,FALSE
Binding and Uptake of Ligands by Scavenger Receptors,Down,0.067172264,0.071505959,11,2.925236887,3.045714626,-0.135820871,FALSE,Up,0.054,0.032,8,2.06487269,2.137945383,0.236993894,FALSE
Regulation of HSF1-mediated heat shock response,Up,0.094257855,0.072589382,8,1.698168236,1.922689048,0.233364032,FALSE,Up,0.02,0.011,7,2.132117286,2.234238947,0.490947696,FALSE
Cytokine Signaling in Immune system,Up,0.044420368,0.076923077,49,1.079812569,0.889328636,0.156336884,FALSE,Down,0.487,0.612,49,-0.441825234,-1.347554993,-0.051300435,FALSE
Interferon Signaling,Up,0.048754063,0.076923077,13,1.137932094,1.126811218,0.159893114,FALSE,Down,0.639,0.741,8,-1.110780326,-1.26614709,-0.207732915,FALSE
Scavenging by Class A Receptors,Up,0.088840737,0.080173348,7,2.425734702,2.486495618,0.19603285,FALSE,Up,0.135,0.088,4,1.209365937,1.216163942,0.371536976,FALSE
RAC1 GTPase cycle,Up,0.109425785,0.081256771,3,1.21907983,1.188076054,0.18462092,FALSE,Up,0.524,0.436,5,-0.124018544,-0.076903445,0.131215421,FALSE
Metabolism of fat-soluble vitamins,Down,0.158179848,0.082340195,3,0.774312284,0.780998426,-0.184155364,FALSE,Up,0.041,0.03,3,2.308364785,2.275122853,0.841468307,FALSE
Retinoid metabolism and transport,Down,0.158179848,0.082340195,3,0.774312284,0.780998426,-0.184155364,FALSE,Up,0.041,0.03,3,2.308364785,2.275122853,0.841468307,FALSE
CHL1 interactions,Up,0.105092091,0.083423619,2,1.490308714,1.382363924,0.272593304,FALSE,Up,0.16,0.122,2,0.801834196,0.739205033,0.260484991,FALSE
GPVI-mediated activation cascade,Up,0.091007584,0.084507042,2,2.713755367,2.694290501,0.849982394,FALSE,,,,,,,,
RUNX2 regulates osteoblast differentiation,Up,0.108342362,0.088840737,1,1.856168912,1.855448259,0.855319379,FALSE,,,,,,,,
RUNX2 regulates bone development,Up,0.108342362,0.088840737,1,1.856168912,1.855448259,0.855319379,FALSE,,,,,,,,
Leishmania infection,Down,0.108342362,0.088840737,14,1.104778496,1.127096329,-0.059867139,FALSE,Down,0.705,0.642,13,-0.707512582,-0.840758782,-0.347618371,FALSE
Hemostasis,Up,0.124593716,0.093174431,61,1.608191538,1.829921636,0.028632646,FALSE,Up,0.181,0.143,59,1.088895832,1.315213869,0.12957077,FALSE
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,Up,0.256771398,0.096424702,3,0.483413439,0.446497754,0.151825757,FALSE,Up,0.283,0.229,2,0.594073634,0.631303558,0.751651245,FALSE
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Up,0.121343445,0.097508126,2,0.864204591,0.975767512,0.186638819,FALSE,Up,0.56,0.482,1,-0.482435143,-0.453888364,0.092239793,FALSE
Metabolism of steroids,Down,0.120260022,0.098591549,5,1.623839815,1.713219617,-0.125763993,FALSE,Up,0.563,0.451,6,-0.20668521,-0.112263232,0.130882469,FALSE
Propionyl-CoA catabolism,Down,0.150595883,0.100758397,3,0.59724507,0.750767702,-0.010012314,FALSE,Down,0.369,0.282,2,0.16155628,0.255524991,-0.354480936,FALSE
Sema4D mediated inhibition of cell attachment and migration,Up,0.169014085,0.10184182,1,1.290297092,1.429662277,0.298561963,FALSE,,,,,,,,
Fibronectin matrix formation,Up,0.120260022,0.102925244,2,1.414918413,1.294226785,0.214020446,FALSE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
Neurexins and neuroligins,Up,0.189599133,0.102925244,1,1.254388687,1.40866428,0.348040209,FALSE,Down,0.293,0.198,1,0.50016452,0.608402688,-0.825389725,FALSE
Protein-protein interactions at synapses,Up,0.189599133,0.102925244,1,1.254388687,1.40866428,0.348040209,FALSE,Down,0.293,0.198,1,0.50016452,0.608402688,-0.825389725,FALSE
Neutrophil degranulation,Up,0.154929577,0.102925244,43,1.635927656,1.996661849,0.052603784,FALSE,Down,0.051,0.043,67,1.557220991,1.80606784,-0.040811854,FALSE
Interleukin-4 and Interleukin-13 signaling,Up,0.118093174,0.105092091,10,2.46498072,2.516184689,0.253085507,FALSE,Up,0.273,0.188,7,0.578048736,0.623651026,0.09552602,FALSE
RAC3 GTPase cycle,Up,0.189599133,0.105092091,7,0.890554605,0.971302253,0.170501104,FALSE,Up,0.411,0.324,3,0.211456983,0.21846996,0.046057326,FALSE
Diseases of metabolism,Up,0.100758397,0.107258938,20,1.397656534,1.522094991,0.180935258,FALSE,Down,0.247,0.298,19,0.157581721,0.234126432,-0.052906673,FALSE
Erythrocytes take up oxygen and release carbon dioxide,Down,0.134344529,0.108342362,2,2.119275972,2.261585815,-1.052981459,FALSE,Up,0.037,0.024,1,2.235124911,2.306750304,0.959759232,FALSE
Factors involved in megakaryocyte development and platelet production,Down,0.127843987,0.110509209,16,0.522564661,0.578349659,-0.065412924,FALSE,Down,0.632,0.598,15,-0.575126992,-0.513495902,-0.002018291,FALSE
Basigin interactions,Up,0.313109426,0.111592633,3,0.391365173,0.321670895,0.155883946,FALSE,Up,0.449,0.37,2,-0.012471521,-0.039331095,0.200466724,FALSE
ABC transporters in lipid homeostasis,Down,0.162513543,0.112676056,1,1.45411996,1.430566999,-0.923985129,FALSE,Up,0.028,0.017,1,2.139917235,2.070042799,0.526350913,FALSE
Defective ABCA1 causes TGD,Down,0.162513543,0.112676056,1,1.45411996,1.430566999,-0.923985129,FALSE,Up,0.028,0.017,1,2.139917235,2.070042799,0.526350913,FALSE
HDL assembly,Down,0.162513543,0.112676056,1,1.45411996,1.430566999,-0.923985129,FALSE,Up,0.064,0.046,2,2.276341576,2.293937132,0.557323712,FALSE
Chylomicron remodeling,Down,0.162513543,0.112676056,1,1.45411996,1.430566999,-0.923985129,FALSE,Up,0.04,0.025,2,2.501318049,2.449170277,0.861349385,FALSE
HDL clearance,Down,0.162513543,0.112676056,1,1.45411996,1.430566999,-0.923985129,FALSE,Up,0.028,0.017,1,2.139917235,2.070042799,0.526350913,FALSE
Neurotransmitter clearance,Up,0.115926327,0.11375948,2,2.008552426,2.118428102,0.250588319,FALSE,Down,0.577,0.485,2,-0.395195572,-0.318232003,-0.228341849,FALSE
Metabolism of serotonin,Up,0.115926327,0.11375948,2,2.008552426,2.118428102,0.250588319,FALSE,Down,0.577,0.485,2,-0.395195572,-0.318232003,-0.228341849,FALSE
Serotonin clearance from the synaptic cleft,Up,0.115926327,0.11375948,2,2.008552426,2.118428102,0.250588319,FALSE,Down,0.577,0.485,2,-0.395195572,-0.318232003,-0.228341849,FALSE
Innate Immune System,Up,0.149512459,0.114842904,71,0.627366003,0.654651017,0.047845435,FALSE,Down,0.02,0.017,97,1.706442101,1.360785508,-0.075696171,FALSE
Fcgamma receptor (FCGR) dependent phagocytosis,Up,0.199349946,0.114842904,7,0.321544805,0.318604448,0.022009787,FALSE,Down,0.643,0.574,6,-0.554132224,-0.556343859,-0.418793704,FALSE
Regulation of actin dynamics for phagocytic cup formation,Up,0.199349946,0.114842904,7,0.321544805,0.318604448,0.022009787,FALSE,Down,0.643,0.574,6,-0.554132224,-0.556343859,-0.418793704,FALSE
RHOBTB2 GTPase cycle,Up,0.151679307,0.114842904,6,0.976674903,1.012628109,0.046404809,FALSE,Up,0.713,0.636,7,-0.645531544,-0.544440058,0.279752346,FALSE
Striated Muscle Contraction,Down,0.136511376,0.119176598,21,1.679229039,2.125003003,-0.013414302,FALSE,Up,0.165,0.107,17,1.150065952,1.516854622,0.284770825,FALSE
Biological oxidations,Up,0.135427952,0.120260022,14,2.282767637,2.571294246,0.163593116,FALSE,Up,0.881,0.837,16,-1.323551143,-1.060534518,0.090443937,FALSE
Erythrocytes take up carbon dioxide and release oxygen,Down,0.151679307,0.121343445,3,1.826805555,1.991065016,-0.653718351,FALSE,Up,0.187,0.14,2,0.957821171,1.045672981,0.56475388,FALSE
O2/CO2 exchange in erythrocytes,Down,0.151679307,0.121343445,3,1.826805555,1.991065016,-0.653718351,FALSE,Up,0.187,0.14,2,0.957821171,1.045672981,0.56475388,FALSE
Platelet degranulation ,Up,0.180931744,0.122426869,27,1.217348551,1.440807232,0.033447853,FALSE,Up,0.076,0.048,32,1.71317644,1.928944624,0.132713614,FALSE
Response to elevated platelet cytosolic Ca2+,Up,0.180931744,0.122426869,27,1.217348551,1.440807232,0.033447853,FALSE,Up,0.076,0.048,32,1.71317644,1.928944624,0.132713614,FALSE
Reproduction,Up,0.159263272,0.124593716,4,0.683914706,0.761122936,0.132878518,FALSE,Up,0.06,0.042,3,2.042928503,2.171826369,0.869231959,FALSE
Meiosis,Up,0.159263272,0.124593716,4,0.683914706,0.761122936,0.132878518,FALSE,Up,0.019,0.014,2,3.127855414,3.250153307,1.372985739,FALSE
Recycling of bile acids and salts,Down,0.173347779,0.12567714,1,1.389900108,1.422497101,-1.005513646,FALSE,Up,0.132,0.091,1,1.15824047,1.172273499,0.396148902,FALSE
Bile acid and bile salt metabolism,Down,0.173347779,0.12567714,1,1.389900108,1.422497101,-1.005513646,FALSE,Up,0.297,0.215,3,0.409059087,0.486110349,0.047205864,FALSE
Aspirin ADME,Down,0.173347779,0.12567714,1,1.389900108,1.422497101,-1.005513646,FALSE,Up,0.202,0.151,2,1.033530855,1.099770901,0.606345391,FALSE
Prednisone ADME,Down,0.173347779,0.12567714,1,1.389900108,1.422497101,-1.005513646,FALSE,Up,0.132,0.091,1,1.15824047,1.172273499,0.396148902,FALSE
Ciprofloxacin ADME,Down,0.173347779,0.12567714,1,1.389900108,1.422497101,-1.005513646,FALSE,Up,0.132,0.091,1,1.15824047,1.172273499,0.396148902,FALSE
"Platelet activation, signaling and aggregation",Up,0.202600217,0.126760563,34,1.300611941,1.494850566,0.085268607,FALSE,Up,0.143,0.098,38,1.3169465,1.511376611,0.123319166,FALSE
Regulation of FOXO transcriptional activity by acetylation,Down,0.173347779,0.127843987,1,1.042688506,1.086284374,-0.22715514,FALSE,Down,0.584,0.509,1,-0.42315927,-0.385443291,-0.420142299,FALSE
MET activates PTK2 signaling,Up,0.141928494,0.128927411,10,1.638716541,1.685915444,0.178601339,FALSE,Down,0.226,0.174,2,0.776879686,0.800431034,-0.12771091,FALSE
ECM proteoglycans,Up,0.146262189,0.131094258,27,2.432221067,2.680661128,0.254322821,FALSE,Up,0.054,0.03,6,1.896020287,2.02754619,0.229829136,FALSE
ATF6 (ATF6-alpha) activates chaperones,Up,0.167930661,0.131094258,3,2.000888437,2.137509923,0.236018237,FALSE,Up,0.671,0.596,3,-0.671346444,-0.587036209,0.058270956,FALSE
ATF6 (ATF6-alpha) activates chaperone genes,Up,0.167930661,0.131094258,3,2.000888437,2.137509923,0.236018237,FALSE,Up,0.671,0.596,3,-0.671346444,-0.587036209,0.058270956,FALSE
SLC transporter disorders,Down,0.171180932,0.132177681,2,1.256437131,1.414247988,-0.090740518,FALSE,Up,0.142,0.098,2,1.143564425,1.282685566,0.403023989,FALSE
Glycosaminoglycan metabolism,Up,0.154929577,0.133261105,8,2.735677257,2.931369907,0.416735367,FALSE,Up,0.17,0.124,3,1.070774746,1.154396992,0.309256935,FALSE
Diseases associated with glycosaminoglycan metabolism,Up,0.154929577,0.133261105,8,2.735677257,2.931369907,0.416735367,FALSE,Up,0.17,0.124,3,1.070774746,1.154396992,0.309256935,FALSE
Glycolysis,Up,0.148429036,0.135427952,16,1.778896609,2.081814942,0.198651698,FALSE,Down,0.253,0.191,16,0.222038978,0.511638747,-0.033263277,FALSE
Chylomicron assembly,Down,0.205850488,0.138678223,2,0.872504861,0.87637986,-0.38301589,FALSE,Up,0.062,0.042,3,1.852666862,1.830562658,0.644957211,FALSE
Plasma lipoprotein assembly,Down,0.205850488,0.138678223,2,0.872504861,0.87637986,-0.38301589,FALSE,Up,0.061,0.043,4,2.144114515,2.172350868,0.630792036,FALSE
Visual phototransduction,Down,0.242686891,0.14084507,4,0.34260077,0.339711411,-0.146564418,FALSE,Up,0.044,0.026,5,1.925779571,1.637678128,0.276410654,FALSE
Complex I biogenesis,Down,0.210184182,0.14084507,24,1.379067866,1.833778095,-0.155962892,FALSE,Down,0.763,0.692,15,-0.940104565,-0.647065106,-0.035851327,FALSE
Interactions of Rev with host cellular proteins,Up,0.17659805,0.141928494,2,1.023789692,0.99927917,0.118441692,FALSE,Up,0.564,0.461,2,-0.299549956,-0.269087987,0.255993523,FALSE
Nuclear import of Rev protein,Up,0.17659805,0.141928494,2,1.023789692,0.99927917,0.118441692,FALSE,Up,0.564,0.461,2,-0.299549956,-0.269087987,0.255993523,FALSE
MET promotes cell motility,Up,0.169014085,0.143011918,12,1.201987713,1.255042076,0.167123165,FALSE,Up,0.363,0.306,4,0.446741687,0.479002947,0.173196689,FALSE
Assembly of the ORC complex at the origin of replication,Up,0.146262189,0.146262189,3,0.76081972,0.6857249,0.088190676,FALSE,Up,0.579,0.494,1,-0.443629677,-0.43078284,0.28816333,FALSE
PKA activation in glucagon signalling,Down,0.192849404,0.147345612,4,0.904515415,0.928333737,-0.036477045,FALSE,Down,0.744,0.665,1,-0.886351224,-0.857116896,-0.033241615,FALSE
Diseases of glycosylation,Up,0.165763814,0.150595883,9,2.492888114,2.694616485,0.382132308,FALSE,Down,0.008,0.003,5,2.910301357,3.087333808,-0.145706043,TRUE
Platelet Aggregation (Plug Formation),Up,0.210184182,0.151679307,6,1.074457836,1.077862858,0.362801881,FALSE,Up,0.548,0.49,3,-0.397000801,-0.36249681,0.346816123,FALSE
Synthesis of Ketone Bodies,Down,0.18851571,0.153846154,2,1.260325498,1.438149206,-0.163351954,FALSE,Up,0.385,0.288,3,0.162537413,0.313266721,0.222464731,FALSE
Semaphorin interactions,Up,0.386782232,0.154929577,11,0.141647736,0.179054148,0.125588431,FALSE,Down,0.152,0.097,5,0.864005718,0.881173267,-0.470958918,FALSE
Early SARS-CoV-2 Infection Events,Up,0.189599133,0.154929577,4,0.445106858,0.502701995,0.167647948,FALSE,Up,0.246,0.18,2,0.627039005,0.608861579,0.507998594,FALSE
Virus Assembly and Release,Up,0.20368364,0.156013001,2,0.997080439,1.06100886,0.26191001,FALSE,Down,0.684,0.603,2,-0.707780145,-0.649750094,-0.014289422,FALSE
Assembly of Viral Components at the Budding Site,Up,0.20368364,0.156013001,2,0.997080439,1.06100886,0.26191001,FALSE,Down,0.684,0.603,2,-0.707780145,-0.649750094,-0.014289422,FALSE
PKA-mediated phosphorylation of CREB,Up,0.293607801,0.160346696,2,0.087839832,0.073390754,0.099862561,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
PKA activation,Up,0.293607801,0.160346696,2,0.087839832,0.073390754,0.099862561,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
CREB1 phosphorylation through the activation of Adenylate Cyclase,Up,0.293607801,0.160346696,2,0.087839832,0.073390754,0.099862561,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
FCGR3A-mediated IL10 synthesis,Up,0.293607801,0.160346696,2,0.087839832,0.073390754,0.099862561,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
Attachment and Entry,Up,0.252437703,0.163596966,3,0.072725706,0.077780064,0.156160423,FALSE,Up,0.246,0.18,2,0.627039005,0.608861579,0.507998594,FALSE
RHOBTB GTPase Cycle,Up,0.209100758,0.165763814,7,0.908316855,0.958026733,0.084204904,FALSE,Up,0.44,0.347,9,0.136155722,0.259906733,0.278068634,FALSE
Glucose metabolism,Up,0.237269772,0.170097508,22,1.21945205,1.558166045,0.178394467,FALSE,Down,0.1,0.062,22,0.744432732,1.113018703,-0.06061439,FALSE
Phase II - Conjugation of compounds,Up,0.20368364,0.171180932,5,1.474040313,1.705827501,0.155841196,FALSE,Up,0.626,0.533,6,-0.50339729,-0.318220042,0.062175207,FALSE
Alternative complement activation,Down,0.225352113,0.173347779,1,1.053736887,1.105726502,-0.409836801,FALSE,Up,0.379,0.305,2,0.142745776,0.216978534,0.333002011,FALSE
G alpha (s) signalling events,Up,0.196099675,0.174431203,8,0.883223848,0.831272003,0.026818694,FALSE,Down,0.687,0.645,5,-0.842488688,-0.870822048,-0.063950491,FALSE
GPER1 signaling,Up,0.196099675,0.174431203,8,0.883223848,0.831272003,0.026818694,FALSE,Down,0.687,0.645,5,-0.842488688,-0.870822048,-0.063950491,FALSE
Interleukin-35 Signalling,Up,0.247020585,0.175514626,1,0.74361715,0.78415526,0.242310311,FALSE,Up,0.711,0.654,1,-0.805549087,-0.765355989,0.168805021,FALSE
Interleukin-27 signaling,Up,0.247020585,0.175514626,1,0.74361715,0.78415526,0.242310311,FALSE,Up,0.711,0.654,1,-0.805549087,-0.765355989,0.168805021,FALSE
Initial triggering of complement,Down,0.214517876,0.179848321,2,0.980433632,1.076527569,-0.268596177,FALSE,Down,0.073,0.043,4,1.775762147,1.956358572,-0.623964076,FALSE
Activation of C3 and C5,Down,0.214517876,0.179848321,2,0.980433632,1.076527569,-0.268596177,FALSE,Down,0.167,0.117,3,1.177312597,1.308875161,-0.42658142,FALSE
Neuronal System,Up,0.211267606,0.180931744,17,0.350101269,0.399679263,0.118388972,FALSE,Down,0.602,0.559,18,-0.567532412,-0.663595214,-0.147028149,FALSE
Intra-Golgi traffic,Down,0.242686891,0.182015168,1,0.506513899,0.580711016,-0.120541224,FALSE,Down,0.579,0.485,2,-0.35548725,-0.311620796,-0.330593579,FALSE
Retrograde transport at the Trans-Golgi-Network,Down,0.242686891,0.182015168,1,0.506513899,0.580711016,-0.120541224,FALSE,Up,0.626,0.578,1,-0.718717314,-0.668559139,0.180328265,FALSE
Uptake and actions of bacterial toxins,Down,0.279523294,0.184182015,3,0.645657174,0.636619154,-0.007557698,FALSE,Down,0.16,0.106,5,0.907576047,0.77426514,-0.360665308,FALSE
HSF1 activation,Up,0.230769231,0.185265439,4,0.752470178,0.697347379,0.141153913,FALSE,Up,0.172,0.109,3,0.679707446,0.571019468,0.125283338,FALSE
Beta oxidation of butanoyl-CoA to acetyl-CoA,Up,0.206933911,0.185265439,3,1.879739388,2.087056329,0.346230911,FALSE,Up,0.826,0.788,3,-1.268653005,-1.174129107,0.015516881,FALSE
Respiratory electron transport,Down,0.277356446,0.186348862,39,0.850782189,1.363027295,-0.09433793,FALSE,Down,0.925,0.898,25,-1.792046688,-1.453333473,-0.055741902,FALSE
"GABA synthesis, release, reuptake and degradation",Up,0.405200433,0.186348862,2,0.19242228,0.259575308,0.240217056,FALSE,Up,0.187,0.111,3,0.863844465,0.955347799,0.415810035,FALSE
RHOF GTPase cycle,Up,0.25135428,0.186348862,5,0.378898966,0.458351801,0.120581659,FALSE,Down,0.326,0.259,3,0.358655174,0.357961093,-0.043777171,FALSE
Mitochondrial iron-sulfur cluster biogenesis,Up,0.228602384,0.187432286,1,0.764249097,0.870684968,0.202110522,FALSE,Down,0.82,0.756,1,-1.086672671,-1.040229827,-0.048918093,FALSE
Maturation of replicase proteins,Up,0.228602384,0.187432286,1,0.764249097,0.870684968,0.202110522,FALSE,,,,,,,,
Maturation of spike protein,Up,0.358613218,0.187432286,4,0.132401864,0.233750298,0.132943429,FALSE,Up,0.952,0.95,4,-1.955877538,-1.867378639,0.073332331,FALSE
Translation of Replicase and Assembly of the Replication Transcription Complex,Up,0.228602384,0.187432286,1,0.764249097,0.870684968,0.202110522,FALSE,,,,,,,,
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",Up,0.248104009,0.189599133,4,1.274297855,1.400985591,0.207655285,FALSE,Up,0.826,0.76,4,-0.930563886,-0.83418514,0.170640585,FALSE
Keratan sulfate/keratin metabolism,Up,0.231852654,0.192849404,3,1.625162713,1.793304751,0.440465253,FALSE,Up,0.138,0.094,1,1.112706129,1.191667081,0.699245021,FALSE
Keratan sulfate biosynthesis,Up,0.231852654,0.192849404,3,1.625162713,1.793304751,0.440465253,FALSE,Up,0.138,0.094,1,1.112706129,1.191667081,0.699245021,FALSE
Keratan sulfate degradation,Up,0.231852654,0.192849404,3,1.625162713,1.793304751,0.440465253,FALSE,Up,0.138,0.094,1,1.112706129,1.191667081,0.699245021,FALSE
Defective CHST6 causes MCDC1,Up,0.231852654,0.192849404,3,1.625162713,1.793304751,0.440465253,FALSE,Up,0.138,0.094,1,1.112706129,1.191667081,0.699245021,FALSE
Defective ST3GAL3 causes MCT12 and EIEE15,Up,0.231852654,0.192849404,3,1.625162713,1.793304751,0.440465253,FALSE,Up,0.138,0.094,1,1.112706129,1.191667081,0.699245021,FALSE
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),Up,0.231852654,0.192849404,3,1.625162713,1.793304751,0.440465253,FALSE,Up,0.138,0.094,1,1.112706129,1.191667081,0.699245021,FALSE
Ketone body metabolism,Down,0.275189599,0.197183099,3,0.993680431,1.18347292,-0.018499755,FALSE,Up,0.36,0.28,4,0.214409349,0.391073682,0.209010538,FALSE
Utilization of Ketone Bodies,Down,0.275189599,0.197183099,3,0.993680431,1.18347292,-0.018499755,FALSE,Down,0.472,0.39,3,-0.188637252,-0.050893932,-0.010008773,FALSE
Advanced glycosylation endproduct receptor signaling,Down,0.296858072,0.197183099,4,-0.326255005,-0.25554927,-0.094613733,FALSE,Up,0.75,0.685,1,-0.968970443,-0.922747996,0.10808598,FALSE
Attachment and Entry,Up,0.258938245,0.200433369,1,0.238936362,0.212557066,0.096962233,FALSE,Up,0.251,0.189,1,0.425959882,0.384081751,0.214291037,FALSE
Cytoprotection by HMOX1,Down,0.268689057,0.201516793,10,0.634471116,0.808179025,-0.280080442,FALSE,Up,0.108,0.068,6,1.391486094,1.523207551,0.080845811,FALSE
HS-GAG biosynthesis,Up,0.469122427,0.202600217,2,-0.079883086,-0.055039809,0.185759518,FALSE,Up,0.299,0.242,1,0.460807182,0.476978552,0.801706151,FALSE
HS-GAG degradation,Up,0.469122427,0.202600217,2,-0.079883086,-0.055039809,0.185759518,FALSE,Up,0.299,0.242,1,0.460807182,0.476978552,0.801706151,FALSE
Defective EXT2 causes exostoses 2,Up,0.469122427,0.202600217,2,-0.079883086,-0.055039809,0.185759518,FALSE,Up,0.299,0.242,1,0.460807182,0.476978552,0.801706151,FALSE
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",Up,0.469122427,0.202600217,2,-0.079883086,-0.055039809,0.185759518,FALSE,Up,0.299,0.242,1,0.460807182,0.476978552,0.801706151,FALSE
Potential therapeutics for SARS,Up,0.282773564,0.202600217,6,0.60090072,0.557824728,0.108932738,FALSE,Down,0.713,0.632,6,-0.76054654,-0.677695499,-0.010460306,FALSE
TNFR1-mediated ceramide production,Down,0.270855905,0.20368364,1,-0.474326717,-0.422059516,-0.035431206,FALSE,Down,0.35,0.28,1,0.197930904,0.287220167,-0.56349472,FALSE
Glutamate Neurotransmitter Release Cycle,Up,0.304442037,0.206933911,1,0.481525863,0.588839516,0.192622924,FALSE,,,,,,,,
PERK regulates gene expression,Up,0.265438787,0.206933911,1,0.719798299,0.797755196,0.177406209,FALSE,Up,0.53,0.39,1,-0.044140117,0.014545399,0.411363735,FALSE
RHO GTPase cycle,Up,0.347778982,0.206933911,38,0.106919074,0.339365489,0.059033336,FALSE,Up,0.583,0.469,35,-0.16610658,0.034912598,0.130969344,FALSE
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",Down,0.268689057,0.210184182,48,1.082197121,1.65613542,-0.115526767,FALSE,Down,0.938,0.929,34,-2.121920828,-1.727492351,-0.069119772,FALSE
Azathioprine ADME,Up,0.241603467,0.211267606,1,0.729022892,0.833827631,0.270633359,FALSE,Up,0.383,0.307,1,0.182760865,0.25942692,0.528371039,FALSE
Ribavirin ADME,Up,0.241603467,0.211267606,1,0.729022892,0.833827631,0.270633359,FALSE,,,,,,,,
Pre-NOTCH Expression and Processing,Down,0.214517876,0.212351029,3,0.716192361,0.755682218,-0.139070312,FALSE,Down,0.256,0.18,1,0.524817367,0.600724353,-0.204556708,FALSE
RHOG GTPase cycle,Up,0.288190683,0.212351029,11,0.649368854,0.800405497,0.13540846,FALSE,Up,0.62,0.524,6,-0.323271206,-0.243838041,0.084556199,FALSE
Heme biosynthesis,Down,0.30552546,0.214517876,2,0.745479056,0.813322777,-0.575568496,FALSE,Down,0.174,0.12,2,0.91206624,0.983555359,-0.075581411,FALSE
Manipulation of host energy metabolism,Up,0.314192849,0.214517876,2,0.341193899,0.454100258,0.218265309,FALSE,Down,0.873,0.836,2,-1.334498131,-1.264782186,-0.019660014,FALSE
Gluconeogenesis,Up,0.310942579,0.2156013,16,0.872375645,1.209198527,0.218576575,FALSE,Down,0.14,0.085,17,0.656382133,1.004886597,-0.087691917,FALSE
Heme degradation,Down,0.286023835,0.218851571,2,0.91898428,0.991811838,-0.445896848,FALSE,Up,0.344,0.247,2,0.361821234,0.414202603,0.053838254,FALSE
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Up,0.406283857,0.218851571,3,0.327135584,0.430872045,0.220029146,FALSE,Up,0.322,0.248,1,0.25269984,0.307598415,1.066221889,FALSE
Drug ADME,Down,0.283856988,0.218851571,3,0.895076001,1.001251726,-0.26063072,FALSE,Up,0.212,0.15,3,0.949391444,1.047739383,0.580353941,FALSE
Methylation,Up,0.273022752,0.221018418,1,0.813556216,0.904986141,0.230970546,FALSE,Down,0.806,0.76,2,-1.114736635,-1.043139184,-0.202066968,FALSE
Vitamin C (ascorbate) metabolism,Up,0.273022752,0.221018418,1,0.813556216,0.904986141,0.230970546,FALSE,Down,0.61,0.519,1,-0.441633016,-0.384409242,-0.382265386,FALSE
RND1 GTPase cycle,Up,0.409534128,0.221018418,5,0.099915304,0.241573978,0.094688893,FALSE,Up,0.068,0.031,3,1.708157424,1.861677504,0.314814505,FALSE
Metabolism of nucleotides,Up,0.265438787,0.222101842,6,0.719014604,0.913506449,0.090991787,FALSE,Down,0.747,0.676,7,-0.844741359,-0.664245775,-0.125641112,FALSE
Interconversion of nucleotide di- and triphosphates,Up,0.265438787,0.222101842,6,0.719014604,0.913506449,0.090991787,FALSE,Down,0.697,0.612,5,-0.753409949,-0.599394666,-0.250690392,FALSE
Methionine salvage pathway,Up,0.390032503,0.223185265,1,0.14193583,0.221747926,0.176860307,FALSE,Down,0.022,0.012,1,2.154793436,2.297901311,-0.274649375,FALSE
COPI-independent Golgi-to-ER retrograde traffic,Up,0.25135428,0.223185265,8,0.065923653,0.016721824,0.035482754,FALSE,Down,0.842,0.841,8,-1.37068589,-1.449852925,-0.198116458,FALSE
Muscle contraction,Up,0.275189599,0.225352113,46,0.922903673,1.435572611,0.002638697,FALSE,Up,0.327,0.21,37,0.569316929,0.920326194,0.061237747,FALSE
Initiation of Nuclear Envelope (NE) Reformation,Up,0.228602384,0.226435536,4,0.029967063,-0.107022172,0.103545244,FALSE,Up,0.668,0.617,4,-0.698302772,-0.706127515,0.243336352,FALSE
NCAM1 interactions,Up,0.27843987,0.226435536,7,0.693385032,0.845675288,0.204124703,FALSE,Up,0.026,0.013,1,2.839173748,2.937979771,1.813960686,FALSE
MAP2K and MAPK activation,Up,0.358613218,0.226435536,9,0.186550336,0.204951753,0.041804654,FALSE,Up,0.402,0.327,9,0.215348931,0.198443614,0.13449787,FALSE
Signaling by high-kinase activity BRAF mutants,Up,0.358613218,0.226435536,9,0.186550336,0.204951753,0.041804654,FALSE,Up,0.402,0.327,9,0.215348931,0.198443614,0.13449787,FALSE
Bicarbonate transporters,Down,0.361863489,0.22751896,1,0.452401524,0.53884768,-0.452675668,FALSE,,,,,,,,
"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",Down,0.361863489,0.22751896,1,0.452401524,0.53884768,-0.452675668,FALSE,,,,,,,,
Glucagon signaling in metabolic regulation,Down,0.26652221,0.229685807,6,0.202955525,0.212648047,-0.03558189,FALSE,Down,0.673,0.618,3,-0.995541313,-1.01679443,-0.210849073,FALSE
Vasopressin regulates renal water homeostasis via Aquaporins,Down,0.26652221,0.229685807,6,0.202955525,0.212648047,-0.03558189,FALSE,Down,0.673,0.618,3,-0.995541313,-1.01679443,-0.210849073,FALSE
Aquaporin-mediated transport,Down,0.26652221,0.229685807,6,0.202955525,0.212648047,-0.03558189,FALSE,Down,0.673,0.618,3,-0.995541313,-1.01679443,-0.210849073,FALSE
ADORA2B mediated anti-inflammatory cytokines production,Down,0.26652221,0.229685807,6,0.202955525,0.212648047,-0.03558189,FALSE,Down,0.73,0.681,4,-1.060368635,-1.063812199,-0.25424328,FALSE
Non-integrin membrane-ECM interactions,Up,0.263271939,0.230769231,18,0.991627608,1.106805116,0.159643909,FALSE,Up,0.188,0.146,4,0.98777657,1.086825375,0.272130323,FALSE
Fructose metabolism,Up,0.30227519,0.230769231,1,0.466781517,0.562229722,0.154642062,FALSE,Up,0.716,0.635,1,-0.791156815,-0.736407578,0.131690173,FALSE
Fructose biosynthesis,Up,0.30227519,0.230769231,1,0.466781517,0.562229722,0.154642062,FALSE,Up,0.716,0.635,1,-0.791156815,-0.736407578,0.131690173,FALSE
Parasite infection,Down,0.372697725,0.236186349,5,-0.211576968,-0.180043554,-0.0436365,FALSE,Down,0.584,0.506,5,-0.351752756,-0.357565518,-0.484345985,FALSE
Leishmania phagocytosis,Down,0.372697725,0.236186349,5,-0.211576968,-0.180043554,-0.0436365,FALSE,Down,0.584,0.506,5,-0.351752756,-0.357565518,-0.484345985,FALSE
FCGR3A-mediated phagocytosis,Down,0.372697725,0.236186349,5,-0.211576968,-0.180043554,-0.0436365,FALSE,Down,0.584,0.506,5,-0.351752756,-0.357565518,-0.484345985,FALSE
Extracellular matrix organization,Up,0.274106176,0.23943662,43,1.753251378,2.111545152,0.198116829,FALSE,Up,0.044,0.018,14,2.116766813,2.371066945,0.354348067,FALSE
Biotin transport and metabolism,Down,0.366197183,0.240520043,4,-0.066665634,0.06156572,-0.165466421,FALSE,Down,0.463,0.375,2,-0.075593523,0.020693563,-0.179248018,FALSE
Defects in vitamin and cofactor metabolism,Down,0.366197183,0.240520043,4,-0.066665634,0.06156572,-0.165466421,FALSE,Down,0.493,0.388,3,-0.131072623,-0.019182837,-0.282302164,FALSE
Defects in biotin (Btn) metabolism,Down,0.366197183,0.240520043,4,-0.066665634,0.06156572,-0.165466421,FALSE,Down,0.463,0.375,2,-0.075593523,0.020693563,-0.179248018,FALSE
Defective HLCS causes multiple carboxylase deficiency,Down,0.366197183,0.240520043,4,-0.066665634,0.06156572,-0.165466421,FALSE,Down,0.463,0.375,2,-0.075593523,0.020693563,-0.179248018,FALSE
Intra-Golgi and retrograde Golgi-to-ER traffic,Up,0.277356446,0.240520043,10,-0.033150838,-0.044591444,0.014364557,FALSE,Down,0.796,0.762,17,-1.01238528,-0.940913512,-0.10412289,FALSE
Golgi-to-ER retrograde transport,Up,0.277356446,0.240520043,10,-0.033150838,-0.044591444,0.014364557,FALSE,Down,0.796,0.762,17,-1.01238528,-0.940913512,-0.10412289,FALSE
Formation of ATP by chemiosmotic coupling,Down,0.30552546,0.242686891,9,0.72818284,0.987313345,-0.20734506,FALSE,Down,0.696,0.638,9,-1.137528276,-0.935419143,-0.106280522,FALSE
Reduction of cytosolic Ca++ levels,Down,0.372697725,0.242686891,4,0.433990815,0.57890992,-0.121153025,FALSE,Down,0.168,0.123,3,0.989333365,0.762417242,-0.592815377,FALSE
Platelet calcium homeostasis,Down,0.372697725,0.242686891,4,0.433990815,0.57890992,-0.121153025,FALSE,Down,0.168,0.123,3,0.989333365,0.762417242,-0.592815377,FALSE
Anti-inflammatory response favouring Leishmania parasite infection,Down,0.327193933,0.242686891,7,-0.123052137,-0.10676836,-0.025135787,FALSE,Down,0.495,0.411,6,-0.147329008,-0.379893284,-0.513779276,FALSE
Leishmania parasite growth and survival,Down,0.327193933,0.242686891,7,-0.123052137,-0.10676836,-0.025135787,FALSE,Down,0.495,0.411,6,-0.147329008,-0.379893284,-0.513779276,FALSE
Glutamate and glutamine metabolism,Up,0.328277356,0.243770314,2,0.667836701,0.802361553,0.247484143,FALSE,Up,0.33,0.246,2,0.091993793,0.210526584,0.105597724,FALSE
PPARA activates gene expression,Down,0.333694475,0.244853738,7,0.760516191,0.919970813,-0.151311462,FALSE,Down,0.092,0.057,6,1.378544651,1.489552337,-0.088751785,FALSE
Scavenging by Class F Receptors,Up,0.299024919,0.244853738,1,0.666467529,0.71633786,0.281509709,FALSE,Down,0.453,0.369,1,-0.195403193,-0.153529406,-0.197383865,FALSE
Regulation of lipid metabolism by PPARalpha,Down,0.333694475,0.244853738,7,0.760516191,0.919970813,-0.151311462,FALSE,Down,0.092,0.057,6,1.378544651,1.489552337,-0.088751785,FALSE
RHOD GTPase cycle,Up,0.344528711,0.244853738,8,0.383072943,0.552678117,0.19195658,FALSE,Up,0.251,0.191,2,0.678563081,0.723422962,0.127933774,FALSE
Myogenesis,Up,0.287107259,0.245937161,3,0.552923055,0.679365084,0.168715373,FALSE,Down,0.437,0.361,2,-0.285859421,-0.225461274,-0.054910669,FALSE
Signaling by MET,Up,0.193932828,0.245937161,16,0.291170788,0.215021706,0.153323591,FALSE,Down,0.504,0.639,8,-0.749098671,-0.964281777,-0.02449903,FALSE
Sensory Perception,Down,0.296858072,0.247020585,19,-0.453403723,-0.397668396,-0.031951037,FALSE,Up,0.038,0.016,16,2.198981672,1.746358948,0.001178941,FALSE
Mitochondrial translation,Down,0.301191766,0.249187432,1,0.675084363,0.774212745,-0.237857659,FALSE,Down,0.483,0.361,2,-0.128905842,-0.026753963,-0.149187883,FALSE
Mitochondrial translation elongation,Down,0.301191766,0.249187432,1,0.675084363,0.774212745,-0.237857659,FALSE,Down,0.483,0.361,2,-0.128905842,-0.026753963,-0.149187883,FALSE
Protein repair,Down,0.429035753,0.249187432,2,0.087368446,0.1395687,-0.147590912,FALSE,Down,0.817,0.75,2,-1.054096215,-0.993650449,-0.240209081,FALSE
SARS-CoV-2 modulates autophagy,Down,0.301191766,0.249187432,1,0.675084363,0.774212745,-0.237857659,FALSE,Down,0.146,0.098,1,0.903822252,1.002010621,-0.245473247,FALSE
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Up,0.30227519,0.25135428,2,0.623010948,0.750658564,0.264190654,FALSE,Up,0.114,0.077,2,1.259249498,1.322090138,0.52196666,FALSE
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Up,0.30227519,0.25135428,2,0.623010948,0.750658564,0.264190654,FALSE,Down,0.241,0.175,1,0.383367045,0.47611078,-0.152414536,FALSE
Protein methylation,Up,0.327193933,0.25135428,6,0.281356352,0.389761149,0.155772989,FALSE,Down,0.059,0.034,5,1.496862001,1.292697619,-0.258613668,FALSE
Degradation of GABA,Up,0.366197183,0.255687974,1,0.285068041,0.379080244,0.180622162,FALSE,Up,0.344,0.259,2,0.423651008,0.558419368,0.711840394,FALSE
Transmission across Chemical Synapses,Up,0.297941495,0.256771398,16,0.047278956,0.059813885,0.104035769,FALSE,Down,0.649,0.595,17,-0.705293748,-0.830393168,-0.107124527,FALSE
Estrogen-dependent gene expression,Up,0.352112676,0.258938245,4,0.231824861,0.159649156,0.039023636,FALSE,Down,0.42,0.339,2,-0.161323355,-0.112635497,-0.141816391,FALSE
The citric acid (TCA) cycle and respiratory electron transport,Down,0.355362947,0.260021668,73,0.637243523,1.314128844,-0.035068468,FALSE,Down,0.986,0.976,60,-2.842938739,-2.314189948,-0.06019809,FALSE
Complement cascade,Down,0.387865655,0.260021668,3,0.290492962,0.386172842,-0.154456355,FALSE,Down,0.049,0.026,6,2.295377911,2.526627231,-0.078650204,FALSE
Regulation of Complement cascade,Down,0.387865655,0.260021668,3,0.290492962,0.386172842,-0.154456355,FALSE,Up,0.09,0.062,5,1.838112987,2.031811496,0.148842164,FALSE
Lysine catabolism,Up,0.427952329,0.263271939,6,0.057402088,0.247853813,0.176957506,FALSE,Up,0.59,0.483,5,-0.616205096,-0.458111207,0.022417231,FALSE
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Down,0.309859155,0.264355363,7,-0.004534473,0.009903654,-0.014822721,FALSE,Up,0.781,0.74,5,-1.128992939,-1.1270605,0.024395808,FALSE
Cross-presentation of soluble exogenous antigens (endosomes),Up,0.057421452,0.267605634,4,0.112437982,-0.890216948,0.234999019,FALSE,Up,0.273,0.395,14,0.057840462,-1.732942966,0.053516961,FALSE
Regulation of ornithine decarboxylase (ODC),Up,0.057421452,0.267605634,4,0.112437982,-0.890216948,0.234999019,FALSE,Up,0.273,0.395,14,0.057840462,-1.732942966,0.053516961,FALSE
Metabolism of polyamines,Up,0.057421452,0.267605634,4,0.112437982,-0.890216948,0.234999019,FALSE,Up,0.273,0.395,14,0.057840462,-1.732942966,0.053516961,FALSE
Chaperone Mediated Autophagy,Down,0.193932828,0.271939328,10,0.391831128,0.287848253,-0.000406004,FALSE,Up,0.147,0.26,10,0.32454411,0.181330277,0.013623745,FALSE
NRAGE signals death through JNK,Up,0.31744312,0.274106176,1,-0.111985195,-0.053095402,0.074989583,FALSE,,,,,,,,
Class B/2 (Secretin family receptors),Down,0.307692308,0.275189599,4,0.186456598,0.208544505,-0.103304115,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Prostacyclin signalling through prostacyclin receptor,Down,0.307692308,0.275189599,4,0.186456598,0.208544505,-0.103304115,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
G alpha (z) signalling events,Down,0.307692308,0.275189599,4,0.186456598,0.208544505,-0.103304115,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
Glucagon-type ligand receptors,Down,0.307692308,0.275189599,4,0.186456598,0.208544505,-0.103304115,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Metabolism of porphyrins,Down,0.374864572,0.277356446,3,0.556569422,0.652607158,-0.345805681,FALSE,Down,0.336,0.234,3,0.37141432,0.464452177,-0.146545072,FALSE
HCMV Early Events,Up,0.321776815,0.280606717,6,0.00526293,-0.179679624,0.077358047,FALSE,Down,0.74,0.722,7,-1.012997326,-1.140217338,-0.04888078,FALSE
CDC42 GTPase cycle,Up,0.387865655,0.286023835,3,-0.005753803,0.0745207,0.073812556,FALSE,Down,0.645,0.551,4,-0.53667592,-0.46447397,-0.072698812,FALSE
RAC2 GTPase cycle,Up,0.383531961,0.286023835,9,0.226890419,0.319311014,0.13757899,FALSE,Up,0.427,0.338,3,0.142159196,0.132326639,0.055762765,FALSE
Integrin cell surface interactions,Up,0.360780065,0.287107259,15,0.427818749,0.481915902,0.250309133,FALSE,Up,0.075,0.047,4,1.750680398,1.842025831,0.726199416,FALSE
Disorders of transmembrane transporters,Up,0.037919827,0.287107259,12,0.200825023,-0.469030007,0.031599301,FALSE,Up,0.07,0.293,22,0.295770423,-1.258176227,0.06396129,FALSE
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",Up,0.393282774,0.287107259,1,0.177808246,0.224596924,0.305663608,FALSE,Down,0.79,0.715,1,-1.020169545,-0.974129916,-0.071509039,FALSE
Metabolism of water-soluble vitamins and cofactors,Down,0.41603467,0.29035753,6,-0.062057049,0.094073299,-0.065413186,FALSE,Down,0.407,0.307,10,0.22944022,0.472994691,-0.466479859,FALSE
RHOJ GTPase cycle,Up,0.39219935,0.29035753,4,-0.023887742,0.083065652,0.027297512,FALSE,Down,0.559,0.454,3,-0.312063813,-0.236922796,-0.452706604,FALSE
Collagen chain trimerization,Up,0.332611051,0.293607801,8,0.798600827,0.894798652,0.242263268,FALSE,Up,0.002,0.001,2,3.70954459,3.890418605,1.886478165,TRUE
Scavenging by Class B Receptors,Down,0.381365114,0.294691224,2,0.643355372,0.637272896,-0.514672459,FALSE,Up,0.106,0.067,2,1.327212892,1.288419854,0.109211107,FALSE
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Down,0.340195016,0.294691224,19,1.065765148,1.270952234,-0.055985786,FALSE,Up,0.043,0.026,16,2.642420555,2.903527729,0.284944584,FALSE
Post-translational protein phosphorylation,Down,0.340195016,0.294691224,19,1.065765148,1.270952234,-0.055985786,FALSE,Up,0.043,0.026,16,2.642420555,2.903527729,0.284944584,FALSE
Platelet homeostasis,Down,0.333694475,0.296858072,10,0.009801197,0.039988306,-0.071516187,FALSE,Down,0.367,0.321,6,0.041747262,-0.181434014,-0.383875046,FALSE
Sensory processing of sound by inner hair cells of the cochlea,Down,0.396533044,0.296858072,13,-0.507371059,-0.376311011,-0.008854326,FALSE,Down,0.158,0.1,9,1.215429471,1.233307072,-0.200153296,FALSE
Signaling by ALK in cancer,Up,0.362946912,0.297941495,11,0.123565185,0.226799398,0.065236492,FALSE,Down,0.63,0.54,11,-0.533571419,-0.414831222,-0.101138204,FALSE
Signaling by ALK fusions and activated point mutants,Up,0.362946912,0.297941495,11,0.123565185,0.226799398,0.065236492,FALSE,Down,0.63,0.54,11,-0.533571419,-0.414831222,-0.101138204,FALSE
Loss of Nlp from mitotic centrosomes,Up,0.362946912,0.300108342,7,0.02600595,-0.164078032,0.123950387,FALSE,Down,0.756,0.723,8,-0.998248702,-1.103250161,-0.083302042,FALSE
Recruitment of mitotic centrosome proteins and complexes,Up,0.362946912,0.300108342,7,0.02600595,-0.164078032,0.123950387,FALSE,Down,0.756,0.723,8,-0.998248702,-1.103250161,-0.083302042,FALSE
Loss of proteins required for interphase microtubule organization from the centrosome,Up,0.362946912,0.300108342,7,0.02600595,-0.164078032,0.123950387,FALSE,Down,0.756,0.723,8,-0.998248702,-1.103250161,-0.083302042,FALSE
Centrosome maturation,Up,0.362946912,0.300108342,7,0.02600595,-0.164078032,0.123950387,FALSE,Down,0.756,0.723,8,-0.998248702,-1.103250161,-0.083302042,FALSE
Anchoring of the basal body to the plasma membrane,Up,0.362946912,0.300108342,7,0.02600595,-0.164078032,0.123950387,FALSE,Down,0.756,0.723,8,-0.998248702,-1.103250161,-0.083302042,FALSE
AURKA Activation by TPX2,Up,0.362946912,0.300108342,7,0.02600595,-0.164078032,0.123950387,FALSE,Down,0.756,0.723,8,-0.998248702,-1.103250161,-0.083302042,FALSE
RHOV GTPase cycle,Down,0.393282774,0.300108342,5,-0.419786325,-0.31543574,-0.044764443,FALSE,Up,0.248,0.154,6,0.685155431,0.708969847,0.2510243,FALSE
tRNA processing in the mitochondrion,Down,0.377031419,0.301191766,1,0.245988112,0.328426157,-0.183783416,FALSE,Up,0.776,0.716,1,-0.953604478,-0.904148933,0.019692568,FALSE
tRNA modification in the mitochondrion,Down,0.377031419,0.301191766,1,0.245988112,0.328426157,-0.183783416,FALSE,Up,0.776,0.716,1,-0.953604478,-0.904148933,0.019692568,FALSE
rRNA processing in the mitochondrion,Down,0.377031419,0.301191766,1,0.245988112,0.328426157,-0.183783416,FALSE,Up,0.776,0.716,1,-0.953604478,-0.904148933,0.019692568,FALSE
FOXO-mediated transcription,Up,0.406283857,0.30227519,7,0.185468899,0.198603359,0.118247687,FALSE,Up,0.745,0.668,5,-0.852496549,-0.865146039,0.045823694,FALSE
PKMTs methylate histone lysines,Down,0.450704225,0.303358613,1,-0.047440112,0.023256569,-0.257305026,FALSE,,,,,,,,
Smooth Muscle Contraction,Up,0.408450704,0.30552546,17,0.478247864,0.767179643,0.000916125,FALSE,Down,0.554,0.446,16,-0.402640884,-0.307817063,-0.128612572,FALSE
RHOQ GTPase cycle,Up,0.377031419,0.30552546,4,-0.060975537,0.037989118,0.074106813,FALSE,Down,0.681,0.604,3,-0.650884673,-0.60348826,-0.176092802,FALSE
Collagen biosynthesis and modifying enzymes,Up,0.349945829,0.306608884,10,0.743622787,0.865895778,0.236272673,FALSE,Up,0.058,0.032,4,2.110273946,2.28425163,0.978873184,FALSE
Signaling by RAF1 mutants,Up,0.427952329,0.306608884,10,-0.17191111,-0.185920688,0.061142244,FALSE,Up,0.234,0.185,9,0.849256535,0.636803042,0.039070999,FALSE
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,Down,0.357529794,0.307692308,1,-0.02707968,-0.064237824,-0.088346293,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Vesicle-mediated transport,Up,0.332611051,0.308775731,50,-0.199678789,-0.139877709,0.012524223,FALSE,Down,0.2,0.144,60,0.759421841,0.773090084,-0.042670771,FALSE
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,Up,0.421451788,0.310942579,1,-0.085635823,-0.139988273,0.155594637,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",Up,0.421451788,0.310942579,1,-0.085635823,-0.139988273,0.155594637,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Up,0.23943662,0.310942579,10,-0.10642366,-0.168873605,0.145767148,FALSE,Up,0.895,0.92,10,-1.728246798,-1.871414123,0.026942726,FALSE
Choline catabolism,Up,0.451787649,0.313109426,1,-0.080346194,-0.004153561,0.129985047,FALSE,Down,0.5,0.4,1,-0.216985343,-0.13819814,-0.134267178,FALSE
Proline catabolism,Up,0.356446371,0.313109426,1,0.576976029,0.689576484,0.402611195,FALSE,Up,0.786,0.714,1,-0.954839166,-0.90333685,0.153802726,FALSE
Unfolded Protein Response (UPR),Up,0.374864572,0.314192849,8,0.329980351,0.478402235,0.11977847,FALSE,Up,0.733,0.653,9,-0.812089325,-0.670854699,0.01265856,FALSE
VEGFR2 mediated vascular permeability,Up,0.387865655,0.314192849,4,-0.096919607,0.000422687,0.073886795,FALSE,Down,0.536,0.41,4,-0.407012927,-0.614790346,-0.237716556,FALSE
Keratinization,Down,0.468039003,0.316359697,6,-0.163490987,-0.010372087,-0.076334208,FALSE,Down,0.705,0.632,4,-0.806408792,-0.667914828,-0.178856371,FALSE
Formation of the cornified envelope,Down,0.468039003,0.316359697,6,-0.163490987,-0.010372087,-0.076334208,FALSE,Down,0.705,0.632,4,-0.806408792,-0.667914828,-0.178856371,FALSE
Lipophagy,Up,0.433369447,0.316359697,1,-0.012941843,-0.011985323,0.299811949,FALSE,Down,0.115,0.079,1,0.897089502,0.864986682,-0.176250684,FALSE
Collagen degradation,Up,0.388949079,0.31744312,9,0.53476722,0.636798372,0.199948636,FALSE,Up,0.004,0.003,3,3.226660957,3.409720923,1.193451948,TRUE
Signaling by GPCR,Up,0.373781148,0.318526544,17,-0.041095538,-0.084551904,0.002109709,FALSE,Down,0.434,0.389,12,-0.027306211,-0.135178332,-0.166704691,FALSE
GPCR downstream signalling,Up,0.373781148,0.318526544,17,-0.041095538,-0.084551904,0.002109709,FALSE,Down,0.434,0.389,12,-0.027306211,-0.135178332,-0.166704691,FALSE
Calnexin/calreticulin cycle,Up,0.232936078,0.319609967,8,0.059973835,-0.013036974,0.166274785,FALSE,Up,0.933,0.949,9,-1.963718707,-2.100670942,0.006126247,FALSE
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Up,0.370530878,0.320693391,5,0.790710741,0.980930466,0.19146254,FALSE,Down,0.922,0.903,5,-1.731156831,-1.614162233,-0.012622716,FALSE
EGR2 and SOX10-mediated initiation of Schwann cell myelination,Down,0.446370531,0.320693391,3,-0.368251503,-0.284507724,-0.06737103,FALSE,Down,0.213,0.153,1,0.861798496,0.951573322,-0.952642485,FALSE
Epigenetic regulation of gene expression,Down,0.39219935,0.322860238,4,-0.181054455,-0.206963118,-0.046632374,FALSE,Down,0.567,0.504,2,-0.318940434,-0.329415843,-0.444867719,FALSE
Alpha-oxidation of phytanate,Up,0.39219935,0.322860238,1,0.354051654,0.423169879,0.270178141,FALSE,Up,0.018,0.009,1,2.980457846,3.08879291,1.867570959,FALSE
Positive epigenetic regulation of rRNA expression,Down,0.39219935,0.322860238,4,-0.181054455,-0.206963118,-0.046632374,FALSE,Down,0.567,0.504,2,-0.318940434,-0.329415843,-0.444867719,FALSE
B-WICH complex positively regulates rRNA expression,Down,0.39219935,0.322860238,4,-0.181054455,-0.206963118,-0.046632374,FALSE,Down,0.567,0.504,2,-0.318940434,-0.329415843,-0.444867719,FALSE
Class I peroxisomal membrane protein import,Up,0.39219935,0.322860238,1,0.354051654,0.423169879,0.270178141,FALSE,Up,0.018,0.009,1,2.980457846,3.08879291,1.867570959,FALSE
Sulfur amino acid metabolism,Up,0.464788732,0.323943662,3,0.045950475,0.172156932,0.179844611,FALSE,Down,0.328,0.24,3,0.068085137,0.205226586,-0.108162657,FALSE
Assembly of collagen fibrils and other multimeric structures,Up,0.384615385,0.326110509,9,0.406909087,0.505243189,0.215522718,FALSE,Up,0.002,0.001,2,3.70954459,3.890418605,1.886478165,TRUE
Anchoring fibril formation,Up,0.399783315,0.328277356,6,0.282879867,0.316400041,0.307936067,FALSE,,,,,,,,
Crosslinking of collagen fibrils,Up,0.399783315,0.328277356,6,0.282879867,0.316400041,0.307936067,FALSE,,,,,,,,
Antiviral mechanism by IFN-stimulated genes,Up,0.19176598,0.330444204,10,0.209464788,0.146494816,0.14016747,FALSE,Down,0.639,0.741,8,-1.110780326,-1.26614709,-0.207732915,FALSE
Collagen formation,Up,0.384615385,0.330444204,11,0.396030552,0.519522036,0.21493864,FALSE,Up,0.058,0.032,4,2.110273946,2.28425163,0.978873184,FALSE
NCAM signaling for neurite out-growth,Up,0.430119177,0.330444204,11,-0.417131465,-0.264973674,0.128295372,FALSE,Up,0.004,0.001,3,4.614299818,4.633737905,1.012013613,TRUE
Citric acid cycle (TCA cycle),Up,0.440953413,0.330444204,19,0.100930624,0.444335992,0.088235167,FALSE,Down,0.886,0.847,18,-1.599066512,-1.302599642,-0.046735121,FALSE
Mitochondrial Fatty Acid Beta-Oxidation,Up,0.391115926,0.330444204,15,0.69355706,1.008084503,0.125123584,FALSE,Down,0.442,0.315,16,-0.174993712,0.139711554,-0.152603445,FALSE
Calmodulin induced events,Up,0.487540628,0.333694475,4,-0.344366539,-0.369575688,0.040647502,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
Ca-dependent events,Up,0.487540628,0.333694475,4,-0.344366539,-0.369575688,0.040647502,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
CaM pathway,Up,0.487540628,0.333694475,4,-0.344366539,-0.369575688,0.040647502,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
G-protein mediated events,Up,0.487540628,0.333694475,4,-0.344366539,-0.369575688,0.040647502,FALSE,Down,0.599,0.474,3,-0.32089299,-0.600600333,-0.420122121,FALSE
PLC beta mediated events,Up,0.487540628,0.333694475,4,-0.344366539,-0.369575688,0.040647502,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
DAG and IP3 signaling,Up,0.487540628,0.333694475,4,-0.344366539,-0.369575688,0.040647502,FALSE,Down,0.499,0.374,2,-0.112708457,-0.476438301,-0.437970232,FALSE
Ion transport by P-type ATPases,Down,0.526543879,0.333694475,9,-0.395268192,-0.254689433,-0.00616496,FALSE,Down,0.348,0.251,6,0.479474611,0.404157053,-0.417323152,FALSE
Metabolism,Up,0.459371614,0.335861322,252,0.3379412,1.16251069,0.043192052,FALSE,Down,0.754,0.719,231,-1.027195138,-0.576987602,-0.072398973,FALSE
Cardiac conduction,Down,0.442036836,0.335861322,13,-0.137115992,0.074863438,-0.046600199,FALSE,Down,0.595,0.486,10,-0.338975942,-0.32007855,-0.18365463,FALSE
Ion homeostasis,Down,0.442036836,0.335861322,13,-0.137115992,0.074863438,-0.046600199,FALSE,Down,0.646,0.518,9,-0.458442977,-0.465071558,-0.294787576,FALSE
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Up,0.357529794,0.335861322,5,0.662455701,0.840619749,0.198903198,FALSE,Down,0.842,0.792,5,-1.337551107,-1.210980834,-0.02748057,FALSE
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Up,0.357529794,0.335861322,5,0.662455701,0.840619749,0.198903198,FALSE,Down,0.842,0.792,5,-1.337551107,-1.210980834,-0.02748057,FALSE
Sensory processing of sound,Down,0.439869989,0.335861322,14,-0.595806233,-0.456770093,-0.012306134,FALSE,Down,0.224,0.152,10,0.929866537,0.963583689,-0.201167949,FALSE
Regulation of localization of FOXO transcription factors,Up,0.417118093,0.339111593,4,0.09391752,0.058088849,0.178718608,FALSE,Up,0.484,0.412,3,-0.267262032,-0.331948777,0.240256602,FALSE
Beta-oxidation of very long chain fatty acids,Up,0.481040087,0.342361863,2,-0.032998709,0.071285641,0.042500653,FALSE,Down,0.031,0.019,3,2.552052574,2.728055276,-0.698836667,FALSE
Transport of Mature mRNA derived from an Intron-Containing Transcript,Down,0.476706392,0.344528711,2,0.022090359,0.120629011,-0.165617677,FALSE,Up,0.153,0.115,1,1.178411578,1.25840588,1.100935914,FALSE
Pregnenolone biosynthesis,Up,0.437703142,0.344528711,2,0.232777446,0.350732054,0.003631114,FALSE,Up,0.716,0.635,1,-0.791156815,-0.736407578,0.131690173,FALSE
mRNA 3'-end processing,Down,0.476706392,0.344528711,2,0.022090359,0.120629011,-0.165617677,FALSE,Up,0.153,0.115,1,1.178411578,1.25840588,1.100935914,FALSE
Transport of Mature Transcript to Cytoplasm,Down,0.476706392,0.344528711,2,0.022090359,0.120629011,-0.165617677,FALSE,Up,0.153,0.115,1,1.178411578,1.25840588,1.100935914,FALSE
RNA Polymerase II Transcription Termination,Down,0.476706392,0.344528711,2,0.022090359,0.120629011,-0.165617677,FALSE,Up,0.153,0.115,1,1.178411578,1.25840588,1.100935914,FALSE
Degradation of cysteine and homocysteine,Up,0.486457205,0.347778982,2,-0.044086179,0.054048858,0.181336763,FALSE,Down,0.698,0.62,1,-0.902023868,-0.851626099,-0.027970046,FALSE
Regulation of insulin secretion,Down,0.429035753,0.351029252,8,-0.196672967,-0.177881345,-0.026139854,FALSE,Down,0.804,0.769,7,-1.203389314,-1.18477146,-0.081482223,FALSE
Signaling by TGF-beta Receptor Complex,Up,0.206933911,0.352112676,8,0.061584469,-0.151551667,0.220317996,FALSE,Down,0.664,0.744,6,-1.239185291,-1.512941705,-0.069357173,FALSE
Signaling by TGFB family members,Up,0.206933911,0.352112676,8,0.061584469,-0.151551667,0.220317996,FALSE,Down,0.664,0.744,6,-1.239185291,-1.512941705,-0.069357173,FALSE
GPCR ligand binding,Down,0.442036836,0.3531961,8,-0.056504571,0.0218397,-0.101552765,FALSE,Down,0.35,0.3,7,0.37708587,0.473413787,-0.215973151,FALSE
Cristae formation,Down,0.552546046,0.3531961,16,-0.327797875,-0.04654542,-0.097486637,FALSE,Up,0.583,0.493,14,-0.618315351,-0.334731589,0.04658188,FALSE
RHO GTPases activate PAKs,Up,0.495124594,0.354279523,8,-0.292789914,-0.155883142,0.076286158,FALSE,Down,0.117,0.075,5,1.571021748,1.411251173,-0.612177804,FALSE
"Gamma carboxylation, hypusine formation and arylsulfatase activation",Down,0.539544962,0.355362947,1,-0.475258791,-0.432676608,-0.061042783,FALSE,Down,0.528,0.448,3,-0.385880405,-0.282361286,-0.121897077,FALSE
Synthesis of diphthamide-EEF2,Down,0.539544962,0.355362947,1,-0.475258791,-0.432676608,-0.061042783,FALSE,Down,0.081,0.051,1,1.708403934,1.801972068,-0.372467752,FALSE
RHO GTPases Activate WASPs and WAVEs,Down,0.496208017,0.355362947,3,-0.35158931,-0.362539978,-0.041245057,FALSE,Down,0.8,0.743,3,-0.985430848,-1.010647329,-0.232063288,FALSE
Aspartate and asparagine metabolism,Up,0.486457205,0.356446371,3,-0.162554615,-0.047537179,0.164866728,FALSE,Down,0.102,0.078,3,1.053535864,1.220471287,-0.184478316,FALSE
Signaling by MRAS-complex mutants,Up,0.477789816,0.356446371,2,-0.337018378,-0.35872787,0.106177241,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
SHOC2 M1731 mutant abolishes MRAS complex function,Up,0.477789816,0.356446371,2,-0.337018378,-0.35872787,0.106177241,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
Gain-of-function MRAS complexes activate RAF signaling,Up,0.477789816,0.356446371,2,-0.337018378,-0.35872787,0.106177241,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
Release of apoptotic factors from the mitochondria,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
Formation of apoptosome,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
Cytochrome c-mediated apoptotic response,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
SMAC (DIABLO) binds to IAPs ,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
"SMAC, XIAP-regulated apoptotic response",Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
Apoptotic factor-mediated response,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
Regulation of the apoptosome activity,Up,0.434452871,0.358613218,2,0.025531285,0.09053134,0.133672633,FALSE,Down,0.685,0.606,2,-0.786845935,-0.73611526,-0.328722464,FALSE
Glutathione conjugation,Up,0.41603467,0.359696641,4,0.069703117,0.216388001,0.099249251,FALSE,Up,0.341,0.256,4,0.311845775,0.488212497,0.1361716,FALSE
Signaling by Rho GTPases,Up,0.555796316,0.360780065,63,-0.395053551,-0.213260491,0.078234888,FALSE,Up,0.679,0.588,56,-0.50041386,-0.430997392,0.029951619,FALSE
"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Up,0.555796316,0.360780065,63,-0.395053551,-0.213260491,0.078234888,FALSE,Up,0.715,0.624,57,-0.598346448,-0.522511502,0.025778995,FALSE
KSRP (KHSRP) binds and destabilizes mRNA,Up,0.511375948,0.361863489,1,-0.249390126,-0.261026688,0.144194389,FALSE,Up,0.527,0.416,1,-0.133409519,-0.150525417,0.474815609,FALSE
mitochondrial fatty acid beta-oxidation of saturated fatty acids,Up,0.400866739,0.361863489,7,0.906175641,1.129453883,0.205252167,FALSE,Down,0.878,0.856,7,-1.583416774,-1.432137591,-0.000594678,FALSE
NOTCH4 Activation and Transmission of Signal to the Nucleus,Up,0.511375948,0.361863489,1,-0.249390126,-0.261026688,0.144194389,FALSE,Up,0.527,0.416,1,-0.133409519,-0.150525417,0.474815609,FALSE
NOTCH4 Intracellular Domain Regulates Transcription,Down,0.539544962,0.364030336,1,-0.25585674,-0.192278558,-0.122190862,FALSE,Up,0.804,0.731,1,-1.071531855,-1.024766891,0.028482927,FALSE
Intrinsic Pathway for Apoptosis,Up,0.456121343,0.367280607,7,-0.082229922,-0.081203392,0.153336958,FALSE,Up,0.608,0.505,7,-0.513682003,-0.571428346,0.035836018,FALSE
Activation of caspases through apoptosome-mediated cleavage,Up,0.421451788,0.36836403,1,0.089440337,0.116475643,0.188495654,FALSE,Down,0.424,0.342,1,0.029582231,0.057378092,-0.636990291,FALSE
MHC class II antigen presentation,Up,0.424702059,0.36836403,12,-0.385445817,-0.395900681,0.044275422,FALSE,Down,0.802,0.776,14,-1.059143437,-1.073167428,-0.201894783,FALSE
Pyroptosis,Up,0.421451788,0.36836403,1,0.089440337,0.116475643,0.188495654,FALSE,Down,0.424,0.342,1,0.029582231,0.057378092,-0.636990291,FALSE
tRNA processing,Down,0.546045504,0.36836403,3,-0.485717243,-0.378708125,-0.025175533,FALSE,Down,0.423,0.338,4,0.118618201,0.253858887,-0.098780992,FALSE
RHOB GTPase cycle,Up,0.550379198,0.36836403,5,-0.388536946,-0.280311573,0.032735034,FALSE,Up,0.945,0.94,3,-1.948107171,-1.871661538,0.013254118,FALSE
Glyoxylate metabolism and glycine degradation,Up,0.516793066,0.369447454,13,0.141633124,0.414956626,0.115964064,FALSE,Down,0.869,0.834,10,-1.401683948,-1.203266206,-0.047389106,FALSE
Creatine metabolism,Down,0.489707476,0.370530878,2,-0.185656141,-0.079540966,-0.212000647,FALSE,Down,0.013,0.007,2,2.46659267,2.687765908,-0.338787387,FALSE
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Up,0.437703142,0.370530878,4,0.118171057,0.255129683,0.144715299,FALSE,Down,0.896,0.846,4,-1.516988733,-1.413184105,-0.067584973,FALSE
Insulin processing,Up,0.516793066,0.371614301,1,-0.220211752,-0.191178716,0.157953349,FALSE,Up,0.574,0.472,2,-0.296448656,-0.240369513,0.276246312,FALSE
Intraflagellar transport,Up,0.447453954,0.371614301,3,-0.274699166,-0.434833866,0.113769646,FALSE,Down,0.734,0.717,5,-1.164471008,-1.266222078,-0.108677932,FALSE
VLDL assembly,Up,0.516793066,0.371614301,1,-0.220211752,-0.191178716,0.157953349,FALSE,Up,0.518,0.429,1,-0.328484773,-0.293022292,0.212172864,FALSE
LDL remodeling,Up,0.516793066,0.371614301,1,-0.220211752,-0.191178716,0.157953349,FALSE,Up,0.518,0.429,1,-0.328484773,-0.293022292,0.212172864,FALSE
Interleukin-23 signaling,Up,0.516793066,0.371614301,1,-0.220211752,-0.191178716,0.157953349,FALSE,Up,0.518,0.429,1,-0.328484773,-0.293022292,0.212172864,FALSE
Signaling by Hedgehog,Up,0.17659805,0.373781148,17,-0.344955009,-1.00483695,0.108118346,FALSE,Down,0.712,0.853,26,-1.213674043,-2.699911526,-0.011142651,FALSE
Metabolism of steroid hormones,Up,0.523293608,0.375947996,3,0.016298461,0.146379184,0.05875293,FALSE,Up,0.716,0.635,1,-0.791156815,-0.736407578,0.131690173,FALSE
PTK6 Regulates Proteins Involved in RNA Processing,Down,0.457204767,0.379198267,1,-0.20248642,-0.140814774,-0.103665424,FALSE,,,,,,,,
Suppression of apoptosis,Down,0.457204767,0.379198267,1,-0.20248642,-0.140814774,-0.103665424,FALSE,,,,,,,,
Aflatoxin activation and detoxification,Up,0.459371614,0.381365114,1,-0.088505765,-0.011024989,0.138578145,FALSE,Down,0.739,0.655,1,-0.801354258,-0.743498371,-0.178719034,FALSE
Metabolism of lipids,Up,0.520043337,0.381365114,45,0.160430691,0.576588077,0.003079403,FALSE,Down,0.149,0.078,50,1.035902381,1.522405825,-0.140671615,FALSE
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Up,0.524377031,0.381365114,2,-0.238495121,-0.162018703,0.195170945,FALSE,Up,0.018,0.009,1,2.980457846,3.08879291,1.867570959,FALSE
HCMV Infection,Up,0.440953413,0.381365114,7,-0.340453794,-0.501212156,0.06406073,FALSE,Down,0.74,0.722,7,-1.012997326,-1.140217338,-0.04888078,FALSE
Formation of RNA Pol II elongation complex ,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Formation of HIV elongation complex in the absence of HIV Tat,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
HIV Transcription Elongation,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Transcription of the HIV genome,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Formation of HIV-1 elongation complex containing HIV-1 Tat,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Pausing and recovery of Tat-mediated HIV elongation,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Tat-mediated HIV elongation arrest and recovery,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Tat-mediated elongation of the HIV-1 transcript,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
HIV elongation arrest and recovery,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
Pausing and recovery of HIV elongation,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
"Unblocking of NMDA receptors, glutamate binding and activation",Up,0.485373781,0.383531961,3,-0.513907789,-0.507146338,0.014610909,FALSE,Down,0.181,0.129,2,0.843167829,0.492359414,-0.277752056,FALSE
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,Up,0.485373781,0.383531961,3,-0.513907789,-0.507146338,0.014610909,FALSE,Down,0.181,0.129,2,0.843167829,0.492359414,-0.277752056,FALSE
Ras activation upon Ca2+ influx through NMDA receptor,Up,0.485373781,0.383531961,3,-0.513907789,-0.507146338,0.014610909,FALSE,Down,0.181,0.129,2,0.843167829,0.492359414,-0.277752056,FALSE
RNA Polymerase II Pre-transcription Events,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
TP53 Regulates Transcription of DNA Repair Genes,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
RNA Polymerase II Transcription Elongation,Down,0.463705309,0.383531961,1,-0.876251077,-0.857770965,-0.011605204,FALSE,Up,0.563,0.465,1,-0.386004347,-0.37218117,0.393273689,FALSE
RHOA GTPase cycle,Up,0.515709642,0.383531961,10,-0.370019386,-0.195141396,0.105273062,FALSE,Up,0.932,0.922,5,-1.796809744,-1.695912341,0.111533497,FALSE
Negative regulation of NMDA receptor-mediated neuronal transmission,Up,0.485373781,0.383531961,3,-0.513907789,-0.507146338,0.014610909,FALSE,Down,0.181,0.129,2,0.843167829,0.492359414,-0.277752056,FALSE
Long-term potentiation,Up,0.485373781,0.383531961,3,-0.513907789,-0.507146338,0.014610909,FALSE,Down,0.181,0.129,2,0.843167829,0.492359414,-0.277752056,FALSE
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Down,0.452871073,0.385698808,1,-0.332562925,-0.278243186,-0.068747415,FALSE,Down,0.049,0.028,4,2.110317492,2.293455479,-0.525164164,FALSE
Linoleic acid (LA) metabolism,Down,0.452871073,0.385698808,1,-0.332562925,-0.278243186,-0.068747415,FALSE,Down,0.179,0.13,1,1.128189755,1.232315871,-0.602576575,FALSE
alpha-linolenic acid (ALA) metabolism,Down,0.452871073,0.385698808,1,-0.332562925,-0.278243186,-0.068747415,FALSE,Down,0.049,0.028,4,2.110317492,2.293455479,-0.525164164,FALSE
Activation of BAD and translocation to mitochondria ,Up,0.447453954,0.386782232,5,-0.113443158,-0.153338196,0.161202688,FALSE,Up,0.458,0.357,5,-0.110151678,-0.210562968,0.181659411,FALSE
Activation of BH3-only proteins,Up,0.447453954,0.386782232,5,-0.113443158,-0.153338196,0.161202688,FALSE,Up,0.458,0.357,5,-0.110151678,-0.210562968,0.181659411,FALSE
RA biosynthesis pathway,Up,0.464788732,0.386782232,2,-0.038400655,0.069284363,0.123149669,FALSE,Down,0.656,0.585,2,-0.657193314,-0.559937761,-0.098154559,FALSE
Signaling by moderate kinase activity BRAF mutants,Up,0.501625135,0.386782232,12,-0.280897446,-0.263808222,0.031629556,FALSE,Up,0.408,0.329,11,0.228336471,0.065061597,0.041918143,FALSE
Signaling by RAS mutants,Up,0.501625135,0.386782232,12,-0.280897446,-0.263808222,0.031629556,FALSE,Up,0.408,0.329,11,0.228336471,0.065061597,0.041918143,FALSE
Paradoxical activation of RAF signaling by kinase inactive BRAF,Up,0.501625135,0.386782232,12,-0.280897446,-0.263808222,0.031629556,FALSE,Up,0.408,0.329,11,0.228336471,0.065061597,0.041918143,FALSE
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Up,0.447453954,0.386782232,5,-0.113443158,-0.153338196,0.161202688,FALSE,Up,0.458,0.357,5,-0.110151678,-0.210562968,0.181659411,FALSE
Signaling downstream of RAS mutants,Up,0.501625135,0.386782232,12,-0.280897446,-0.263808222,0.031629556,FALSE,Up,0.408,0.329,11,0.228336471,0.065061597,0.041918143,FALSE
Infection with Mycobacterium tuberculosis,Up,0.144095341,0.388949079,8,-0.178969952,-0.293903364,0.122624945,FALSE,Down,0.838,0.88,8,-1.639149934,-1.834724818,-0.181286255,FALSE
Response of Mtb to phagocytosis,Up,0.144095341,0.388949079,8,-0.178969952,-0.293903364,0.122624945,FALSE,Down,0.838,0.88,8,-1.639149934,-1.834724818,-0.181286255,FALSE
mRNA Editing: C to U Conversion,Down,0.537378115,0.39219935,1,-0.223911191,-0.15567035,-0.12206736,FALSE,,,,,,,,
mRNA Editing,Down,0.537378115,0.39219935,1,-0.223911191,-0.15567035,-0.12206736,FALSE,,,,,,,,
Formation of the Editosome,Down,0.537378115,0.39219935,1,-0.223911191,-0.15567035,-0.12206736,FALSE,,,,,,,,
Signaling by Interleukins,Up,0.310942579,0.397616468,40,0.058206743,-0.224276614,0.150307016,FALSE,Down,0.438,0.593,44,-0.388537387,-1.381661511,-0.04849797,FALSE
COPII-mediated vesicle transport,Down,0.489707476,0.398699892,3,-0.521830951,-0.44251057,-0.028486619,FALSE,Up,0.389,0.298,3,0.233021163,0.34674029,0.049669836,FALSE
Hedgehog 'off' state,Up,0.174431203,0.399783315,15,-0.372067323,-1.075250487,0.105539754,FALSE,Down,0.752,0.875,24,-1.283129019,-2.828744447,-0.029840534,FALSE
Beta-oxidation of pristanoyl-CoA,Down,0.496208017,0.403033586,1,-0.663486344,-0.621726266,-0.03246624,FALSE,Down,0.554,0.458,3,-0.347602572,-0.234927122,-0.135652828,FALSE
Signaling by VEGF,Up,0.51787649,0.407367281,7,-0.454985614,-0.38454186,0.031158289,FALSE,Down,0.625,0.537,7,-0.583703057,-0.747588201,-0.229071793,FALSE
Activation of the phototransduction cascade,Down,0.489707476,0.407367281,1,-0.655946676,-0.673306133,-0.033791578,FALSE,Down,0.536,0.472,1,-0.418988455,-0.462000143,-0.299652802,FALSE
The phototransduction cascade,Down,0.489707476,0.407367281,1,-0.655946676,-0.673306133,-0.033791578,FALSE,Down,0.342,0.261,2,0.217766926,-0.197048566,-0.571175825,FALSE
"Inactivation, recovery and regulation of the phototransduction cascade",Down,0.489707476,0.407367281,1,-0.655946676,-0.673306133,-0.033791578,FALSE,Down,0.342,0.261,2,0.217766926,-0.197048566,-0.571175825,FALSE
VEGFA-VEGFR2 Pathway,Up,0.51787649,0.407367281,7,-0.454985614,-0.38454186,0.031158289,FALSE,Down,0.625,0.537,7,-0.583703057,-0.747588201,-0.229071793,FALSE
Sensory perception of taste,Down,0.489707476,0.407367281,1,-0.655946676,-0.673306133,-0.033791578,FALSE,Down,0.536,0.472,1,-0.418988455,-0.462000143,-0.299652802,FALSE
"Sensory perception of sweet, bitter, and umami (glutamate) taste",Down,0.489707476,0.407367281,1,-0.655946676,-0.673306133,-0.033791578,FALSE,Down,0.536,0.472,1,-0.418988455,-0.462000143,-0.299652802,FALSE
Sialic acid metabolism,Up,0.50595883,0.409534128,1,-0.327544169,-0.293676393,0.084144919,FALSE,Down,0.753,0.677,1,-1.044431311,-1.001852637,-0.011953378,FALSE
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",Up,0.50595883,0.409534128,1,-0.327544169,-0.293676393,0.084144919,FALSE,Down,0.023,0.017,2,2.316514719,2.473073678,-0.750935204,FALSE
Synthesis of substrates in N-glycan biosythesis,Up,0.50595883,0.409534128,1,-0.327544169,-0.293676393,0.084144919,FALSE,Down,0.023,0.017,2,2.316514719,2.473073678,-0.750935204,FALSE
Defective PGM1 causes PGM1-CDG,Up,0.483206934,0.411700975,1,-0.258999415,-0.207316702,0.105307843,FALSE,Down,0.259,0.202,1,0.33251756,0.404707048,-0.16638399,FALSE
Diseases associated with glycosylation precursor biosynthesis,Up,0.483206934,0.411700975,1,-0.258999415,-0.207316702,0.105307843,FALSE,Down,0.008,0.004,2,3.290164604,3.467661569,-0.82815051,TRUE
Galactose catabolism,Up,0.483206934,0.411700975,1,-0.258999415,-0.207316702,0.105307843,FALSE,Down,0.259,0.202,1,0.33251756,0.404707048,-0.16638399,FALSE
Metabolism of vitamins and cofactors,Down,0.565547129,0.413867822,12,-0.492510302,-0.355220203,-0.081317854,FALSE,Down,0.18,0.114,18,1.115961807,1.229135154,-0.21808563,FALSE
Peroxisomal lipid metabolism,Up,0.530877573,0.413867822,4,-0.178050956,-0.048871633,0.080678302,FALSE,Down,0.031,0.02,6,2.489894498,2.707269283,-0.062583516,FALSE
ALK mutants bind TKIs,Up,0.508125677,0.417118093,4,-0.241599847,-0.253849287,0.12150528,FALSE,Up,0.744,0.674,2,-0.948711068,-0.924001127,0.030254281,FALSE
CaMK IV-mediated phosphorylation of CREB,Down,0.550379198,0.418201517,2,-0.574847663,-0.596049705,-0.018567557,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Trafficking of AMPA receptors,Down,0.550379198,0.418201517,2,-0.574847663,-0.596049705,-0.018567557,FALSE,,,,,,,,
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",Down,0.550379198,0.418201517,2,-0.574847663,-0.596049705,-0.018567557,FALSE,,,,,,,,
Phase 0 - rapid depolarisation,Down,0.550379198,0.418201517,2,-0.574847663,-0.596049705,-0.018567557,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Transcriptional Regulation by MECP2,Down,0.550379198,0.418201517,2,-0.574847663,-0.596049705,-0.018567557,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Regulation of MECP2 expression and activity,Down,0.550379198,0.418201517,2,-0.574847663,-0.596049705,-0.018567557,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Signaling by Hippo,Up,0.514626219,0.421451788,2,-0.372742484,-0.423585671,0.123366822,FALSE,Up,0.066,0.046,2,1.408524433,1.208922698,0.249410517,FALSE
G alpha (12/13) signalling events,Up,0.469122427,0.421451788,3,-0.822076663,-0.801872359,0.002468809,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
COPI-mediated anterograde transport,Up,0.497291441,0.422535211,16,-0.987837638,-0.945941724,0.004396579,FALSE,Down,0.402,0.338,20,0.244673201,0.315985886,-0.104043006,FALSE
Androgen biosynthesis,Up,0.58396533,0.423618635,1,-0.300967259,-0.242473843,0.168996563,FALSE,,,,,,,,
Nuclear Envelope (NE) Reassembly,Up,0.421451788,0.423618635,8,-0.44807261,-0.642134878,0.091068115,FALSE,Up,0.821,0.822,11,-1.294574468,-1.374638067,0.014343909,FALSE
Glutathione synthesis and recycling,Down,0.522210184,0.424702059,1,-0.568605889,-0.52210587,-0.047011872,FALSE,,,,,,,,
Paracetamol ADME,Down,0.522210184,0.424702059,1,-0.568605889,-0.52210587,-0.047011872,FALSE,,,,,,,,
Degradation of the extracellular matrix,Up,0.508125677,0.425785482,18,0.026416668,0.181820333,0.138849014,FALSE,Up,0.013,0.005,6,2.671940833,2.884594281,0.556033155,FALSE
Elastic fibre formation,Up,0.510292524,0.425785482,8,0.362015432,0.45366561,0.15478282,FALSE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
Molecules associated with elastic fibres,Up,0.510292524,0.425785482,8,0.362015432,0.45366561,0.15478282,FALSE,Up,0.356,0.291,1,0.236875293,0.180407101,0.697220665,FALSE
tRNA processing in the nucleus,Up,0.65872156,0.429035753,2,-0.768819564,-0.696053197,0.054128409,FALSE,Up,0.498,0.412,2,-0.178626066,-0.101865114,0.321519048,FALSE
Golgi Cisternae Pericentriolar Stack Reorganization,Down,0.538461538,0.434452871,1,-0.797806301,-0.769018002,-0.019675236,FALSE,Down,0.505,0.401,2,-0.190982981,-0.098766161,-0.383803368,FALSE
Laminin interactions,Up,0.536294691,0.434452871,15,-0.891086893,-0.772695158,0.018750533,FALSE,Down,0.388,0.293,3,0.237452281,0.292126611,-0.187016843,FALSE
Integration of energy metabolism,Down,0.457204767,0.435536295,10,-0.55851385,-0.617143513,-0.002645214,FALSE,Down,0.883,0.877,9,-1.625935981,-1.624221021,-0.050677935,FALSE
Fatty acyl-CoA biosynthesis,Up,0.596966414,0.435536295,2,-0.447973489,-0.368202542,0.050124574,FALSE,Down,0.313,0.225,2,0.43114516,0.55260152,-0.391056666,FALSE
Synthesis of very long-chain fatty acyl-CoAs,Up,0.596966414,0.435536295,2,-0.447973489,-0.368202542,0.050124574,FALSE,Down,0.179,0.13,1,1.128189755,1.232315871,-0.602576575,FALSE
ABC-family proteins mediated transport,Up,0.141928494,0.438786566,10,-0.341902976,-1.146267557,0.056067265,FALSE,Up,0.111,0.423,20,-0.051420187,-1.725207151,0.03005502,FALSE
ABC transporter disorders,Up,0.141928494,0.438786566,10,-0.341902976,-1.146267557,0.056067265,FALSE,Up,0.111,0.423,20,-0.051420187,-1.725207151,0.03005502,FALSE
RHO GTPases Activate Formins,Up,0.44312026,0.438786566,10,-0.445997021,-0.661521464,0.070213305,FALSE,Down,0.887,0.897,11,-1.584640443,-1.725531701,-0.093937645,FALSE
Class A/1 (Rhodopsin-like receptors),Down,0.604550379,0.439869989,4,-0.266366128,-0.177658505,-0.099801415,FALSE,Down,0.245,0.175,5,0.820928685,0.964441997,-0.18250129,FALSE
Peptide ligand-binding receptors,Down,0.604550379,0.439869989,4,-0.266366128,-0.177658505,-0.099801415,FALSE,Down,0.245,0.175,5,0.820928685,0.964441997,-0.18250129,FALSE
Arachidonic acid metabolism,Down,0.554712893,0.442036836,1,-0.805828828,-0.7716364,-0.019965538,FALSE,Up,0.726,0.641,2,-0.731677138,-0.655778758,0.190156148,FALSE
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Down,0.554712893,0.442036836,1,-0.805828828,-0.7716364,-0.019965538,FALSE,Down,0.844,0.78,1,-1.144662076,-1.100515613,-0.015997307,FALSE
Signaling by PDGF,Up,0.557963164,0.44312026,6,-0.503800744,-0.368634517,0.16115862,FALSE,Up,0.026,0.013,1,2.839173748,2.937979771,1.813960686,FALSE
Regulation of pyruvate dehydrogenase (PDH) complex,Up,0.581798483,0.44312026,5,-0.364781802,-0.227992591,0.149793278,FALSE,Down,0.725,0.64,7,-0.766444734,-0.590622083,-0.051926899,FALSE
COPI-dependent Golgi-to-ER retrograde traffic,Up,0.518959913,0.445287107,6,-0.660777313,-0.730966257,0.02902458,FALSE,Down,0.72,0.691,15,-0.829928843,-0.768353697,-0.08163624,FALSE
Activation of G protein gated Potassium channels,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
G protein gated Potassium channels,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Inwardly rectifying K+ channels,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Potassium Channels,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
G-protein activation,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
ADP signalling through P2Y purinoceptor 12,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
G beta:gamma signalling through PI3Kgamma,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Signal amplification,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
G-protein beta:gamma signalling,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
"Adrenaline,noradrenaline inhibits insulin secretion",Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
G beta:gamma signalling through PLC beta,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
ADP signalling through P2Y purinoceptor 1,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Thromboxane signalling through TP receptor,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Activation of kainate receptors upon glutamate binding,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.437,0.363,3,-0.064097147,-0.416091333,-0.480668151,FALSE
Thrombin signalling through proteinase activated receptors (PARs),Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Presynaptic function of Kainate receptors,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
G beta:gamma signalling through BTK,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
G beta:gamma signalling through CDC42,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Fatty acid metabolism,Up,0.537378115,0.448537378,25,-0.263064339,0.085258629,0.091099927,FALSE,Down,0.237,0.141,29,0.627197173,1.048189165,-0.112303001,FALSE
GABA receptor activation,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
GABA B receptor activation,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
Activation of GABAB receptors,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.627,0.573,3,-0.712673115,-0.733527848,-0.327910501,FALSE
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Down,0.502708559,0.448537378,2,-0.927648685,-0.94454494,-0.033791578,FALSE,Down,0.534,0.499,2,-0.592539156,-0.639240594,-0.299652802,FALSE
Expression and translocation of olfactory receptors,Up,0.34127844,0.449620802,1,-0.432239757,-0.70374198,0.15147384,FALSE,Up,0.088,0.085,1,1.54925648,0.276357,0.648489266,FALSE
NADE modulates death signalling,Up,0.570964247,0.453954496,1,-0.441501653,-0.459052328,0.091139008,FALSE,Up,0.084,0.055,1,1.322126072,1.16817075,0.252591272,FALSE
ER to Golgi Anterograde Transport,Up,0.54496208,0.45503792,17,-1.106907338,-1.057918738,0.007358933,FALSE,Down,0.372,0.303,21,0.366513547,0.451528503,-0.061524169,FALSE
G alpha (i) signalling events,Down,0.502708559,0.45503792,14,-0.550144667,-0.568153062,-0.033368959,FALSE,Down,0.462,0.406,11,-0.099940995,-0.195583951,-0.24524336,FALSE
Transport to the Golgi and subsequent modification,Up,0.54496208,0.45503792,17,-1.106907338,-1.057918738,0.007358933,FALSE,Down,0.372,0.303,21,0.366513547,0.451528503,-0.061524169,FALSE
Processing of SMDT1,Up,0.609967497,0.456121343,3,-0.812047899,-0.71979311,0.053540526,FALSE,Up,0.507,0.413,4,-0.304286177,-0.145358837,0.188794344,FALSE
DARPP-32 events,Up,0.468039003,0.457204767,4,-0.542838218,-0.672332262,0.095597954,FALSE,Down,0.589,0.501,3,-0.538513696,-0.886076169,-0.267146334,FALSE
Suppression of phagosomal maturation,Up,0.083423619,0.460455038,5,-0.351616362,-0.595985557,0.129626872,FALSE,Down,0.607,0.706,6,-1.122254456,-1.388335399,-0.235161668,FALSE
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,Up,0.510292524,0.460455038,6,-0.478178701,-0.508056232,0.140060725,FALSE,Up,0.361,0.278,6,0.258612052,-0.221577956,0.246502906,FALSE
SARS-CoV-2 targets host intracellular signalling and regulatory pathways,Up,0.510292524,0.460455038,6,-0.478178701,-0.508056232,0.140060725,FALSE,Up,0.458,0.357,5,-0.110151678,-0.210562968,0.181659411,FALSE
RHO GTPases activate IQGAPs,Up,0.503791983,0.462621885,8,-0.513966631,-0.58553256,0.05315671,FALSE,Down,0.805,0.778,12,-1.145680318,-1.374972012,-0.207156872,FALSE
Pyruvate metabolism and Citric Acid (TCA) cycle,Up,0.614301192,0.464788732,28,-0.507800649,-0.12896654,0.096014774,FALSE,Down,0.966,0.956,28,-2.233865905,-1.877003733,-0.042806362,FALSE
CRMPs in Sema3A signaling,Up,0.563380282,0.465872156,1,-0.510717113,-0.461325146,0.069155459,FALSE,,,,,,,,
L1CAM interactions,Up,0.572047671,0.468039003,22,-0.700656624,-0.672193894,0.057756866,FALSE,Down,0.413,0.361,17,-0.005996051,-0.074622442,-0.051345036,FALSE
Interleukin-12 family signaling,Up,0.723726977,0.47020585,16,-0.363660416,-0.18062437,0.129725249,FALSE,Down,0.534,0.416,16,-0.116680175,0.068390727,-0.178395484,FALSE
RNA Polymerase I Transcription Termination,Up,0.683640303,0.471289274,1,-0.602972405,-0.560677392,0.064428364,FALSE,Up,0.822,0.754,1,-1.165971763,-1.122559212,0.009625464,FALSE
Apoptotic execution phase,Down,0.622968581,0.471289274,11,-0.852410677,-0.746166665,-0.023836326,FALSE,Up,0.097,0.08,7,1.494275474,1.562640753,0.251857074,FALSE
Golgi Associated Vesicle Biogenesis,Up,0.58071506,0.474539545,4,-0.558623119,-0.506844277,0.080742967,FALSE,Down,0.439,0.348,5,-0.110090258,-0.058389108,-0.247564844,FALSE
Cargo concentration in the ER,Up,0.563380282,0.474539545,1,-0.612545318,-0.578143804,0.054756602,FALSE,Up,0.286,0.221,1,0.585364252,0.656031704,0.788852573,FALSE
Adaptive Immune System,Up,0.352112676,0.475622969,40,-0.343439547,-0.742723081,0.130201845,FALSE,Down,0.742,0.847,49,-0.992277745,-2.094075404,-0.043819223,FALSE
Late endosomal microautophagy,Down,0.250270856,0.477789816,8,-0.165613892,-0.258424166,-0.047571806,FALSE,Up,0.09,0.182,8,0.730358099,0.545234547,0.069622757,FALSE
Glycine degradation,Up,0.621885157,0.481040087,1,-0.597528935,-0.558391589,0.282567577,FALSE,Up,0.27,0.203,1,0.172930718,0.242035107,0.118325547,FALSE
tRNA Aminoacylation,Down,0.554712893,0.483206934,3,-0.500020004,-0.388520351,-0.108149132,FALSE,Down,0.454,0.345,8,0.184155241,0.418827525,-0.099467946,FALSE
Mitochondrial tRNA aminoacylation,Down,0.554712893,0.483206934,3,-0.500020004,-0.388520351,-0.108149132,FALSE,Down,0.7,0.608,3,-0.692059082,-0.5752134,-0.146518338,FALSE
Uptake and function of anthrax toxins,Down,0.51787649,0.483206934,1,-0.419670412,-0.371574518,-0.192156143,FALSE,Down,0.088,0.072,2,1.256384155,0.938509213,-0.600775444,FALSE
rRNA modification in the nucleus and cytosol,Up,0.582881907,0.483206934,4,-0.786072202,-0.783428933,0.015634422,FALSE,,,,,,,,
Sensory processing of sound by outer hair cells of the cochlea,Up,0.565547129,0.483206934,11,-0.803295286,-0.680523317,0.005921518,FALSE,Down,0.224,0.152,10,0.929866537,0.963583689,-0.201167949,FALSE
Triglyceride catabolism,Up,0.573131094,0.484290358,3,-0.536976251,-0.455406351,0.11291627,FALSE,Down,0.395,0.313,4,0.040270124,0.19298047,-0.277408175,FALSE
ESR-mediated signaling,Up,0.594799567,0.484290358,8,-0.68047101,-0.713524466,0.035347512,FALSE,Down,0.496,0.414,7,-0.298226572,-0.465319688,-0.284043049,FALSE
Triglyceride metabolism,Up,0.573131094,0.484290358,3,-0.536976251,-0.455406351,0.11291627,FALSE,Down,0.395,0.313,4,0.040270124,0.19298047,-0.277408175,FALSE
Translation of Structural Proteins,Up,0.161430119,0.484290358,6,-0.373771166,-0.513141507,0.15321561,FALSE,Down,0.943,0.955,6,-2.006647253,-2.24693617,-0.108997391,FALSE
Signaling by FLT3 fusion proteins,Up,0.614301192,0.484290358,2,-0.975176129,-0.93680888,0.015090925,FALSE,Up,0.024,0.011,1,2.550441509,2.533087268,0.717407244,FALSE
Glycogen storage disease type XV (GYG1),Up,0.606717226,0.485373781,1,-0.56132498,-0.518090001,0.082512041,FALSE,Up,0.692,0.636,1,-0.872980138,-0.822381053,0.109173687,FALSE
Glycogen storage disease type 0 (muscle GYS1),Up,0.606717226,0.485373781,1,-0.56132498,-0.518090001,0.082512041,FALSE,Up,0.692,0.636,1,-0.872980138,-0.822381053,0.109173687,FALSE
Cell Cycle,Up,0.252437703,0.486457205,32,-0.438715658,-0.950774754,0.116647031,FALSE,Up,0.757,0.886,44,-1.134293583,-2.233440153,0.041714501,FALSE
Signaling by FGFR in disease,Down,0.61971831,0.487540628,1,-0.851762674,-0.819781224,-0.017003653,FALSE,,,,,,,,
Prolonged ERK activation events,Up,0.592632719,0.487540628,2,-0.420566175,-0.448775837,0.132663465,FALSE,Up,0.33,0.251,2,0.401094355,0.317594631,0.360167025,FALSE
Frs2-mediated activation,Up,0.592632719,0.487540628,2,-0.420566175,-0.448775837,0.132663465,FALSE,Up,0.33,0.251,2,0.401094355,0.317594631,0.360167025,FALSE
ARMS-mediated activation,Up,0.592632719,0.487540628,2,-0.420566175,-0.448775837,0.132663465,FALSE,Up,0.33,0.251,2,0.401094355,0.317594631,0.360167025,FALSE
Signaling by cytosolic FGFR1 fusion mutants,Down,0.61971831,0.487540628,1,-0.851762674,-0.819781224,-0.017003653,FALSE,,,,,,,,
FGFR1 mutant receptor activation,Down,0.61971831,0.487540628,1,-0.851762674,-0.819781224,-0.017003653,FALSE,,,,,,,,
Signalling to ERKs,Up,0.592632719,0.487540628,2,-0.420566175,-0.448775837,0.132663465,FALSE,Down,0.192,0.136,4,1.132557083,1.164682732,-0.232399581,FALSE
Signaling by FGFR1 in disease,Down,0.61971831,0.487540628,1,-0.851762674,-0.819781224,-0.017003653,FALSE,,,,,,,,
Recruitment of NuMA to mitotic centrosomes,Up,0.54496208,0.488624052,9,-0.455719057,-0.632302425,0.10370282,FALSE,Down,0.885,0.888,12,-1.534986473,-1.647220023,-0.100130993,FALSE
Formyl peptide receptors bind formyl peptides and many other ligands,Up,0.661971831,0.488624052,2,-0.596263841,-0.529766094,0.114293299,FALSE,Up,0.556,0.468,2,-0.309470363,-0.211186282,0.305524736,FALSE
Integrin signaling,Up,0.613217768,0.489707476,4,-0.602978099,-0.585044076,0.119211624,FALSE,Up,0.548,0.49,3,-0.397000801,-0.36249681,0.346816123,FALSE
GRB2:SOS provides linkage to MAPK signaling for Integrins ,Up,0.613217768,0.489707476,4,-0.602978099,-0.585044076,0.119211624,FALSE,Up,0.548,0.49,3,-0.397000801,-0.36249681,0.346816123,FALSE
p130Cas linkage to MAPK signaling for integrins,Up,0.613217768,0.489707476,4,-0.602978099,-0.585044076,0.119211624,FALSE,Up,0.548,0.49,3,-0.397000801,-0.36249681,0.346816123,FALSE
Mitochondrial biogenesis,Down,0.680390033,0.496208017,22,-0.507320279,-0.200555119,-0.0376275,FALSE,Down,0.377,0.271,20,0.013346021,0.223293747,-0.068899952,FALSE
Signaling by Retinoic Acid,Up,0.659804984,0.497291441,8,-0.62282714,-0.450108558,0.118263866,FALSE,Down,0.569,0.468,10,-0.330815772,-0.10122761,-0.232392719,FALSE
trans-Golgi Network Vesicle Budding,Up,0.606717226,0.498374865,5,-0.591516918,-0.526239769,0.094575026,FALSE,Down,0.353,0.279,6,0.138475759,0.214522102,-0.074828608,FALSE
Translocation of SLC2A4 (GLUT4) to the plasma membrane,Up,0.543878657,0.502708559,13,-0.636856606,-0.731622756,0.060659469,FALSE,Down,0.527,0.461,18,-0.247200565,-0.47116322,-0.206695004,FALSE
G alpha (q) signalling events,Up,0.566630553,0.502708559,3,-0.861988088,-0.845223042,0.025743127,FALSE,Down,0.604,0.545,4,-0.506937039,-0.477886637,-0.329039617,FALSE
Sulfide oxidation to sulfate,Up,0.653304442,0.50595883,1,-0.68993969,-0.648172274,0.046445517,FALSE,,,,,,,,
Uncoating of the HIV Virion,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.525,0.448,1,-0.254512687,-0.236029669,-0.296287217,FALSE
Reverse Transcription of HIV RNA,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.525,0.448,1,-0.254512687,-0.236029669,-0.296287217,FALSE
Integration of provirus,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.499,0.41,3,-0.234677857,-0.154416936,-0.290333066,FALSE
Early Phase of HIV Life Cycle,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.499,0.41,3,-0.234677857,-0.154416936,-0.290333066,FALSE
Minus-strand DNA synthesis,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.525,0.448,1,-0.254512687,-0.236029669,-0.296287217,FALSE
Plus-strand DNA synthesis,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.525,0.448,1,-0.254512687,-0.236029669,-0.296287217,FALSE
Binding and entry of HIV virion,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.525,0.448,1,-0.254512687,-0.236029669,-0.296287217,FALSE
APOBEC3G mediated resistance to HIV-1 infection,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.525,0.448,1,-0.254512687,-0.236029669,-0.296287217,FALSE
Calcineurin activates NFAT,Up,0.635969664,0.50595883,1,-0.525065064,-0.5081889,0.187926266,FALSE,Down,0.338,0.247,2,0.334068857,-0.037263312,-0.569493033,FALSE
MAPK family signaling cascades,Up,0.345612134,0.50595883,30,-0.83047234,-1.242765631,0.098133649,FALSE,Up,0.157,0.284,35,0.273397481,-1.063076762,0.058486722,FALSE
Post NMDA receptor activation events,Up,0.593716143,0.507042254,9,-0.697721656,-0.792266796,0.06199131,FALSE,Down,0.7,0.65,9,-0.870315381,-1.119318051,-0.180903539,FALSE
Activation of NMDA receptors and postsynaptic events,Up,0.593716143,0.507042254,9,-0.697721656,-0.792266796,0.06199131,FALSE,Down,0.7,0.65,9,-0.870315381,-1.119318051,-0.180903539,FALSE
SUMOylation of transcription cofactors,Up,0.586132178,0.508125677,2,-0.549367012,-0.485701885,0.125322203,FALSE,Down,0.656,0.575,1,-0.639245887,-0.582875743,-0.250727781,FALSE
G2/M DNA damage checkpoint,Up,0.538461538,0.508125677,7,-0.755500813,-0.793344776,0.097357463,FALSE,Up,0.458,0.357,5,-0.110151678,-0.210562968,0.181659411,FALSE
IRE1alpha activates chaperones,Up,0.624052004,0.511375948,6,-0.739956868,-0.633354249,0.071263211,FALSE,Up,0.654,0.543,7,-0.498006724,-0.370874675,0.050068272,FALSE
Olfactory Signaling Pathway,Up,0.461538462,0.511375948,2,-0.769464006,-0.973720059,0.058841131,FALSE,Up,0.248,0.145,2,0.799220185,-0.131269525,0.174418232,FALSE
Transport of small molecules,Down,0.500541712,0.511375948,45,-0.747419025,-0.902206958,-0.055008724,FALSE,Up,0.316,0.381,52,-0.008894055,-0.87954836,0.065784098,FALSE
Dissolution of Fibrin Clot,Down,0.613217768,0.511375948,1,-0.752003977,-0.717459623,-0.038565079,FALSE,Up,0.8,0.718,1,-1.092642954,-1.047645816,0.009304389,FALSE
RAF/MAP kinase cascade,Up,0.323943662,0.512459372,29,-0.815182576,-1.245430704,0.096003161,FALSE,Up,0.106,0.222,33,0.488570166,-0.907603355,0.057737405,FALSE
MAPK1/MAPK3 signaling,Up,0.323943662,0.512459372,29,-0.815182576,-1.245430704,0.096003161,FALSE,Up,0.106,0.222,33,0.488570166,-0.907603355,0.057737405,FALSE
Apoptotic cleavage of cell adhesion  proteins,Down,0.65872156,0.515709642,3,-0.72881858,-0.657443484,-0.099519554,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Down,0.643553629,0.51787649,1,-0.999785773,-0.975980575,-0.004670341,FALSE,,,,,,,,
Cellular response to chemical stress,Down,0.413867822,0.51787649,28,-0.552491843,-0.85322869,-0.030069087,FALSE,Down,0.638,0.765,37,-0.916721526,-1.977938801,-0.00353115,FALSE
Acyl chain remodeling of CL,Down,0.608884074,0.520043337,2,-1.051977719,-1.005124287,-0.040690015,FALSE,Down,0.799,0.74,2,-1.183423025,-1.114205982,-0.054832112,FALSE
TP53 Regulates Transcription of Cell Cycle Genes,Up,0.618634886,0.520043337,1,-0.765029074,-0.741648085,0.036448494,FALSE,,,,,,,,
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Up,0.618634886,0.520043337,1,-0.765029074,-0.741648085,0.036448494,FALSE,,,,,,,,
Beta oxidation of myristoyl-CoA to lauroyl-CoA,Down,0.608884074,0.520043337,2,-1.051977719,-1.005124287,-0.040690015,FALSE,Down,0.799,0.74,2,-1.183423025,-1.114205982,-0.054832112,FALSE
RAB geranylgeranylation,Down,0.660888407,0.526543879,2,-0.771139916,-0.708158458,-0.075373663,FALSE,Down,0.605,0.493,5,-0.323433789,-0.200786566,-0.070024568,FALSE
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.783,0.762,6,-1.190866099,-1.305226375,-0.173231021,FALSE
Gap junction assembly,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.783,0.762,6,-1.190866099,-1.305226375,-0.173231021,FALSE
Transport of connexons to the plasma membrane,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.783,0.762,6,-1.190866099,-1.305226375,-0.173231021,FALSE
Post-chaperonin tubulin folding pathway,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.763,0.742,7,-1.133524797,-1.207009544,-0.208662614,FALSE
Carboxyterminal post-translational modifications of tubulin,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.783,0.762,6,-1.190866099,-1.305226375,-0.173231021,FALSE
Activation of AMPK downstream of NMDARs,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.707,0.656,7,-0.827763702,-1.139112061,-0.268869282,FALSE
Sealing of the nuclear envelope (NE) by ESCRT-III,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.783,0.762,6,-1.190866099,-1.305226375,-0.173231021,FALSE
Kinesins,Up,0.588299025,0.527627302,4,-0.663637424,-0.801093682,0.078590985,FALSE,Down,0.796,0.774,7,-1.136830669,-1.226135706,-0.099866624,FALSE
Mitochondrial transcription initiation,Down,0.69772481,0.528710726,1,-0.622531872,-0.577937789,-0.123308206,FALSE,Up,0.681,0.623,1,-0.837675874,-0.783077232,0.170611932,FALSE
Transcription from mitochondrial promoters,Down,0.69772481,0.528710726,1,-0.622531872,-0.577937789,-0.123308206,FALSE,Up,0.681,0.623,1,-0.837675874,-0.783077232,0.170611932,FALSE
RAB GEFs exchange GTP for GDP on RABs,Up,0.655471289,0.52979415,5,-0.768983067,-0.672951208,0.07067647,FALSE,Up,0.134,0.08,6,1.326309547,1.412620843,0.309733927,FALSE
Rab regulation of trafficking,Up,0.655471289,0.52979415,5,-0.768983067,-0.672951208,0.07067647,FALSE,Up,0.194,0.12,7,1.094548523,1.200676273,0.198035975,FALSE
TP53 Regulates Metabolic Genes,Up,0.656554713,0.53304442,17,-0.678253804,-0.565497199,0.036309137,FALSE,Up,0.621,0.531,13,-0.601766839,-0.541807277,0.006174871,FALSE
Assembly of the pre-replicative complex,Up,0.109425785,0.534127844,11,-0.439142244,-1.23023563,0.150206143,FALSE,Up,0.492,0.744,19,-0.743184208,-2.431868335,0.007822199,FALSE
DNA Replication Pre-Initiation,Up,0.109425785,0.534127844,11,-0.439142244,-1.23023563,0.150206143,FALSE,Up,0.492,0.744,19,-0.743184208,-2.431868335,0.007822199,FALSE
DNA Replication,Up,0.109425785,0.534127844,11,-0.439142244,-1.23023563,0.150206143,FALSE,Up,0.492,0.744,19,-0.743184208,-2.431868335,0.007822199,FALSE
EPHB-mediated forward signaling,Up,0.606717226,0.535211268,4,-0.649191354,-0.644653873,0.004497502,FALSE,Down,0.8,0.743,3,-0.985430848,-1.010647329,-0.232063288,FALSE
Transcriptional regulation by RUNX2,Up,0.230769231,0.538461538,10,-0.577043553,-1.356829354,0.205937939,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Neurotransmitter receptors and postsynaptic signal transmission,Up,0.582881907,0.539544962,11,-1.026663712,-1.119387596,0.044576239,FALSE,Down,0.771,0.75,12,-1.110051787,-1.336121791,-0.21765528,FALSE
Glycosphingolipid metabolism,Down,0.68255688,0.539544962,2,-0.46198913,-0.383656359,-0.225016173,FALSE,Down,0.416,0.32,2,0.176555085,0.26534012,-0.682917885,FALSE
Asparagine N-linked glycosylation,Up,0.497291441,0.542795233,30,-1.28655524,-1.269380498,0.057569926,FALSE,Down,0.559,0.605,35,-0.425673979,-0.383299429,-0.070454744,FALSE
RHOH GTPase cycle,Down,0.689057421,0.543878657,6,-0.876597946,-0.833217926,-0.001416917,FALSE,Down,0.605,0.501,7,-0.408846702,-0.347438843,-0.280511256,FALSE
Signal Transduction,Up,0.58396533,0.54496208,130,-0.718506472,-0.593963722,0.075652849,FALSE,Down,0.47,0.488,118,-0.227993781,-0.635270341,-0.019932288,FALSE
DDX58/IFIH1-mediated induction of interferon-alpha/beta,Up,0.393282774,0.547128927,8,-0.813954905,-0.989286918,0.077229499,FALSE,Down,0.584,0.676,6,-1.201878628,-1.453996758,-0.310386177,FALSE
RHO GTPase Effectors,Up,0.566630553,0.547128927,29,-0.577476368,-0.622024215,0.096074709,FALSE,Down,0.706,0.674,27,-0.800132874,-0.950903449,-0.087381269,FALSE
The role of GTSE1 in G2/M progression after G2 checkpoint,Up,0.1375948,0.547128927,13,-0.579185517,-1.376549518,0.148660409,FALSE,Down,0.744,0.881,25,-1.256729521,-2.785968373,-0.050798399,FALSE
Cross-presentation of particulate exogenous antigens (phagosomes),Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
Telomere Maintenance,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,Down,0.685,0.625,2,-0.755296007,-0.680708166,-0.277237089,FALSE
Pre-NOTCH Transcription and Translation,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Gene Silencing by RNA,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,Up,0.39,0.325,1,0.020002066,0.050234959,0.223823717,FALSE
PRC2 methylates histones and DNA,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Condensation of Prophase Chromosomes,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Transcriptional regulation of white adipocyte differentiation,Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Up,0.698,0.616,3,-0.760086106,-0.68034622,0.030949368,FALSE
Free fatty acids regulate insulin secretion,Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
SIRT1 negatively regulates rRNA expression,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
NoRC negatively regulates rRNA expression,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Intracellular metabolism of fatty acids regulates insulin secretion,Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
Negative epigenetic regulation of rRNA expression,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Diseases of Immune System,Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
DNA methylation,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Transcriptional regulation by small RNAs,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,Up,0.39,0.325,1,0.020002066,0.050234959,0.223823717,FALSE
Diseases associated with the TLR signaling cascade,Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
MyD88 deficiency (TLR2/4),Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
IRAK4 deficiency (TLR2/4),Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
Activation of anterior HOX genes in hindbrain development during early embryogenesis,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Activation of HOX genes during differentiation,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Regulation of TLR by endogenous ligand,Down,0.611050921,0.548212351,1,-0.544278067,-0.529327027,-0.10535979,FALSE,Down,0.462,0.39,1,-0.262954763,-0.247941967,-0.307928699,FALSE
RNA Polymerase I Promoter Opening,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
RNA Polymerase I Promoter Escape,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
RNA Polymerase I Promoter Clearance,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Meiotic recombination,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Transcriptional regulation of granulopoiesis,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Inhibition of DNA recombination at telomere,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Defective pyroptosis,Up,0.638136511,0.548212351,2,-0.632936888,-0.683865506,0.032068569,FALSE,,,,,,,,
Caspase-mediated cleavage of cytoskeletal proteins,Up,0.672806067,0.551462622,4,-1.227251007,-1.15927289,0.064326878,FALSE,Up,0.034,0.019,3,2.587594265,2.621575502,0.402451124,FALSE
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Down,0.693391116,0.552546046,3,-0.544180367,-0.544946661,-0.064389296,FALSE,,,,,,,,
Interactions of Vpr with host cellular proteins,Down,0.667388949,0.554712893,2,-0.868577889,-0.811630274,-0.053808878,FALSE,Up,0.282,0.214,2,0.530244087,0.648876049,0.467201056,FALSE
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Down,0.667388949,0.554712893,2,-0.868577889,-0.811630274,-0.053808878,FALSE,Up,0.282,0.214,2,0.530244087,0.648876049,0.467201056,FALSE
"Transport of vitamins, nucleosides, and related molecules",Down,0.667388949,0.554712893,2,-0.868577889,-0.811630274,-0.053808878,FALSE,Up,0.282,0.214,2,0.530244087,0.648876049,0.467201056,FALSE
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Down,0.667388949,0.554712893,2,-0.868577889,-0.811630274,-0.053808878,FALSE,Up,0.282,0.214,2,0.530244087,0.648876049,0.467201056,FALSE
Type I hemidesmosome assembly,Up,0.716143012,0.555796316,1,-1.038056979,-1.015143212,0.001598312,FALSE,,,,,,,,
Rap1 signalling,Up,0.608884074,0.55687974,4,-0.67664754,-0.692377212,0.129813403,FALSE,Up,0.418,0.358,4,0.165614175,0.10850209,0.417313487,FALSE
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",Up,0.268689057,0.560130011,8,-0.608958227,-0.794763826,0.047644546,FALSE,Down,0.787,0.827,6,-1.635529106,-1.891850213,-0.233325599,FALSE
RHOU GTPase cycle,Up,0.707475623,0.560130011,3,-1.267593548,-1.237763957,0.054635382,FALSE,Up,0.05,0.025,4,2.000058764,1.985792445,0.399063075,FALSE
NFE2L2 regulating anti-oxidant/detoxification enzymes,Up,0.693391116,0.561213434,2,-1.04766046,-1.00240837,0.028524621,FALSE,Up,0.697,0.618,1,-0.859713748,-0.812376712,0.105954082,FALSE
ISG15 antiviral mechanism,Up,0.434452871,0.562296858,9,-0.783076285,-0.896884382,0.113714307,FALSE,Down,0.62,0.721,7,-1.111499222,-1.298267425,-0.258117924,FALSE
Signaling by BRAF and RAF1 fusions,Up,0.661971831,0.562296858,13,-0.62220881,-0.602677462,0.028626604,FALSE,Down,0.16,0.117,12,1.236491004,1.115099832,-0.000307495,FALSE
Pyrophosphate hydrolysis,Up,0.648970748,0.562296858,1,-0.825004606,-0.790893269,0.042345503,FALSE,Up,0.67,0.596,1,-0.668167388,-0.607890573,0.24602847,FALSE
Assembly and cell surface presentation of NMDA receptors,Up,0.632719393,0.565547129,7,-0.838094359,-0.937575114,0.051170952,FALSE,Down,0.704,0.68,7,-0.926599678,-1.014520388,-0.107455913,FALSE
G2/M Checkpoints,Up,0.453954496,0.5687974,15,-1.232413182,-1.902134008,0.137946519,FALSE,Up,0.414,0.682,23,-0.63433042,-2.218659796,0.033424152,FALSE
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Up,0.169014085,0.569880823,5,-0.455023597,-0.685423057,0.258468976,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Up,0.169014085,0.569880823,5,-0.455023597,-0.685423057,0.258468976,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Ca2+ pathway,Down,0.624052004,0.569880823,3,-1.338804078,-1.341461055,-0.020663614,FALSE,Down,0.535,0.468,4,-0.45701804,-0.754449223,-0.349706344,FALSE
SARS-CoV-1 activates/modulates innate immune responses,Up,0.456121343,0.570964247,9,-0.785073134,-0.912694579,0.142351091,FALSE,Down,0.74,0.794,8,-1.332326784,-1.522224861,-0.231130639,FALSE
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Up,0.773564464,0.572047671,14,-0.528655315,-0.351575221,0.119667166,FALSE,Down,0.425,0.315,14,0.178346944,0.355976256,-0.231093259,FALSE
Mitotic G2-G2/M phases,Up,0.30227519,0.573131094,21,-0.727352713,-1.384805086,0.117152944,FALSE,Down,0.907,0.952,33,-1.674024265,-3.003781812,-0.022921846,FALSE
G2/M Transition,Up,0.30227519,0.573131094,21,-0.727352713,-1.384805086,0.117152944,FALSE,Down,0.907,0.952,33,-1.674024265,-3.003781812,-0.022921846,FALSE
Signaling by Nuclear Receptors,Up,0.703141928,0.573131094,16,-0.92157096,-0.822812802,0.076805689,FALSE,Down,0.508,0.393,19,-0.148171884,-0.068146882,-0.134538069,FALSE
Metabolism of Angiotensinogen to Angiotensins,Down,0.712892741,0.574214518,1,-0.654482581,-0.620477661,-0.138568426,FALSE,Up,0.205,0.149,4,0.930126897,1.073240525,0.193052951,FALSE
Signaling by Insulin receptor,Down,0.712892741,0.574214518,1,-0.654482581,-0.620477661,-0.138568426,FALSE,Down,0.301,0.231,1,0.342652448,0.403927123,-0.192600487,FALSE
Insulin receptor recycling,Down,0.712892741,0.574214518,1,-0.654482581,-0.620477661,-0.138568426,FALSE,Down,0.301,0.231,1,0.342652448,0.403927123,-0.192600487,FALSE
MTOR signalling,Up,0.718309859,0.577464789,2,-0.773880773,-0.798217523,0.080404553,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
mTORC1-mediated signalling,Up,0.718309859,0.577464789,2,-0.773880773,-0.798217523,0.080404553,FALSE,Up,0.197,0.141,1,0.669828284,0.541504126,0.246229761,FALSE
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Down,0.680390033,0.58071506,3,-1.214307681,-1.152424071,-0.005860784,FALSE,Down,0.777,0.716,3,-1.174952724,-1.081932111,-0.06121681,FALSE
RHOC GTPase cycle,Up,0.732394366,0.58071506,6,-0.925263694,-0.827908757,0.056527339,FALSE,Up,0.923,0.906,3,-1.732206899,-1.66467847,0.097233799,FALSE
Signaling by NOTCH,Up,0.241603467,0.581798483,13,-0.56552067,-1.223770033,0.076345241,FALSE,Up,0.539,0.747,21,-0.758516481,-2.344544673,0.007580966,FALSE
XBP1(S) activates chaperone genes,Up,0.738894908,0.582881907,5,-1.132485721,-1.050571787,0.050034611,FALSE,Down,0.644,0.541,6,-0.519888613,-0.406528568,-0.010147638,FALSE
Mitotic Metaphase and Anaphase,Up,0.323943662,0.58396533,16,-1.010397297,-1.771043015,0.132265029,FALSE,Up,0.797,0.907,29,-1.316478364,-2.735040559,0.000629015,FALSE
Glycogen synthesis,Up,0.388949079,0.58396533,8,-0.550364355,-0.599467438,0.118633463,FALSE,Up,0.618,0.727,8,-1.097610193,-1.233419006,0.00218117,FALSE
Mitotic Anaphase,Up,0.323943662,0.58396533,16,-1.010397297,-1.771043015,0.132265029,FALSE,Up,0.797,0.907,29,-1.316478364,-2.735040559,0.000629015,FALSE
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Up,0.704225352,0.585048754,5,-0.956245837,-0.845945871,0.077328934,FALSE,Down,0.722,0.659,5,-1.132465235,-0.993383854,-0.023715774,FALSE
"Cell Cycle, Mitotic",Up,0.321776815,0.590465872,26,-0.736656968,-1.342947131,0.105238,FALSE,Down,0.868,0.939,38,-1.511693756,-2.720132363,-0.010184589,FALSE
Inhibition of replication initiation of damaged DNA by RB1/E2F1,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
E2F mediated regulation of DNA replication,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Amplification of signal from the kinetochores,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
PP2A-mediated dephosphorylation of key metabolic factors,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
"Plasma lipoprotein assembly, remodeling, and clearance",Down,0.437703142,0.593716143,9,-0.662044802,-0.80267844,-0.131127201,FALSE,Up,0.158,0.218,11,0.616010815,0.462918131,0.135620644,FALSE
Nuclear Events (kinase and transcription factor activation),Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Down,0.56,0.525,2,-0.50252188,-0.543399663,-0.141769565,FALSE
ERK/MAPK targets,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Down,0.56,0.525,2,-0.50252188,-0.543399663,-0.141769565,FALSE
Negative regulation of the PI3K/AKT network,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
ERKs are inactivated,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Down,0.56,0.525,2,-0.50252188,-0.543399663,-0.141769565,FALSE
MASTL Facilitates Mitotic Progression,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Costimulation by the CD28 family,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
CTLA4 inhibitory signaling,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Platelet sensitization by LDL,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
MAPK targets/ Nuclear events mediated by MAP kinases,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Down,0.56,0.525,2,-0.50252188,-0.543399663,-0.141769565,FALSE
Signaling by AXIN mutants,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Signaling by APC mutants,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Signaling by AMER1 mutants,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
APC truncation mutants have impaired AXIN binding,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
AXIN missense mutants destabilize the destruction complex,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Truncations of AMER1 destabilize the destruction complex,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Cyclin A/B1/B2 associated events during G2/M transition,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.861,0.843,2,-1.374987026,-1.406497104,0.030077933,FALSE
Mitotic Spindle Checkpoint,Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Branched-chain amino acid catabolism,Up,0.754062839,0.593716143,16,-0.610267464,-0.339740785,0.001470131,FALSE,Up,0.117,0.059,12,1.191663898,1.523262319,0.030105807,FALSE
"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",Up,0.587215601,0.593716143,2,-0.855529002,-1.024212157,0.091333346,FALSE,Up,0.589,0.567,1,-0.773339253,-0.860943437,0.074501462,FALSE
Ethanol oxidation,Up,0.755146262,0.594799567,3,-0.693592015,-0.596290527,0.12884108,FALSE,Up,0.658,0.567,3,-0.624301172,-0.502932898,0.080621131,FALSE
Resolution of Sister Chromatid Cohesion,Up,0.604550379,0.59588299,6,-1.035797588,-1.245419416,0.082838439,FALSE,Down,0.818,0.828,7,-1.394822534,-1.533810845,-0.137840667,FALSE
MET activates RAP1 and RAC1,Up,0.65872156,0.59588299,2,-0.720025007,-0.695608845,0.109732294,FALSE,Up,0.445,0.384,2,-0.145091533,-0.123018569,0.474104288,FALSE
Interleukin-12 signaling,Up,0.799566631,0.59588299,15,-0.567587986,-0.389016065,0.122219578,FALSE,Down,0.466,0.333,15,0.087485113,0.268247706,-0.201542184,FALSE
EML4 and NUDC in mitotic spindle formation,Up,0.604550379,0.59588299,6,-1.035797588,-1.245419416,0.082838439,FALSE,Down,0.818,0.828,7,-1.394822534,-1.533810845,-0.137840667,FALSE
RND2 GTPase cycle,Up,0.712892741,0.59588299,5,-0.671388472,-0.571582343,0.117821204,FALSE,Up,0.092,0.054,3,1.582158717,1.71536611,0.826482134,FALSE
Mitotic Prometaphase,Up,0.599133261,0.596966414,10,-0.764776639,-0.92571601,0.09313611,FALSE,Down,0.885,0.888,12,-1.534986473,-1.647220023,-0.100130993,FALSE
HATs acetylate histones,Down,0.669555796,0.600216685,2,-0.852745443,-0.905367715,-0.107134397,FALSE,Down,0.752,0.687,3,-0.812085869,-0.788507172,-0.31389108,FALSE
Negative regulation of NOTCH4 signaling,Up,0.336944745,0.601300108,9,-1.00787953,-1.842989014,0.170209993,FALSE,Up,0.436,0.719,19,-0.672014823,-2.367572873,0.017646003,FALSE
Lysosome Vesicle Biogenesis,Up,0.648970748,0.602383532,4,-0.914592968,-0.878709456,0.148354089,FALSE,Down,0.219,0.163,4,0.621553672,0.64963057,-0.033790839,FALSE
Hh mutants are degraded by ERAD,Up,0.202600217,0.603466956,9,-0.845104034,-1.685127763,0.164961975,FALSE,Up,0.303,0.657,19,-0.543686681,-2.244925577,0.003934184,FALSE
Hh mutants abrogate ligand secretion,Up,0.202600217,0.603466956,9,-0.845104034,-1.685127763,0.164961975,FALSE,Up,0.303,0.657,19,-0.543686681,-2.244925577,0.003934184,FALSE
Defective CFTR causes cystic fibrosis,Up,0.202600217,0.603466956,9,-0.845104034,-1.685127763,0.164961975,FALSE,Up,0.303,0.657,19,-0.543686681,-2.244925577,0.003934184,FALSE
Sphingolipid de novo biosynthesis,Up,0.747562297,0.604550379,3,-0.795717628,-0.720149486,0.129627762,FALSE,Up,0.018,0.009,1,2.980457846,3.08879291,1.867570959,FALSE
mRNA Splicing - Minor Pathway,Down,0.74539545,0.604550379,1,-0.919985715,-0.892039034,-0.016869604,FALSE,,,,,,,,
RHOBTB1 GTPase cycle,Up,0.719393283,0.604550379,4,-0.633953591,-0.557941125,0.007412018,FALSE,Up,0.411,0.312,4,0.210132334,0.308496301,0.124699109,FALSE
Metabolism of folate and pterines,Up,0.758396533,0.606717226,1,-0.832233055,-0.797685999,0.038416025,FALSE,Down,0.585,0.496,2,-0.385999829,-0.277504253,-0.070322233,FALSE
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",Down,0.656554713,0.606717226,2,-1.175869086,-1.174501939,-0.014099632,FALSE,Down,0.701,0.647,2,-0.864088037,-0.884030031,-0.128236862,FALSE
"Incretin synthesis, secretion, and inactivation",Down,0.656554713,0.606717226,2,-1.175869086,-1.174501939,-0.014099632,FALSE,Down,0.701,0.647,2,-0.864088037,-0.884030031,-0.128236862,FALSE
ER-Phagosome pathway,Up,0.373781148,0.609967497,11,-0.673379237,-1.380079733,0.153930943,FALSE,Down,0.646,0.802,21,-0.888196679,-2.473496979,-0.016432222,FALSE
Antigen processing-Cross presentation,Up,0.373781148,0.609967497,11,-0.673379237,-1.380079733,0.153930943,FALSE,Down,0.646,0.802,21,-0.888196679,-2.473496979,-0.016432222,FALSE
Oncogenic MAPK signaling,Up,0.711809317,0.612134345,15,-0.86603441,-0.832971878,0.031290239,FALSE,Up,0.199,0.148,13,1.017218288,0.915239182,0.006894435,FALSE
DCC mediated attractive signaling,Up,0.801733478,0.613217768,1,-0.945819146,-0.917762767,0.011717346,FALSE,,,,,,,,
Extra-nuclear estrogen signaling,Up,0.695557963,0.613217768,4,-1.194156191,-1.168725133,0.031671389,FALSE,Down,0.503,0.416,5,-0.250836591,-0.479336737,-0.340933712,FALSE
Regulation of PLK1 Activity at G2/M Transition,Up,0.44312026,0.616468039,13,-0.855354276,-1.103627819,0.094306271,FALSE,Down,0.803,0.871,13,-1.552355365,-1.80119404,-0.066548069,FALSE
Detoxification of Reactive Oxygen Species,Up,0.834236186,0.617551463,10,-0.728947195,-0.600418307,0.066270787,FALSE,Down,0.867,0.835,11,-1.464538835,-1.291264894,-0.127225126,FALSE
Prefoldin mediated transfer of substrate  to CCT/TriC,Down,0.732394366,0.617551463,9,-1.031127891,-1.051539208,-0.031394629,FALSE,Down,0.823,0.799,14,-1.130656083,-1.046320432,-0.162914416,FALSE
Transport of inorganic cations/anions and amino acids/oligopeptides,Down,0.788732394,0.617551463,3,-0.554568955,-0.462025023,-0.195132526,FALSE,Down,0.213,0.168,2,0.840579046,0.508990343,-0.786944712,FALSE
Host Interactions of HIV factors,Up,0.460455038,0.618634886,14,-1.057302035,-1.702059795,0.120948731,FALSE,Up,0.439,0.665,25,-0.578823805,-2.002546821,0.022492746,FALSE
Cell Cycle Checkpoints,Up,0.484290358,0.618634886,17,-1.451094634,-2.138045653,0.132462616,FALSE,Up,0.465,0.728,24,-0.778831814,-2.34768528,0.035135707,FALSE
Autophagy,Up,0.510292524,0.618634886,19,-0.698233585,-0.823449221,0.025773454,FALSE,Down,0.438,0.552,20,-0.547193715,-0.687240421,-0.082861118,FALSE
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Binding of TCF/LEF:CTNNB1 to target gene promoters,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Transcriptional Regulation by VENTX,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
RUNX3 regulates WNT signaling,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Germ layer formation at gastrulation,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Gastrulation,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Formation of paraxial mesoderm,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Formation of axial mesoderm,Up,0.729144095,0.61971831,1,-1.006983333,-0.987690438,0.005592315,FALSE,Up,0.645,0.592,1,-0.803016565,-0.788207116,0.043179078,FALSE
Signaling by NOTCH4,Up,0.365113759,0.622968581,10,-1.037067482,-1.809216715,0.140969907,FALSE,Up,0.62,0.797,20,-0.894600835,-2.536769432,0.018187849,FALSE
Downstream signaling events of B Cell Receptor (BCR),Up,0.391115926,0.625135428,9,-1.099771176,-1.925376418,0.17506909,FALSE,Down,0.342,0.65,20,-0.519525904,-2.285749776,-0.063926381,FALSE
Signaling by the B Cell Receptor (BCR),Up,0.391115926,0.625135428,9,-1.099771176,-1.925376418,0.17506909,FALSE,Down,0.342,0.65,20,-0.519525904,-2.285749776,-0.063926381,FALSE
TGF-beta receptor signaling activates SMADs,Up,0.369447454,0.627302275,7,-0.683160788,-0.900880875,0.131128366,FALSE,Down,0.664,0.744,6,-1.239185291,-1.512941705,-0.069357173,FALSE
Hedgehog ligand biogenesis,Up,0.226435536,0.627302275,10,-0.871373153,-1.659108582,0.164261113,FALSE,Up,0.368,0.674,20,-0.603371655,-2.253604568,0.014346118,FALSE
Mitochondrial protein import,Up,0.729144095,0.628385699,18,-0.908005554,-0.639790004,0.056185991,FALSE,Down,0.549,0.446,17,-0.446195009,-0.136777319,-0.126851865,FALSE
Ion channel transport,Up,0.502708559,0.628385699,15,-0.915385691,-0.884370544,0.010416601,FALSE,Down,0.744,0.773,12,-1.091397256,-1.31004202,-0.288799092,FALSE
Opioid Signalling,Up,0.628385699,0.630552546,8,-1.135092759,-1.245708024,0.034709193,FALSE,Down,0.678,0.625,6,-0.884722679,-1.145232983,-0.297528417,FALSE
Activation of NF-kappaB in B cells,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Autodegradation of Cdh1 by Cdh1:APC/C,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
SCF-beta-TrCP mediated degradation of Emi1,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
APC/C-mediated degradation of cell cycle proteins,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
APC/C:Cdc20 mediated degradation of Securin,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Regulation of APC/C activators between G1/S and early anaphase,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
APC/C:Cdc20 mediated degradation of mitotic proteins,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Vpu mediated degradation of CD4,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
SCF(Skp2)-mediated degradation of p27/p21,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Regulation of activated PAK-2p34 by proteasome mediated degradation,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Autodegradation of the E3 ubiquitin ligase COP1,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
PCP/CE pathway,Up,0.523293608,0.633802817,12,-1.366326055,-2.05057499,0.156532056,FALSE,Down,0.679,0.817,20,-0.978614095,-2.616349666,-0.001852167,FALSE
Regulation of mitotic cell cycle,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Asymmetric localization of PCP proteins,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Degradation of AXIN,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Degradation of DVL,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Dectin-1 mediated noncanonical NF-kB signaling,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Degradation of GLI1 by the proteasome,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Degradation of GLI2 by the proteasome,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
GLI3 is processed to GLI3R by the proteasome,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Hedgehog 'on' state,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Regulation of RAS by GAPs,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
TNFR2 non-canonical NF-kB pathway,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
NIK-->noncanonical NF-kB signaling,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
PTEN Regulation,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Orc1 removal from chromatin,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
CDK-mediated phosphorylation and removal of Cdc6,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Switching of origins to a post-replicative state,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Cyclin E associated events during G1/S transition ,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Synthesis of DNA,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
S Phase,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Stabilization of p53,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
p53-Dependent G1 DNA Damage Response,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
p53-Dependent G1/S DNA damage checkpoint,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
p53-Independent DNA Damage Response,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
p53-Independent G1/S DNA damage checkpoint,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
G1/S DNA Damage Checkpoints,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Cyclin A:Cdk2-associated events at S phase entry,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Ubiquitin-dependent degradation of Cyclin D,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Regulation of RUNX2 expression and activity,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Regulation of RUNX3 expression and activity,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Regulation of PTEN stability and activity,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Up,0.248104009,0.633802817,8,-0.980844951,-1.862498174,0.173461943,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Role of ABL in ROBO-SLIT signaling,Up,0.783315276,0.638136511,1,-0.83774433,-0.803896873,0.035670787,FALSE,Down,0.196,0.135,2,0.999237728,1.143172269,-0.237158504,FALSE
Regulation of mRNA stability by proteins that bind AU-rich elements,Up,0.490790899,0.638136511,12,-0.947145449,-1.668830589,0.178934527,FALSE,Down,0.25,0.518,23,-0.319121,-1.862871974,-0.001319661,FALSE
Glycogen storage disease type IV (GBE1),Down,0.74539545,0.639219935,1,-0.893864753,-0.864207048,-0.068660623,FALSE,Up,0.157,0.117,1,1.170121906,1.279534244,1.113205269,FALSE
UCH proteinases,Up,0.315276273,0.640303359,9,-1.066607447,-1.914481497,0.141001897,FALSE,Down,0.606,0.8,21,-0.844442432,-2.444951961,-0.04887826,FALSE
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,Down,0.702058505,0.641386782,1,-0.906692384,-0.878179061,-0.183635538,FALSE,,,,,,,,
RUNX2 regulates genes involved in differentiation of myeloid cells,Down,0.702058505,0.641386782,1,-0.906692384,-0.878179061,-0.183635538,FALSE,,,,,,,,
CD163 mediating an anti-inflammatory response,Up,0.74539545,0.641386782,1,-0.822702831,-0.803361739,0.037540832,FALSE,Down,0.165,0.11,1,1.032898981,1.013748307,-1.223003686,FALSE
Apoptotic cleavage of cellular proteins,Down,0.758396533,0.647887324,9,-1.348159695,-1.219891634,-0.049662209,FALSE,Up,0.059,0.04,5,2.088656361,2.128785881,0.375111732,FALSE
KEAP1-NFE2L2 pathway,Up,0.425785482,0.648970748,11,-1.211149282,-1.951683778,0.140155184,FALSE,Up,0.695,0.828,22,-1.0569289,-2.60846189,0.011486944,FALSE
Neddylation,Up,0.321776815,0.651137595,11,-1.214618073,-1.956554192,0.155635239,FALSE,Up,0.437,0.666,25,-0.551223113,-1.962134336,0.049173975,FALSE
Chromatin modifying enzymes,Down,0.673889491,0.652221018,4,-1.135219986,-1.126835703,-0.119273559,FALSE,Down,0.752,0.687,3,-0.812085869,-0.788507172,-0.31389108,FALSE
Chromatin organization,Down,0.673889491,0.652221018,4,-1.135219986,-1.126835703,-0.119273559,FALSE,Down,0.752,0.687,3,-0.812085869,-0.788507172,-0.31389108,FALSE
AUF1 (hnRNP D0) binds and destabilizes mRNA,Up,0.384615385,0.653304442,10,-0.931601348,-1.701300252,0.184742529,FALSE,Down,0.257,0.577,21,-0.451027861,-2.034881574,-0.035780837,FALSE
Chromosome Maintenance,Up,0.731310943,0.653304442,3,-0.958480547,-0.986564569,0.033528544,FALSE,Down,0.685,0.625,2,-0.755296007,-0.680708166,-0.277237089,FALSE
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Cleavage of the damaged pyrimidine ,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Recognition and association of DNA glycosylase with site containing an affected purine,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Cleavage of the damaged purine,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Packaging Of Telomere Ends,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
DNA Damage/Telomere Stress Induced Senescence,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
HDACs deacetylate histones,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Carnitine synthesis,Up,0.773564464,0.654387866,2,-0.770241968,-0.697556942,0.031649787,FALSE,Up,0.799,0.723,1,-1.01586759,-0.966315595,0.013082424,FALSE
Base Excision Repair,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Depurination,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
Depyrimidination,Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
"Base-Excision Repair, AP Site Formation",Down,0.704225352,0.654387866,1,-0.780390296,-0.804879165,-0.095590317,FALSE,,,,,,,,
SARS-CoV-2 activates/modulates innate and adaptive immune responses,Up,0.497291441,0.657638137,8,-1.120676104,-1.309466743,0.090561836,FALSE,Down,0.584,0.676,6,-1.201878628,-1.453996758,-0.310386177,FALSE
Synthesis of PA,Up,0.795232936,0.65872156,1,-0.845399228,-0.811961951,0.062029763,FALSE,Down,0.362,0.284,2,0.217154416,0.344645581,-0.536001372,FALSE
MAPK6/MAPK4 signaling,Up,0.343445287,0.659804984,9,-0.977680095,-1.789332819,0.171957038,FALSE,Up,0.586,0.768,20,-0.891076622,-2.514446833,0.000107968,FALSE
Gap junction degradation,Up,0.678223185,0.660888407,5,-1.192893897,-1.191208414,0.01124949,FALSE,Down,0.694,0.64,3,-0.653662748,-0.700508544,-0.226882649,FALSE
Formation of annular gap junctions,Up,0.678223185,0.660888407,5,-1.192893897,-1.191208414,0.01124949,FALSE,Down,0.694,0.64,3,-0.653662748,-0.700508544,-0.226882649,FALSE
EPH-ephrin mediated repulsion of cells,Up,0.678223185,0.660888407,5,-1.192893897,-1.191208414,0.01124949,FALSE,Down,0.694,0.64,3,-0.653662748,-0.700508544,-0.226882649,FALSE
Sema4D in semaphorin signaling,Up,0.720476706,0.661971831,6,-0.978060012,-0.860416623,0.103329323,FALSE,Down,0.075,0.044,2,1.94336525,1.984892828,-1.526611377,FALSE
SUMOylation,Up,0.7843987,0.665222102,4,-1.305730452,-1.233544917,0.062879823,FALSE,Down,0.656,0.575,1,-0.639245887,-0.582875743,-0.250727781,FALSE
SUMO E3 ligases SUMOylate target proteins,Up,0.7843987,0.665222102,4,-1.305730452,-1.233544917,0.062879823,FALSE,Down,0.656,0.575,1,-0.639245887,-0.582875743,-0.250727781,FALSE
Cellular response to hypoxia,Up,0.258938245,0.666305525,9,-1.216833181,-2.041903773,0.152898927,FALSE,Up,0.468,0.73,19,-0.729964051,-2.41842419,0.013354323,FALSE
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Up,0.258938245,0.666305525,9,-1.216833181,-2.041903773,0.152898927,FALSE,Up,0.468,0.73,19,-0.729964051,-2.41842419,0.013354323,FALSE
Vif-mediated degradation of APOBEC3G,Up,0.258938245,0.666305525,9,-1.216833181,-2.041903773,0.152898927,FALSE,Up,0.468,0.73,19,-0.729964051,-2.41842419,0.013354323,FALSE
Regulation of Apoptosis,Up,0.430119177,0.67063922,9,-1.154099961,-1.970932213,0.158584849,FALSE,Down,0.555,0.771,19,-0.851018482,-2.53037426,-0.005274355,FALSE
Gap junction trafficking and regulation,Up,0.706392199,0.671722644,9,-1.331555564,-1.421936784,0.041179043,FALSE,Down,0.863,0.853,9,-1.349730462,-1.470151669,-0.191114897,FALSE
Gap junction trafficking,Up,0.706392199,0.671722644,9,-1.331555564,-1.421936784,0.041179043,FALSE,Down,0.863,0.853,9,-1.349730462,-1.470151669,-0.191114897,FALSE
Transcriptional activation of mitochondrial biogenesis,Up,0.794149512,0.671722644,7,-0.625731431,-0.4908572,0.072868634,FALSE,Down,0.124,0.081,7,1.032415186,1.017898732,-0.312754613,FALSE
WNT5A-dependent internalization of FZD4,Up,0.698808234,0.672806067,3,-1.048609016,-1.007726552,0.097868135,FALSE,Up,0.555,0.467,1,-0.455328835,-0.44961803,0.093750177,FALSE
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",Up,0.698808234,0.672806067,3,-1.048609016,-1.007726552,0.097868135,FALSE,Up,0.555,0.467,1,-0.455328835,-0.44961803,0.093750177,FALSE
Terminal pathway of complement,Up,0.806067172,0.673889491,1,-0.883393969,-0.853568905,0.073823289,FALSE,Up,0.115,0.081,2,1.464404253,1.609537911,1.011977541,FALSE
Antimicrobial peptides,Up,0.806067172,0.673889491,1,-0.883393969,-0.853568905,0.073823289,FALSE,Up,0.01,0.008,1,3.046845682,3.201747839,1.911523402,TRUE
Ub-specific processing proteases,Up,0.635969664,0.677139762,13,-1.946485603,-2.615413873,0.108284081,FALSE,Down,0.778,0.866,23,-1.150503977,-2.638409835,-0.0521979,FALSE
Translation of Structural Proteins,Up,0.521126761,0.677139762,8,-0.966728354,-1.067733312,0.122434149,FALSE,Down,0.985,0.994,8,-2.448007017,-2.623424108,-0.074431209,FALSE
Late SARS-CoV-2 Infection Events,Up,0.521126761,0.677139762,8,-0.966728354,-1.067733312,0.122434149,FALSE,Down,0.985,0.994,8,-2.448007017,-2.623424108,-0.074431209,FALSE
Metabolism of nitric oxide: NOS3 activation and regulation,Up,0.764897075,0.678223185,1,-0.91762721,-0.901603899,0.034350914,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
eNOS activation,Up,0.764897075,0.678223185,1,-0.91762721,-0.901603899,0.034350914,FALSE,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
NOSTRIN mediated eNOS trafficking,Up,0.764897075,0.678223185,1,-0.91762721,-0.901603899,0.034350914,FALSE,,,,,,,,
FOXO-mediated transcription of cell cycle genes,Up,0.764897075,0.678223185,1,-0.91762721,-0.901603899,0.034350914,FALSE,,,,,,,,
Plasma lipoprotein clearance,Down,0.526543879,0.680390033,7,-1.192788887,-1.375546405,-0.047512074,FALSE,Up,0.226,0.371,8,0.047377975,-0.183140537,0.036901101,FALSE
PIP3 activates AKT signaling,Up,0.393282774,0.683640303,10,-1.259898596,-2.123910611,0.157036224,FALSE,Down,0.467,0.757,19,-0.818824773,-2.530553944,-0.003423162,FALSE
Mitotic G1 phase and G1/S transition,Up,0.393282774,0.683640303,10,-1.259898596,-2.123910611,0.157036224,FALSE,Down,0.681,0.843,20,-1.059976828,-2.71873952,-0.003969284,FALSE
G1/S Transition,Up,0.393282774,0.683640303,10,-1.259898596,-2.123910611,0.157036224,FALSE,Down,0.467,0.757,19,-0.818824773,-2.530553944,-0.003423162,FALSE
Association of TriC/CCT with target proteins during biosynthesis,Down,0.799566631,0.686890574,6,-1.133500316,-1.036837872,-0.068760742,FALSE,Down,0.609,0.525,8,-0.383632397,-0.214773543,-0.191083533,FALSE
Cargo trafficking to the periciliary membrane,Down,0.799566631,0.686890574,6,-1.133500316,-1.036837872,-0.068760742,FALSE,Down,0.361,0.29,7,0.414464768,0.585689816,-0.36378454,FALSE
BBSome-mediated cargo-targeting to cilium,Down,0.799566631,0.686890574,6,-1.133500316,-1.036837872,-0.068760742,FALSE,Down,0.465,0.368,6,0.085704678,0.238331772,-0.275702934,FALSE
Deadenylation-dependent mRNA decay,Down,0.754062839,0.689057421,2,-1.087638171,-1.043566962,-0.0530427,FALSE,Up,0.447,0.369,1,-0.186200961,-0.129492182,0.116770936,FALSE
Deadenylation of mRNA,Down,0.754062839,0.689057421,2,-1.087638171,-1.043566962,-0.0530427,FALSE,Up,0.447,0.369,1,-0.186200961,-0.129492182,0.116770936,FALSE
Interleukin-1 family signaling,Up,0.530877573,0.690140845,11,-1.360687287,-2.093497465,0.098087317,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
RHO GTPases activate PKNs,Up,0.744312026,0.690140845,14,-1.333239161,-1.310868562,0.078728136,FALSE,Down,0.18,0.12,8,0.968968952,0.936139053,-0.181856908,FALSE
Interleukin-1 signaling,Up,0.530877573,0.690140845,11,-1.360687287,-2.093497465,0.098087317,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Organelle biogenesis and maintenance,Down,0.797399783,0.691224269,37,-1.072407079,-0.884025617,-0.008298489,FALSE,Down,0.613,0.538,39,-0.666308171,-0.505676375,-0.131437506,FALSE
RNA Polymerase I Transcription,Up,0.798483207,0.692307692,3,-0.864917085,-0.882081091,0.042855167,FALSE,Up,0.822,0.754,1,-1.165971763,-1.122559212,0.009625464,FALSE
Nuclear events mediated by NFE2L2,Up,0.51787649,0.692307692,10,-1.345822396,-2.114159661,0.144474479,FALSE,Up,0.775,0.867,21,-1.174753285,-2.753659372,0.001829607,FALSE
Formation of the beta-catenin:TCF transactivating complex,Up,0.778981582,0.696641387,3,-1.098172903,-1.128617188,0.023243151,FALSE,Down,0.711,0.646,2,-0.904026147,-0.861889375,-0.115969539,FALSE
Intracellular signaling by second messengers,Up,0.471289274,0.696641387,14,-1.248880316,-1.992578604,0.123782303,FALSE,Down,0.517,0.76,21,-0.813640301,-2.554068978,-0.044808598,FALSE
Folding of actin by CCT/TriC,Down,0.801733478,0.69772481,7,-1.210269181,-1.139649012,-0.075891847,FALSE,Down,0.644,0.578,9,-0.474500135,-0.33684636,-0.212874147,FALSE
Separation of Sister Chromatids,Up,0.514626219,0.698808234,14,-1.419537783,-2.223234674,0.134623298,FALSE,Down,0.768,0.901,25,-1.297237746,-2.845513506,-0.044177049,FALSE
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,Up,0.436619718,0.700975081,5,-1.234393629,-1.464601893,0.108932341,FALSE,Down,0.544,0.664,5,-1.156626059,-1.476397369,-0.134897592,FALSE
Translesion Synthesis by POLH,Up,0.436619718,0.700975081,5,-1.234393629,-1.464601893,0.108932341,FALSE,Down,0.544,0.664,5,-1.156626059,-1.476397369,-0.134897592,FALSE
Ovarian tumor domain proteases,Up,0.436619718,0.700975081,5,-1.234393629,-1.464601893,0.108932341,FALSE,Down,0.714,0.786,6,-1.419352972,-1.689478828,-0.119458148,FALSE
DNA Damage Bypass,Up,0.436619718,0.700975081,5,-1.234393629,-1.464601893,0.108932341,FALSE,Down,0.592,0.689,6,-1.094040957,-1.360649645,-0.023952607,FALSE
RMTs methylate histone arginines,Down,0.836403034,0.702058505,1,-1.017035688,-0.996544673,-0.005520417,FALSE,,,,,,,,
Cilium Assembly,Up,0.774647887,0.705308776,15,-1.069887009,-1.1455332,0.034717395,FALSE,Down,0.741,0.722,19,-0.968312978,-0.953577497,-0.19726651,FALSE
Deubiquitination,Up,0.698808234,0.705308776,16,-1.987475078,-2.600666015,0.088530486,FALSE,Down,0.752,0.869,26,-1.115916511,-2.524660025,-0.061463247,FALSE
HCMV Late Events,Down,0.782231853,0.706392199,2,-1.19786566,-1.195603361,-0.055656746,FALSE,,,,,,,,
TCR signaling,Up,0.599133261,0.707475623,10,-1.439926291,-2.220411499,0.131778176,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Downstream TCR signaling,Up,0.599133261,0.707475623,10,-1.439926291,-2.220411499,0.131778176,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Fc epsilon receptor (FCERI) signaling,Up,0.599133261,0.707475623,10,-1.439926291,-2.220411499,0.131778176,FALSE,Down,0.298,0.641,19,-0.474633116,-2.290980869,-0.051696863,FALSE
FCERI mediated NF-kB activation,Up,0.599133261,0.707475623,10,-1.439926291,-2.220411499,0.131778176,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
CLEC7A (Dectin-1) signaling,Up,0.599133261,0.707475623,10,-1.439926291,-2.220411499,0.131778176,FALSE,Down,0.298,0.641,19,-0.474633116,-2.290980869,-0.051696863,FALSE
C-type lectin receptors (CLRs),Up,0.599133261,0.707475623,10,-1.439926291,-2.220411499,0.131778176,FALSE,Down,0.298,0.641,19,-0.474633116,-2.290980869,-0.051696863,FALSE
RUNX1 regulates transcription of genes involved in differentiation of HSCs,Up,0.490790899,0.707475623,10,-1.160352376,-1.971702961,0.145183268,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
RAF activation,Up,0.74864572,0.711809317,7,-1.216752674,-1.317012024,0.056904851,FALSE,Down,0.338,0.296,4,0.003874319,-0.349492624,-0.107162509,FALSE
HIV Infection,Up,0.540628386,0.713976165,15,-1.129809243,-1.740286111,0.100075073,FALSE,Down,0.362,0.586,28,-0.377254314,-1.681987515,-0.013258763,FALSE
Amyloid fiber formation,Up,0.439869989,0.715059588,11,-0.726934482,-0.828333585,0.018084581,FALSE,Up,0.164,0.292,8,0.393335207,0.194072955,0.227677445,FALSE
Class I MHC mediated antigen processing & presentation,Up,0.456121343,0.716143012,18,-0.946845229,-1.433864418,0.138540546,FALSE,Down,0.694,0.816,27,-0.900485129,-2.22343834,-0.02693843,FALSE
M Phase,Up,0.523293608,0.718309859,23,-1.170967726,-1.813460474,0.112827514,FALSE,Down,0.871,0.947,36,-1.497756542,-2.75272935,-0.027390348,FALSE
Sodium/Calcium exchangers,Down,0.873239437,0.719393283,2,-0.999101668,-0.946885626,-0.066360955,FALSE,Down,0.213,0.168,2,0.840579046,0.508990343,-0.786944712,FALSE
Transcriptional regulation by RUNX1,Up,0.644637053,0.720476706,12,-1.334686278,-2.04670518,0.08424101,FALSE,Down,0.398,0.716,18,-0.658984672,-2.396970714,-0.007752308,FALSE
Transcriptional regulation by RUNX3,Up,0.475622969,0.722643554,9,-1.260410599,-2.085210264,0.154809762,FALSE,Down,0.503,0.755,19,-0.825633215,-2.513867088,-0.005071709,FALSE
RNA Polymerase II Transcription,Up,0.645720477,0.723726977,43,-1.115644734,-1.401915576,0.093134684,FALSE,Up,0.387,0.568,40,-0.459972392,-1.636993352,0.014012624,FALSE
ROBO receptors bind AKAP5,Up,0.816901408,0.723726977,1,-0.918036759,-0.900180494,0.047656002,FALSE,,,,,,,,
Post-translational protein modification,Up,0.726977248,0.724810401,73,-1.373193117,-1.41313549,0.039514681,FALSE,Up,0.283,0.279,90,0.384116347,-0.122031119,0.001146373,FALSE
Generic Transcription Pathway,Up,0.624052004,0.725893824,41,-1.14741054,-1.462344012,0.10575675,FALSE,Down,0.466,0.631,39,-0.65452902,-1.859353821,-0.013857204,FALSE
Sphingolipid metabolism,Down,0.849404117,0.725893824,5,-0.908547805,-0.80047098,-0.012229812,FALSE,Up,0.074,0.046,3,1.864924763,1.999964719,0.167245063,FALSE
Membrane Trafficking,Up,0.70964247,0.726977248,39,-1.779641152,-1.775913683,0.054365147,FALSE,Down,0.438,0.428,52,0.005840211,-0.008139209,-0.085696104,FALSE
Interaction between L1 and Ankyrins,Down,0.81148429,0.729144095,8,-1.660875795,-1.612537842,-0.038832158,FALSE,Up,0.097,0.057,5,1.772674425,1.730228484,0.015064397,FALSE
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,Up,0.577464789,0.73347779,5,-1.330012838,-1.51524535,0.134211269,FALSE,Down,0.726,0.767,5,-1.507747349,-1.778511194,-0.246599472,FALSE
Iron uptake and transport,Up,0.469122427,0.73347779,5,-1.185075553,-1.356515438,0.12657783,FALSE,Up,0.563,0.664,8,-0.874730397,-0.999582509,0.000187929,FALSE
SUMOylation of RNA binding proteins,Up,0.845070423,0.734561213,2,-1.297214702,-1.258794065,0.000437442,FALSE,,,,,,,,
Gene expression (Transcription),Up,0.686890574,0.734561213,47,-1.168127258,-1.426324008,0.078622233,FALSE,Down,0.505,0.662,46,-0.674479495,-1.738339078,-0.01673553,FALSE
RHO GTPases activate CIT,Up,0.79631636,0.735644637,7,-1.451288938,-1.358712181,0.033149046,FALSE,Down,0.108,0.069,3,1.724524878,1.800544294,-0.787717439,FALSE
Peptide hormone metabolism,Down,0.819068256,0.736728061,4,-1.268812171,-1.236326474,-0.002203585,FALSE,Up,0.396,0.321,8,0.07743069,0.196695881,0.133528838,FALSE
Antigen processing: Ubiquitination & Proteasome degradation,Up,0.687973998,0.739978332,13,-1.670047457,-2.317541768,0.136036037,FALSE,Down,0.428,0.668,22,-0.544722596,-2.05461792,-0.050089602,FALSE
RHO GTPases Activate ROCKs,Up,0.798483207,0.742145179,8,-1.601300501,-1.504788503,0.046721063,FALSE,Down,0.108,0.069,3,1.724524878,1.800544294,-0.787717439,FALSE
Entry of Influenza Virion into Host Cell via Endocytosis,Up,0.794149512,0.743228602,2,-1.139020539,-1.118935845,0.071850571,FALSE,Up,0.555,0.467,1,-0.455328835,-0.44961803,0.093750177,FALSE
Retrograde neurotrophin signalling,Up,0.794149512,0.743228602,2,-1.139020539,-1.118935845,0.071850571,FALSE,Up,0.555,0.467,1,-0.455328835,-0.44961803,0.093750177,FALSE
Regulation of TNFR1 signaling,Up,0.502708559,0.743228602,5,-1.553374575,-1.748411056,0.082453653,FALSE,Down,0.597,0.696,5,-1.258603718,-1.519715186,-0.290454744,FALSE
TNFR1-induced NFkappaB signaling pathway,Up,0.502708559,0.743228602,5,-1.553374575,-1.748411056,0.082453653,FALSE,Down,0.597,0.696,5,-1.258603718,-1.519715186,-0.290454744,FALSE
Deposition of new CENPA-containing nucleosomes at the centromere,Down,0.806067172,0.743228602,2,-1.092776516,-1.093559906,-0.029570912,FALSE,Down,0.561,0.469,1,-0.475469472,-0.430688527,-0.275118156,FALSE
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Down,0.842903575,0.743228602,8,-1.445464411,-1.370200406,-0.060018451,FALSE,Down,0.673,0.601,10,-0.608122814,-0.477976382,-0.212797387,FALSE
TNF signaling,Up,0.502708559,0.743228602,5,-1.553374575,-1.748411056,0.082453653,FALSE,Down,0.597,0.696,5,-1.258603718,-1.519715186,-0.290454744,FALSE
Nucleosome assembly,Down,0.806067172,0.743228602,2,-1.092776516,-1.093559906,-0.029570912,FALSE,Down,0.561,0.469,1,-0.475469472,-0.430688527,-0.275118156,FALSE
LDL clearance,Up,0.794149512,0.743228602,2,-1.139020539,-1.118935845,0.071850571,FALSE,Down,0.527,0.439,2,-0.276576604,-0.209475333,-0.269355483,FALSE
Signaling by NTRKs,Up,0.735644637,0.744312026,6,-1.394367709,-1.496447926,0.098615794,FALSE,Down,0.306,0.258,7,0.415425316,0.42001841,-0.159912468,FALSE
Signaling by NTRK1 (TRKA),Up,0.735644637,0.744312026,6,-1.394367709,-1.496447926,0.098615794,FALSE,Down,0.306,0.258,7,0.415425316,0.42001841,-0.159912468,FALSE
EPH-Ephrin signaling,Up,0.768147346,0.744312026,12,-1.963184865,-1.897168742,0.052750699,FALSE,Down,0.372,0.304,6,0.239310397,0.247787037,-0.609277073,FALSE
"Interleukin-3, Interleukin-5 and GM-CSF signaling",Up,0.628385699,0.746478873,5,-1.452779874,-1.676394986,0.118378772,FALSE,Down,0.733,0.787,5,-1.40678366,-1.715480963,-0.082792678,FALSE
Oxidative Stress Induced Senescence,Up,0.472372698,0.747562297,7,-1.07778227,-1.273118128,0.040668781,FALSE,Down,0.862,0.886,6,-1.731453505,-1.967593033,-0.191992143,FALSE
Cellular Senescence,Up,0.472372698,0.747562297,7,-1.07778227,-1.273118128,0.040668781,FALSE,Down,0.862,0.886,6,-1.731453505,-1.967593033,-0.191992143,FALSE
Regulation of NF-kappa B signaling,Up,0.569880823,0.747562297,5,-1.323111329,-1.524682793,0.04177564,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Apoptosis,Up,0.633802817,0.74864572,27,-1.252270076,-1.655531782,0.082904547,FALSE,Up,0.303,0.493,33,-0.194113489,-1.463495949,0.057989057,FALSE
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Up,0.833152763,0.74864572,6,-1.054316147,-0.978376897,0.117786939,FALSE,Up,0.251,0.175,5,0.558612148,0.575795513,0.170899705,FALSE
Neurodegenerative Diseases,Up,0.833152763,0.74864572,6,-1.054316147,-0.978376897,0.117786939,FALSE,Up,0.251,0.175,5,0.558612148,0.575795513,0.170899705,FALSE
Defective Intrinsic Pathway for Apoptosis,Up,0.833152763,0.74864572,6,-1.054316147,-0.978376897,0.117786939,FALSE,Up,0.251,0.175,5,0.558612148,0.575795513,0.170899705,FALSE
Nuclear events stimulated by ALK signaling in cancer,Up,0.809317443,0.750812568,4,-1.267128798,-1.250265521,0.084791616,FALSE,Up,0.571,0.488,2,-0.386140952,-0.351099421,0.217034969,FALSE
Assembly Of The HIV Virion,Up,0.629469122,0.752979415,5,-1.576065454,-1.786929288,0.127125147,FALSE,Down,0.703,0.758,5,-1.460942643,-1.753719626,-0.237013243,FALSE
Netrin-1 signaling,Down,0.864572048,0.754062839,2,-1.327180454,-1.287752082,-0.00180589,FALSE,Up,0.758,0.68,1,-0.928608408,-0.878914182,0.019371916,FALSE
Protein localization,Up,0.747562297,0.754062839,30,-1.458195998,-1.242185977,0.066622243,FALSE,Down,0.316,0.301,32,-0.068215962,0.196440252,-0.116566078,FALSE
Josephin domain DUBs,Up,0.575297941,0.755146262,6,-1.431031595,-1.626729636,0.095862112,FALSE,Down,0.544,0.664,5,-1.156626059,-1.476397369,-0.134897592,FALSE
Stimuli-sensing channels,Up,0.591549296,0.756229686,7,-1.273990193,-1.378991554,0.028809421,FALSE,Down,0.765,0.788,8,-1.331630862,-1.699982349,-0.316942451,FALSE
Death Receptor Signaling,Up,0.557963164,0.759479957,7,-1.522039497,-1.67125069,0.082628122,FALSE,Down,0.369,0.517,6,-0.609187037,-0.910400102,-0.199947074,FALSE
Negative regulation of MAPK pathway,Up,0.561213434,0.762730228,8,-1.415746804,-1.667394182,0.064205641,FALSE,Down,0.771,0.839,7,-1.621668198,-1.941449604,-0.07884354,FALSE
Nuclear Envelope Breakdown,Up,0.85915493,0.763813651,1,-0.943051498,-0.920431859,0.031079394,FALSE,Up,0.181,0.139,1,0.991549434,1.007615089,0.625026212,FALSE
Breakdown of the nuclear lamina,Up,0.85915493,0.763813651,1,-0.943051498,-0.920431859,0.031079394,FALSE,Up,0.181,0.139,1,0.991549434,1.007615089,0.625026212,FALSE
Depolymerisation of the Nuclear Lamina,Up,0.85915493,0.763813651,1,-0.943051498,-0.920431859,0.031079394,FALSE,Up,0.181,0.139,1,0.991549434,1.007615089,0.625026212,FALSE
Carnitine metabolism,Down,0.873239437,0.767063922,3,-1.27363222,-1.205452312,-0.00078413,FALSE,Down,0.766,0.702,3,-0.921693311,-0.808110534,-0.012609928,FALSE
Beta-catenin independent WNT signaling,Up,0.690140845,0.768147346,15,-1.820810561,-2.43400965,0.121092922,FALSE,Down,0.676,0.832,24,-1.079925192,-2.696392156,-0.059827863,FALSE
Formation of tubulin folding intermediates by CCT/TriC,Down,0.848320693,0.769230769,10,-1.29772673,-1.309787292,-0.009820051,FALSE,Down,0.765,0.739,14,-1.069603697,-1.016824776,-0.183432456,FALSE
Degradation of beta-catenin by the destruction complex,Up,0.603466956,0.770314193,11,-1.504883076,-2.322869182,0.143268596,FALSE,Down,0.569,0.797,20,-0.977651629,-2.642727357,-0.00109305,FALSE
p75 NTR receptor-mediated signalling,Up,0.612134345,0.77248104,6,-1.45034748,-1.632851985,0.102304677,FALSE,Down,0.378,0.522,5,-0.755848355,-1.125742108,-0.127237545,FALSE
"Cell death signalling via NRAGE, NRIF and NADE",Up,0.612134345,0.77248104,6,-1.45034748,-1.632851985,0.102304677,FALSE,Down,0.378,0.522,5,-0.755848355,-1.125742108,-0.127237545,FALSE
Signaling by Receptor Tyrosine Kinases,Up,0.731310943,0.77248104,38,-1.166398959,-1.153698671,0.101665622,FALSE,Down,0.181,0.222,24,0.432316573,0.251848875,-0.023969929,FALSE
Surfactant metabolism,Up,0.860238353,0.773564464,1,-0.942169481,-0.915803966,0.046245031,FALSE,Up,0.493,0.414,1,-0.294092046,-0.234016041,0.374392286,FALSE
Negative regulators of DDX58/IFIH1 signaling,Up,0.676056338,0.773564464,6,-1.596570942,-1.769968009,0.04518783,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Cargo recognition for clathrin-mediated endocytosis,Up,0.70964247,0.774647887,7,-1.820038225,-1.977865427,0.105900554,FALSE,Down,0.905,0.928,9,-1.831294885,-1.978854197,-0.20977319,FALSE
Translesion synthesis by REV1,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Recognition of DNA damage by PCNA-containing replication complex,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.686,0.755,5,-1.388956873,-1.662283588,-0.071601336,FALSE
Signaling by ERBB2,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by ERBB4,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Up,0.383,0.546,5,-0.722148753,-1.024923942,0.061513772,FALSE
Downregulation of ERBB4 signaling,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Downregulation of ERBB2:ERBB3 signaling,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by EGFR in Cancer,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
APC/C:Cdc20 mediated degradation of Cyclin B,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Membrane binding and targetting of GAG proteins,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
"Synthesis And Processing Of GAG, GAGPOL Polyproteins",Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by EGFR,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
APC-Cdc20 mediated degradation of Nek2A,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
EGFR downregulation,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
p75NTR signals via NF-kB,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by NOTCH1,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by NOTCH2,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
NRIF signals cell death from the nucleus,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
p75NTR recruits signalling complexes,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
NF-kB is activated and signals survival,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
NOTCH1 Intracellular Domain Regulates Transcription,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Activated NOTCH1 Transmits Signal to the Nucleus,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Downregulation of SMAD2/3:SMAD4 transcriptional activity,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Oncogene Induced Senescence,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by NOTCH1 PEST Domain Mutants in Cancer,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by NOTCH1 in Cancer,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Constitutive Signaling by NOTCH1 PEST Domain Mutants,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by NOTCH1 HD Domain Mutants in Cancer,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Constitutive Signaling by NOTCH1 HD Domain Mutants,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
NOTCH2 Activation and Transmission of Signal to the Nucleus,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of innate immune responses to cytosolic DNA,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of FZD by ubiquitination,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by Ligand-Responsive EGFR Variants in Cancer,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Translesion synthesis by POLK,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Translesion synthesis by POLI,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Termination of translesion DNA synthesis,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
MAP3K8 (TPL2)-dependent MAPK1/3 activation,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
HDR through Homologous Recombination (HRR),Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Metalloprotease DUBs,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Gap-filling DNA repair synthesis and ligation in GG-NER,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Dual Incision in GG-NER,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.686,0.755,5,-1.388956873,-1.662283588,-0.071601336,FALSE
Formation of TC-NER Pre-Incision Complex,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.803,0.848,7,-1.561814139,-1.752655795,-0.14514987,FALSE
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.803,0.848,7,-1.561814139,-1.752655795,-0.14514987,FALSE
Dual incision in TC-NER,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.686,0.755,5,-1.388956873,-1.662283588,-0.071601336,FALSE
Gap-filling DNA repair synthesis and ligation in TC-NER,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.686,0.755,5,-1.388956873,-1.662283588,-0.071601336,FALSE
Fanconi Anemia Pathway,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of TP53 Activity through Phosphorylation,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of TP53 Activity through Methylation,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Negative regulation of MET activity,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Downregulation of ERBB2 signaling,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
InlB-mediated entry of Listeria monocytogenes into host cell,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of PTEN localization,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
ER Quality Control Compartment (ERQC),Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.652,0.734,5,-1.331225211,-1.594769344,-0.056410403,FALSE
Signaling by NOTCH3,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
NOTCH3 Activation and Transmission of Signal to the Nucleus,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
TICAM1-dependent activation of IRF3/IRF7,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
"TICAM1,TRAF6-dependent induction of TAK1 complex",Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of signaling by CBL,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Endosomal Sorting Complex Required For Transport (ESCRT),Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
IRAK2 mediated activation of TAK1 complex,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
TRAF6-mediated induction of TAK1 complex within TLR4 complex,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
FLT3 Signaling,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Prevention of phagosomal-lysosomal fusion,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.502,0.632,5,-1.030970939,-1.328193289,-0.339826668,FALSE
Modulation by Mtb of host immune system,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Alpha-protein kinase 1 signaling pathway,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
RAS processing,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.524,0.639,5,-1.022015878,-1.56617566,-0.346295569,FALSE
Pexophagy,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by CSF1 (M-CSF) in myeloid cells,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Maturation of protein E,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Maturation of protein E,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
RND3 GTPase cycle,Down,0.812567714,0.775731311,4,-1.206164736,-1.1378903,-0.020870197,FALSE,Up,0.492,0.414,2,-0.16976118,-0.083220566,0.305937721,FALSE
Negative regulation of FLT3,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
FLT3 signaling by CBL mutants,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Regulation of BACH1 activity,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Up,0.593716143,0.775731311,4,-1.499562214,-1.743753229,0.111924868,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,Down,0.834236186,0.780065005,11,-1.365649239,-1.392203075,-0.019716272,FALSE,Down,0.822,0.815,16,-1.213930568,-1.164075823,-0.166886491,FALSE
Chaperonin-mediated protein folding,Down,0.851570964,0.780065005,13,-1.620068341,-1.651121574,-0.021881704,FALSE,Down,0.857,0.842,18,-1.342017767,-1.310581409,-0.181638303,FALSE
Protein folding,Down,0.851570964,0.780065005,13,-1.620068341,-1.651121574,-0.021881704,FALSE,Down,0.849,0.831,19,-1.325038658,-1.274779376,-0.194249559,FALSE
Nonhomologous End-Joining (NHEJ),Down,0.819068256,0.780065005,2,-1.234043216,-1.241763195,-0.062255598,FALSE,Down,0.479,0.373,2,-0.107452855,-0.022223171,-0.28735599,FALSE
FGFR2 alternative splicing,Down,0.860238353,0.782231853,3,-1.36034016,-1.304961471,-0.039445862,FALSE,,,,,,,,
Transcriptional Regulation by TP53,Up,0.736728061,0.7843987,25,-1.729363474,-1.773396983,0.050898592,FALSE,Down,0.769,0.831,19,-1.454793802,-1.576555282,-0.017933185,FALSE
Mitophagy,Up,0.735644637,0.785482124,6,-1.802088021,-1.977492205,0.100007126,FALSE,Down,0.789,0.828,7,-1.509825668,-1.708096685,-0.265306246,FALSE
PINK1-PRKN Mediated Mitophagy,Up,0.735644637,0.785482124,6,-1.802088021,-1.977492205,0.100007126,FALSE,Down,0.789,0.828,7,-1.509825668,-1.708096685,-0.265306246,FALSE
Beta-catenin phosphorylation cascade,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
Signaling by WNT in cancer,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
Signaling by CTNNB1 phospho-site mutants,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
Signaling by GSK3beta mutants,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
CTNNB1 S33 mutants aren't phosphorylated,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
CTNNB1 S37 mutants aren't phosphorylated,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
CTNNB1 S45 mutants aren't phosphorylated,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
CTNNB1 T41 mutants aren't phosphorylated,Up,0.799566631,0.786565547,3,-1.279918603,-1.406509064,0.062753002,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
Peroxisomal protein import,Up,0.660888407,0.788732394,10,-1.20079401,-1.220703894,0.059697757,FALSE,Down,0.408,0.504,14,-0.408010753,-0.377803619,-0.245800267,FALSE
Programmed Cell Death,Up,0.696641387,0.789815818,28,-1.309015056,-1.695920921,0.07308095,FALSE,Up,0.222,0.394,34,-0.011191823,-1.245632484,0.045729025,FALSE
SLC-mediated transmembrane transport,Down,0.918743229,0.790899242,5,-0.978904156,-0.8712031,-0.138603067,FALSE,Down,0.261,0.175,5,0.699170646,0.590650193,-0.034481394,FALSE
Protein ubiquitination,Up,0.674972914,0.791982665,8,-1.584012319,-1.743637956,0.080438423,FALSE,Down,0.601,0.705,6,-1.202481329,-1.466750448,-0.169784387,FALSE
EPHA-mediated growth cone collapse,Up,0.863488624,0.794149512,5,-1.648449464,-1.581903594,0.064282795,FALSE,Down,0.075,0.044,2,1.94336525,1.984892828,-1.526611377,FALSE
Sema4D induced cell migration and growth-cone collapse,Up,0.863488624,0.794149512,5,-1.648449464,-1.581903594,0.064282795,FALSE,Down,0.075,0.044,2,1.94336525,1.984892828,-1.526611377,FALSE
Toll-like Receptor Cascades,Up,0.678223185,0.795232936,11,-1.330439712,-1.493238164,0.042310009,FALSE,Down,0.598,0.755,9,-1.073993108,-1.247752706,-0.037615604,FALSE
SARS-CoV Infections,Up,0.802816901,0.800650054,48,-1.69663971,-1.686307563,0.08547501,FALSE,Up,0.943,0.946,31,-1.862585482,-2.070369691,0.028433718,FALSE
SARS-CoV-2 Infection,Up,0.791982665,0.800650054,37,-1.839811133,-1.850167861,0.075135557,FALSE,Up,0.881,0.924,22,-1.825607989,-1.929775762,0.016373398,FALSE
mRNA Splicing - Major Pathway,Down,0.860238353,0.803900325,17,-2.12095391,-1.940585126,-0.015139261,FALSE,Up,0.116,0.067,4,1.441190358,1.553873773,0.273646153,FALSE
mRNA Splicing,Down,0.860238353,0.803900325,17,-2.12095391,-1.940585126,-0.015139261,FALSE,Up,0.116,0.067,4,1.441190358,1.553873773,0.273646153,FALSE
Processing of Capped Intron-Containing Pre-mRNA,Down,0.860238353,0.803900325,17,-2.12095391,-1.940585126,-0.015139261,FALSE,Up,0.116,0.067,4,1.441190358,1.553873773,0.273646153,FALSE
Pyruvate metabolism,Up,0.887323944,0.807150596,10,-1.177791513,-1.004856121,0.129451307,FALSE,Down,0.888,0.846,11,-1.46634372,-1.255394594,-0.021729127,FALSE
Signaling by CSF3 (G-CSF),Up,0.630552546,0.80823402,5,-1.733120614,-1.94326714,0.087218853,FALSE,Down,0.718,0.779,5,-1.519747501,-1.814608428,-0.099101062,FALSE
Inactivation of CSF3 (G-CSF) signaling,Up,0.630552546,0.80823402,5,-1.733120614,-1.94326714,0.087218853,FALSE,Down,0.718,0.779,5,-1.519747501,-1.814608428,-0.099101062,FALSE
Clathrin-mediated endocytosis,Up,0.770314193,0.81148429,12,-1.718186479,-1.828596989,0.083471182,FALSE,Down,0.779,0.837,14,-1.385789987,-1.489028824,-0.11850897,FALSE
Signaling by PTK6,Up,0.641386782,0.814734561,5,-1.431803899,-1.622634584,0.068806809,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Signaling by Non-Receptor Tyrosine Kinases,Up,0.641386782,0.814734561,5,-1.431803899,-1.622634584,0.068806809,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Diseases of programmed cell death,Up,0.889490791,0.815817985,8,-1.229533011,-1.189232,0.096357347,FALSE,Up,0.251,0.175,5,0.558612148,0.575795513,0.170899705,FALSE
Downregulation of TGF-beta receptor signaling,Up,0.622968581,0.817984832,5,-1.516100852,-1.723935069,0.100891863,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Circadian Clock,Up,0.622968581,0.817984832,5,-1.516100852,-1.723935069,0.100891863,FALSE,Down,0.394,0.564,5,-0.742162509,-0.998026761,-0.402124276,FALSE
SARS-CoV-1 Infection,Up,0.817984832,0.817984832,34,-1.878759497,-1.903606649,0.091857835,FALSE,Up,0.907,0.922,21,-1.715927568,-2.057793565,0.015687596,FALSE
Recycling pathway of L1,Up,0.851570964,0.821235103,11,-1.675980847,-1.737063011,0.032607216,FALSE,Down,0.903,0.905,12,-1.67412985,-1.727916073,-0.186962975,FALSE
RIPK1-mediated regulated necrosis,Up,0.699891658,0.821235103,5,-1.528931533,-1.725833479,0.051108666,FALSE,Down,0.412,0.558,5,-0.87761923,-1.136586895,-0.249526207,FALSE
Regulation of necroptotic cell death,Up,0.699891658,0.821235103,5,-1.528931533,-1.725833479,0.051108666,FALSE,Down,0.412,0.558,5,-0.87761923,-1.136586895,-0.249526207,FALSE
Disease,Up,0.850487541,0.822318527,144,-1.904184642,-1.860117382,0.053448184,FALSE,Down,0.765,0.833,120,-1.021199086,-1.470082452,-0.042881929,FALSE
TAK1-dependent IKK and NF-kappa-B activation  ,Up,0.743228602,0.82340195,7,-1.790706908,-1.951397198,0.019852059,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Diseases of signal transduction by growth factor receptors and second messengers,Up,0.776814735,0.824485374,38,-1.844153814,-2.212197051,0.064576685,FALSE,Down,0.41,0.565,45,-0.404110026,-1.523684503,-0.011437582,FALSE
TCF dependent signaling in response to WNT,Up,0.778981582,0.830985915,15,-1.821143328,-2.539088629,0.121242466,FALSE,Up,0.67,0.833,22,-1.061967691,-2.643656897,0.008083475,FALSE
E3 ubiquitin ligases ubiquitinate target proteins,Up,0.739978332,0.833152763,7,-1.702876873,-1.901564868,0.060021501,FALSE,Down,0.544,0.664,5,-1.156626059,-1.476397369,-0.134897592,FALSE
Regulated Necrosis,Up,0.61971831,0.834236186,6,-1.359203284,-1.527912229,0.074006497,FALSE,Down,0.43,0.578,6,-0.789076187,-1.014132627,-0.314103555,FALSE
MyD88-independent TLR4 cascade ,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
Toll Like Receptor 9 (TLR9) Cascade,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Up,0.431,0.612,7,-0.769445605,-0.989330935,0.00122218,FALSE
Toll Like Receptor 10 (TLR10) Cascade,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
Toll Like Receptor 3 (TLR3) Cascade,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
Toll Like Receptor 5 (TLR5) Cascade,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
Toll Like Receptor 7/8 (TLR7/8) Cascade,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
TRIF(TICAM1)-mediated TLR4 signaling ,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
MyD88 dependent cascade initiated on endosome,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
MyD88 cascade initiated on plasma membrane,Up,0.769230769,0.836403034,9,-1.982555289,-2.203788806,0.035736789,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
Spry regulation of FGF signaling,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Regulation of TP53 Activity,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Negative regulation of FGFR1 signaling,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Negative regulation of FGFR2 signaling,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Negative regulation of FGFR3 signaling,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Negative regulation of FGFR4 signaling,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Signaling by FGFR1,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Signaling by FGFR3,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Signaling by FGFR4,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Regulation of TP53 Degradation,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Regulation of TP53 Expression and Degradation,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Cyclin D associated events in G1,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.94,0.956,6,-2.023596828,-2.316602438,-0.138103855,FALSE
G1 Phase,Up,0.751895991,0.838569881,6,-1.71832732,-2.015097714,0.105061027,FALSE,Down,0.94,0.956,6,-2.023596828,-2.316602438,-0.138103855,FALSE
Budding and maturation of HIV virion,Up,0.738894908,0.840736728,6,-1.610074064,-1.782930461,0.073911599,FALSE,Down,0.472,0.608,6,-0.905057452,-1.133915844,-0.257319709,FALSE
Disassembly of the destruction complex and recruitment of AXIN to the membrane,Up,0.864572048,0.84723727,4,-1.56725563,-1.66887453,0.05565248,FALSE,Up,0.739,0.706,2,-1.114651889,-1.166125539,0.05884027,FALSE
Senescence-Associated Secretory Phenotype (SASP),Up,0.739978332,0.848320693,6,-1.589813703,-1.818598483,0.085306102,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
VLDLR internalisation and degradation,Up,0.815817985,0.848320693,6,-1.882001235,-2.06978646,0.098566769,FALSE,Down,0.725,0.778,5,-1.550750354,-1.849239245,-0.159005764,FALSE
Myoclonic epilepsy of Lafora,Up,0.702058505,0.850487541,5,-1.592281381,-1.791357195,0.106042302,FALSE,Down,0.834,0.872,5,-1.737529695,-2.015943937,-0.155921062,FALSE
DNA Damage Recognition in GG-NER,Up,0.79631636,0.850487541,6,-1.702316764,-1.907629446,0.059921994,FALSE,Down,0.853,0.908,9,-1.648688468,-1.823615887,-0.186485146,FALSE
Macroautophagy,Up,0.81148429,0.852654388,16,-1.823935645,-1.972509903,0.110404279,FALSE,Down,0.558,0.654,17,-0.883504781,-1.069932183,-0.129190411,FALSE
Selective autophagy,Up,0.81148429,0.852654388,16,-1.823935645,-1.972509903,0.110404279,FALSE,Down,0.558,0.654,17,-0.883504781,-1.069932183,-0.129190411,FALSE
SARS-CoV-2-host interactions,Up,0.837486457,0.852654388,29,-2.292622809,-2.363351314,0.054401728,FALSE,Down,0.751,0.809,16,-1.384468118,-1.544438418,-0.059319485,FALSE
HIV Life Cycle,Up,0.797399783,0.853737811,7,-1.821830707,-1.974879808,0.061694913,FALSE,Down,0.55,0.65,10,-0.864848949,-0.990074271,-0.150153283,FALSE
Late Phase of HIV Life Cycle,Up,0.797399783,0.853737811,7,-1.821830707,-1.974879808,0.061694913,FALSE,Down,0.51,0.63,8,-0.913204092,-1.095825101,-0.115852606,FALSE
Signaling by WNT,Up,0.817984832,0.854821235,21,-2.2528804,-2.837944616,0.106749665,FALSE,Down,0.723,0.858,28,-1.152205736,-2.639082001,-0.070008076,FALSE
Cellular responses to stress,Up,0.849404117,0.863488624,95,-1.587238181,-1.589111652,0.024153867,FALSE,Up,0.652,0.749,71,-0.834270627,-1.516879698,0.012611909,FALSE
Cellular responses to stimuli,Up,0.849404117,0.863488624,95,-1.587238181,-1.589111652,0.024153867,FALSE,Up,0.652,0.749,71,-0.834270627,-1.516879698,0.012611909,FALSE
NOD1/2 Signaling Pathway,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
"TICAM1, RIP1-mediated IKK complex recruitment",Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Interleukin-17 signaling,Up,0.810400867,0.864572048,8,-2.117156695,-2.365123163,0.070056546,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
MAP kinase activation,Up,0.810400867,0.864572048,8,-2.117156695,-2.365123163,0.070056546,FALSE,Down,0.758,0.837,6,-1.519878841,-1.818292898,-0.195386355,FALSE
activated TAK1 mediates p38 MAPK activation,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
IRAK1 recruits IKK complex,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
IKK complex recruitment mediated by RIP1,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Up,0.832069339,0.864572048,6,-1.950742076,-2.139679825,0.06296428,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
DNA Repair,Up,0.807150596,0.865655471,9,-1.892023914,-2.072093349,0.036887,FALSE,Down,0.797,0.857,12,-1.348709515,-1.477495405,-0.169898938,FALSE
Deactivation of the beta-catenin transactivating complex,Up,0.804983749,0.867822319,6,-1.737299737,-1.933555181,0.099581029,FALSE,Down,0.825,0.86,6,-1.612042046,-1.887796908,-0.061797385,FALSE
Aggrephagy,Up,0.781148429,0.867822319,13,-1.627415226,-1.808797982,0.101101018,FALSE,Down,0.577,0.693,13,-0.98667413,-1.232165994,-0.080893968,FALSE
Nucleotide Excision Repair,Up,0.872156013,0.876489707,7,-1.940703114,-2.125656302,0.047230155,FALSE,Down,0.853,0.908,9,-1.648688468,-1.823615887,-0.186485146,FALSE
Global Genome Nucleotide Excision Repair (GG-NER),Up,0.872156013,0.876489707,7,-1.940703114,-2.125656302,0.047230155,FALSE,Down,0.853,0.908,9,-1.648688468,-1.823615887,-0.186485146,FALSE
Mitotic Prophase,Up,0.900325027,0.876489707,6,-1.570068403,-1.675874116,0.043034665,FALSE,Down,0.422,0.377,4,-0.025940271,0.003497604,-0.017019765,FALSE
Glycogen storage diseases,Up,0.873239437,0.881906826,6,-1.818466142,-1.988088957,0.076925148,FALSE,Up,0.622,0.697,6,-1.108440079,-1.317928947,0.055599993,FALSE
Diseases of carbohydrate metabolism,Up,0.873239437,0.881906826,6,-1.818466142,-1.988088957,0.076925148,FALSE,Up,0.734,0.79,7,-1.374170136,-1.551681144,0.053338948,FALSE
DNA Double-Strand Break Repair,Up,0.834236186,0.881906826,6,-1.936862604,-2.140700864,0.053864713,FALSE,Down,0.652,0.734,6,-1.291785633,-1.517391509,-0.243915163,FALSE
Homology Directed Repair,Up,0.834236186,0.881906826,6,-1.936862604,-2.140700864,0.053864713,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,Up,0.834236186,0.881906826,6,-1.936862604,-2.140700864,0.053864713,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),Up,0.834236186,0.881906826,6,-1.936862604,-2.140700864,0.053864713,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
DNA Double Strand Break Response,Up,0.834236186,0.881906826,6,-1.936862604,-2.140700864,0.053864713,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Processing of DNA double-strand break ends,Up,0.834236186,0.881906826,6,-1.936862604,-2.140700864,0.053864713,FALSE,Down,0.656,0.739,4,-1.506127187,-1.842703315,-0.222194749,FALSE
Cytosolic sensors of pathogen-associated DNA ,Up,0.803900325,0.885157096,5,-1.791585856,-2.001368894,0.090658357,FALSE,Down,0.755,0.811,7,-1.499472837,-1.702745846,-0.2029017,FALSE
Listeria monocytogenes entry into host cells,Up,0.803900325,0.885157096,5,-1.791585856,-2.001368894,0.090658357,FALSE,Down,0.805,0.839,5,-1.706241034,-2.000660888,-0.169119984,FALSE
InlA-mediated entry of Listeria monocytogenes into host cells,Up,0.803900325,0.885157096,5,-1.791585856,-2.001368894,0.090658357,FALSE,Down,0.805,0.839,5,-1.706241034,-2.000660888,-0.169119984,FALSE
Mitochondrial calcium ion transport,Up,0.924160347,0.885157096,7,-2.012938622,-1.913576855,0.025567578,FALSE,Up,0.78,0.731,7,-1.095867267,-0.914146757,0.174368938,FALSE
Formation of Incision Complex in GG-NER,Up,0.87432286,0.887323944,6,-1.922459135,-2.101847467,0.074881594,FALSE,Down,0.686,0.755,5,-1.388956873,-1.662283588,-0.071601336,FALSE
FLT3 signaling in disease,Up,0.807150596,0.887323944,6,-1.787405621,-1.964635408,0.079646887,FALSE,Down,0.24,0.434,5,-0.206528992,-0.515332884,-0.034274351,FALSE
SARS-CoV-1-host interactions,Up,0.893824485,0.891657638,31,-2.384703722,-2.432388762,0.082406773,FALSE,Down,0.869,0.885,18,-1.505270144,-1.884589491,-0.00664701,FALSE
Toll Like Receptor 4 (TLR4) Cascade,Up,0.899241603,0.912242687,10,-2.052932928,-2.258085536,0.021627131,FALSE,Down,0.76,0.854,7,-1.506521939,-1.777125367,-0.211463832,FALSE
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Up,0.899241603,0.912242687,10,-2.052932928,-2.258085536,0.021627131,FALSE,Down,0.76,0.854,7,-1.506521939,-1.777125367,-0.211463832,FALSE
Toll Like Receptor TLR1:TLR2 Cascade,Up,0.899241603,0.912242687,10,-2.052932928,-2.258085536,0.021627131,FALSE,Down,0.76,0.854,7,-1.506521939,-1.777125367,-0.211463832,FALSE
Toll Like Receptor TLR6:TLR2 Cascade,Up,0.899241603,0.912242687,10,-2.052932928,-2.258085536,0.021627131,FALSE,Down,0.76,0.854,7,-1.506521939,-1.777125367,-0.211463832,FALSE
Toll Like Receptor 2 (TLR2) Cascade,Up,0.899241603,0.912242687,10,-2.052932928,-2.258085536,0.021627131,FALSE,Down,0.76,0.854,7,-1.506521939,-1.777125367,-0.211463832,FALSE
Signaling by FGFR,Up,0.88624052,0.914409534,9,-2.188401139,-2.39874025,0.056892064,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Signaling by FGFR2,Up,0.88624052,0.914409534,9,-2.188401139,-2.39874025,0.056892064,FALSE,Down,0.789,0.849,5,-1.692968937,-2.033189559,-0.162855507,FALSE
Glycerophospholipid biosynthesis,Down,0.970747562,0.918743229,4,-1.690084151,-1.628944334,-0.004347645,FALSE,Down,0.663,0.573,4,-0.683255086,-0.544161378,-0.295416742,FALSE
Phospholipid metabolism,Down,0.970747562,0.918743229,4,-1.690084151,-1.628944334,-0.004347645,FALSE,Down,0.551,0.482,6,-0.38152653,-0.236629429,-0.477449635,FALSE
Eukaryotic Translation Elongation,Up,0.939328277,0.921993499,39,-2.72522546,-2.581501973,0.034378546,FALSE,Down,0.696,0.737,12,-0.863197966,-0.828330501,-0.153088122,FALSE
Infectious disease,Up,0.932827736,0.926327194,101,-2.874953405,-2.989431001,0.046181496,FALSE,Down,0.924,0.963,81,-1.878390507,-2.640556233,-0.088021869,FALSE
Ubiquinol biosynthesis,Down,0.977248104,0.933911159,3,-1.671570967,-1.624478568,-0.010289681,FALSE,Down,0.43,0.328,3,0.052628877,0.204936162,-0.324895115,FALSE
Metabolism of cofactors,Down,0.977248104,0.933911159,3,-1.671570967,-1.624478568,-0.010289681,FALSE,Down,0.467,0.338,5,0.004859511,-0.099098108,-0.357029533,FALSE
Translation,Up,0.971830986,0.952329361,48,-3.024473247,-2.828392517,0.013584161,FALSE,Down,0.814,0.816,27,-1.12192222,-0.890156222,-0.124683866,FALSE
Metabolism of RNA,Up,0.962080173,0.959913326,69,-4.493769195,-4.634941413,0.026256198,FALSE,Up,0.546,0.723,40,-0.700648439,-1.754724765,0.035900411,FALSE
Metabolism of proteins,Up,0.965330444,0.96099675,130,-2.865332637,-2.72528241,0.022641194,FALSE,Down,0.669,0.668,132,-0.410372836,-0.625388043,-0.038583216,FALSE
"Formation of the ternary complex, and subsequently, the 43S complex",Up,0.975081257,0.962080173,16,-2.454302499,-2.440374406,0.017628812,FALSE,Up,0.961,0.973,5,-1.790849986,-1.819592578,0.005637349,FALSE
Translation initiation complex formation,Up,0.975081257,0.964247021,18,-2.676484644,-2.648662709,0.009776422,FALSE,Up,0.937,0.956,6,-1.710831115,-1.71391813,0.024159613,FALSE
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",Up,0.975081257,0.964247021,18,-2.676484644,-2.648662709,0.009776422,FALSE,Up,0.937,0.956,6,-1.710831115,-1.71391813,0.024159613,FALSE
Ribosomal scanning and start codon recognition,Up,0.975081257,0.964247021,18,-2.676484644,-2.648662709,0.009776422,FALSE,Up,0.937,0.956,6,-1.710831115,-1.71391813,0.024159613,FALSE
Influenza Infection,Up,0.980498375,0.967497291,39,-3.196006095,-3.147929408,0.036880973,FALSE,Down,0.952,0.968,14,-1.950747037,-1.961193278,-0.049624174,FALSE
SARS-CoV-2 modulates host translation machinery,Up,0.97616468,0.967497291,15,-2.434808462,-2.433502821,0.024171573,FALSE,Up,0.961,0.973,5,-1.790849986,-1.819592578,0.005637349,FALSE
SARS-CoV-1 modulates host translation machinery,Up,0.97616468,0.969664139,16,-2.433926802,-2.422658432,0.031785136,FALSE,Up,0.961,0.973,5,-1.790849986,-1.819592578,0.005637349,FALSE
Nervous system development,Up,0.978331528,0.971830986,85,-3.706305313,-3.830385421,0.063559582,FALSE,Down,0.37,0.522,54,-0.253480689,-1.190860089,-0.060011694,FALSE
Developmental Biology,Up,0.973997833,0.973997833,97,-3.559053444,-3.620681685,0.055767863,FALSE,Down,0.565,0.696,63,-0.654670582,-1.459456013,-0.063063971,FALSE
Peptide chain elongation,Up,0.982665222,0.973997833,36,-3.792032962,-3.738354733,0.018204102,FALSE,Down,0.733,0.783,9,-0.988286329,-1.033229397,-0.158726892,FALSE
Influenza Viral RNA Transcription and Replication,Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.941,0.966,9,-1.806372779,-1.86302067,-0.141321868,FALSE
Viral mRNA Translation,Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.933,0.953,8,-1.652247951,-1.732998604,-0.132009284,FALSE
Selenoamino acid metabolism,Up,0.989165764,0.973997833,35,-3.882806015,-3.838304312,0.016163758,FALSE,Down,0.773,0.806,12,-0.984888645,-0.951254997,-0.170276515,FALSE
Selenocysteine synthesis,Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.933,0.953,8,-1.652247951,-1.732998604,-0.132009284,FALSE
rRNA processing,Up,0.982665222,0.973997833,36,-3.792564966,-3.734982969,0.010631159,FALSE,Down,0.911,0.934,10,-1.569540727,-1.590915748,-0.033487196,FALSE
Formation of a pool of free 40S subunits,Up,0.982665222,0.973997833,35,-3.779266437,-3.73022618,0.013996836,FALSE,Down,0.933,0.953,8,-1.652247951,-1.732998604,-0.132009284,FALSE
Eukaryotic Translation Termination,Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.947,0.964,10,-1.788697156,-1.821030784,-0.166666746,FALSE
Response of EIF2AK4 (GCN2) to amino acid deficiency,Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.933,0.953,8,-1.652247951,-1.732998604,-0.132009284,FALSE
Cellular response to starvation,Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.933,0.953,8,-1.652247951,-1.732998604,-0.132009284,FALSE
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Up,0.982665222,0.973997833,34,-3.768030467,-3.726961628,0.016776526,FALSE,Down,0.944,0.964,9,-1.758992081,-1.816391568,-0.143281762,FALSE
SRP-dependent cotranslational protein targeting to membrane,Up,0.984832069,0.97616468,36,-3.964996076,-3.915800828,0.01751615,FALSE,Down,0.974,0.988,10,-2.113037255,-2.156033656,-0.09975396,FALSE
Axon guidance,Up,0.978331528,0.97616468,84,-3.685146764,-3.815318406,0.06346062,FALSE,Down,0.431,0.576,53,-0.374237969,-1.332750767,-0.043169603,FALSE
Major pathway of rRNA processing in the nucleolus and cytosol,Up,0.993499458,0.97616468,35,-3.88794248,-3.84347825,0.016185861,FALSE,Down,0.85,0.889,9,-1.336573033,-1.375589465,-0.039396058,FALSE
rRNA processing in the nucleus and cytosol,Up,0.993499458,0.97616468,35,-3.88794248,-3.84347825,0.016185861,FALSE,Down,0.85,0.889,9,-1.336573033,-1.375589465,-0.039396058,FALSE
L13a-mediated translational silencing of Ceruloplasmin expression,Up,0.984832069,0.978331528,37,-3.928575922,-3.870633141,0.010373078,FALSE,Down,0.912,0.938,9,-1.619821294,-1.677050813,-0.104367038,FALSE
Eukaryotic Translation Initiation,Up,0.984832069,0.978331528,37,-3.928575922,-3.870633141,0.010373078,FALSE,Down,0.912,0.938,9,-1.619821294,-1.677050813,-0.104367038,FALSE
GTP hydrolysis and joining of the 60S ribosomal subunit,Up,0.984832069,0.978331528,37,-3.928575922,-3.870633141,0.010373078,FALSE,Down,0.912,0.938,9,-1.619821294,-1.677050813,-0.104367038,FALSE
Cap-dependent Translation Initiation,Up,0.984832069,0.978331528,37,-3.928575922,-3.870633141,0.010373078,FALSE,Down,0.912,0.938,9,-1.619821294,-1.677050813,-0.104367038,FALSE
Regulation of expression of SLITs and ROBOs,Up,0.980498375,0.978331528,42,-3.813118512,-4.115567508,0.042159397,FALSE,Down,0.877,0.929,26,-1.363534414,-2.774678151,-0.022746701,FALSE
Signaling by ROBO receptors,Up,0.984832069,0.980498375,45,-3.966816367,-4.24346512,0.045580137,FALSE,Down,0.796,0.874,30,-1.132704329,-2.398301381,-0.008509235,FALSE
Nonsense-Mediated Decay (NMD),Up,0.982665222,0.980498375,36,-3.863517518,-3.863364782,0.020918571,FALSE,Down,0.974,0.992,11,-2.17736464,-2.242720372,-0.111761817,FALSE
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Up,0.982665222,0.980498375,36,-3.863517518,-3.863364782,0.020918571,FALSE,Down,0.974,0.992,11,-2.17736464,-2.242720372,-0.111761817,FALSE
Metabolism of amino acids and derivatives,Up,0.993499458,0.986998917,75,-3.091127366,-3.001303884,0.048760335,FALSE,Down,0.174,0.165,55,0.546186183,0.018708801,-0.061892358,FALSE
Cam-PDE 1 activation,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Fertilization,,,,,,,,,Down,0.758,0.665,1,-0.884999585,-0.834697269,-0.138275603,FALSE
Nuclear signaling by ERBB4,,,,,,,,,Up,0.126,0.089,1,1.397480673,1.393607024,1.196347856,FALSE
Acrosome Reaction and Sperm:Oocyte Membrane Binding,,,,,,,,,Down,0.758,0.665,1,-0.884999585,-0.834697269,-0.138275603,FALSE
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",,,,,,,,,Down,0.12,0.094,1,1.352728554,1.453750949,-1.121842384,FALSE
Intrinsic Pathway of Fibrin Clot Formation,,,,,,,,,Up,0.048,0.031,2,2.422785197,2.59505881,1.133835548,FALSE
Common Pathway of Fibrin Clot Formation,,,,,,,,,Up,0.031,0.024,1,2.34701979,2.495893159,1.679374585,FALSE
Formation of Fibrin Clot (Clotting Cascade),,,,,,,,,Up,0.048,0.031,2,2.422785197,2.59505881,1.133835548,FALSE
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Inositol phosphate metabolism,,,,,,,,,Down,0.31,0.228,2,0.527387266,0.206347698,-0.101671054,FALSE
PI Metabolism,,,,,,,,,Down,0.379,0.324,2,0.305445274,0.359706207,-0.841515422,FALSE
Insulin effects increased synthesis of Xylulose-5-Phosphate,,,,,,,,,Up,0.747,0.676,1,-0.920599834,-0.877108983,0.039772678,FALSE
2-LTR circle formation,,,,,,,,,Down,0.479,0.373,2,-0.107452855,-0.022223171,-0.28735599,FALSE
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,,,,,,,,,Down,0.365,0.303,1,0.215982425,0.227860784,-0.841515422,FALSE
The role of Nef in HIV-1 replication and disease pathogenesis,,,,,,,,,Down,0.365,0.303,1,0.215982425,0.227860784,-0.841515422,FALSE
Rev-mediated nuclear export of HIV RNA,,,,,,,,,Up,0.39,0.325,1,0.020002066,0.050234959,0.223823717,FALSE
Synthesis of PIPs at the plasma membrane,,,,,,,,,Down,0.365,0.303,1,0.215982425,0.227860784,-0.841515422,FALSE
Synthesis of PIPs at the Golgi membrane,,,,,,,,,Down,0.379,0.324,2,0.305445274,0.359706207,-0.841515422,FALSE
Creation of C4 and C2 activators,,,,,,,,,Down,0.094,0.073,1,1.512359059,1.645678864,-1.216112046,FALSE
Signalling to RAS,,,,,,,,,Down,0.18,0.133,2,1.200583232,1.329515483,-0.824966187,FALSE
Nef Mediated CD4 Down-regulation,,,,,,,,,Down,0.365,0.303,1,0.215982425,0.227860784,-0.841515422,FALSE
Export of Viral Ribonucleoproteins from Nucleus,,,,,,,,,Up,0.39,0.325,1,0.020002066,0.050234959,0.223823717,FALSE
NEP/NS2 Interacts with the Cellular Export Machinery,,,,,,,,,Up,0.39,0.325,1,0.020002066,0.050234959,0.223823717,FALSE
Adenylate cyclase inhibitory pathway,,,,,,,,,Down,0.53,0.453,1,-0.396409134,-0.366484784,-0.384425899,FALSE
p38MAPK events,,,,,,,,,Down,0.18,0.133,2,1.200583232,1.329515483,-0.824966187,FALSE
Telomere Extension By Telomerase,,,,,,,,,Down,0.685,0.625,2,-0.755296007,-0.680708166,-0.277237089,FALSE
Classical antibody-mediated complement activation,,,,,,,,,Down,0.094,0.073,1,1.512359059,1.645678864,-1.216112046,FALSE
Extension of Telomeres,,,,,,,,,Down,0.685,0.625,2,-0.755296007,-0.680708166,-0.277237089,FALSE
STING mediated induction of host immune responses,,,,,,,,,Down,0.479,0.373,2,-0.107452855,-0.022223171,-0.28735599,FALSE
"Synthesis of IP2, IP, and Ins in the cytosol",,,,,,,,,Up,0.426,0.355,1,0.018880829,0.108488324,0.63935674,FALSE
Synthesis of IP3 and IP4 in the cytosol,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Synthesis of bile acids and bile salts,,,,,,,,,Down,0.528,0.428,2,-0.318006671,-0.233561383,-0.127265654,FALSE
vRNP Assembly,,,,,,,,,Down,0.662,0.57,1,-0.745855416,-0.687401752,-0.215822536,FALSE
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,,,,,,,,,Down,0.528,0.428,2,-0.318006671,-0.233561383,-0.127265654,FALSE
"Cobalamin (Cbl, vitamin B12) transport and metabolism",,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
Coenzyme A biosynthesis,,,,,,,,,Down,0.477,0.373,1,-0.056168885,0.026590183,-0.526581599,FALSE
Nicotinate metabolism,,,,,,,,,Down,0.12,0.094,1,1.352728554,1.453750949,-1.121842384,FALSE
Nicotinamide salvaging,,,,,,,,,Down,0.12,0.094,1,1.352728554,1.453750949,-1.121842384,FALSE
Vitamin B5 (pantothenate) metabolism,,,,,,,,,Down,0.477,0.373,1,-0.056168885,0.026590183,-0.526581599,FALSE
MicroRNA (miRNA) biogenesis,,,,,,,,,Up,0.39,0.325,1,0.020002066,0.050234959,0.223823717,FALSE
Hypusine synthesis from eIF5A-lysine,,,,,,,,,Up,0.878,0.852,2,-1.680629054,-1.620007205,0.003388261,FALSE
Synthesis of Leukotrienes (LT) and Eoxins (EX),,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",,,,,,,,,Down,0.821,0.737,1,-1.134842652,-1.090812339,-0.021868549,FALSE
FCERI mediated Ca+2 mobilization,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,,,,,,,,,Up,0.657,0.58,1,-0.807247087,-0.759881338,0.032236529,FALSE
WNT ligand biogenesis and trafficking,,,,,,,,,Down,0.268,0.205,1,0.575849933,0.687017911,-0.798556317,FALSE
IRF3-mediated induction of type I IFN,,,,,,,,,Down,0.479,0.373,2,-0.107452855,-0.022223171,-0.28735599,FALSE
Defects in cobalamin (B12) metabolism,,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
"Defective MMAA causes MMA, cblA type",,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
Defective MUT causes MMAM,,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
Cytosolic tRNA aminoacylation,,,,,,,,,Down,0.259,0.177,6,0.910414468,1.137057978,-0.173580329,FALSE
NADPH regeneration,,,,,,,,,Up,0.657,0.58,1,-0.807247087,-0.759881338,0.032236529,FALSE
Defective MPI causes MPI-CDG,,,,,,,,,Down,0.005,0.003,1,4.320477845,4.499306973,-1.489917029,TRUE
"Transport of bile salts and organic acids, metal ions and amine compounds",,,,,,,,,Up,0.572,0.475,1,-0.375243574,-0.316736373,0.467080343,FALSE
Metal ion SLC transporters,,,,,,,,,Up,0.572,0.475,1,-0.375243574,-0.316736373,0.467080343,FALSE
Synthesis of GDP-mannose,,,,,,,,,Down,0.005,0.003,1,4.320477845,4.499306973,-1.489917029,TRUE
Ionotropic activity of kainate receptors,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Activation of Ca-permeable Kainate Receptor,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
VEGFR2 mediated cell proliferation,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Mitochondrial translation initiation,,,,,,,,,Down,0.849,0.762,1,-1.086122642,-1.039846437,-0.052902519,FALSE
Mitochondrial translation termination,,,,,,,,,Down,0.849,0.762,1,-1.086122642,-1.039846437,-0.052902519,FALSE
Physiological factors,,,,,,,,,Up,0.357,0.288,1,0.303392883,0.383037425,0.816541881,FALSE
Defective AHCY causes HMAHCHD,,,,,,,,,Down,0.821,0.737,1,-1.134842652,-1.090812339,-0.021868549,FALSE
CLEC7A (Dectin-1) induces NFAT activation,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),,,,,,,,,Up,0.572,0.475,1,-0.375243574,-0.316736373,0.467080343,FALSE
Defective CP causes aceruloplasminemia (ACERULOP),,,,,,,,,Up,0.572,0.475,1,-0.375243574,-0.316736373,0.467080343,FALSE
VxPx cargo-targeting to cilium,,,,,,,,,Down,0.191,0.148,1,0.886637974,0.965798369,-0.892274176,FALSE
RHO GTPases activate KTN1,,,,,,,,,Up,0.445,0.36,2,-0.025981545,0.0490823,0.288901459,FALSE
tRNA modification in the nucleus and cytosol,,,,,,,,,Down,0.142,0.088,1,1.443456284,1.555925733,-1.057854631,FALSE
"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",,,,,,,,,Up,0.747,0.676,1,-0.920599834,-0.877108983,0.039772678,FALSE
"TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",,,,,,,,,Up,0.747,0.676,1,-0.920599834,-0.877108983,0.039772678,FALSE
Pentose phosphate pathway disease,,,,,,,,,Up,0.747,0.676,1,-0.920599834,-0.877108983,0.039772678,FALSE
Pentose phosphate pathway,,,,,,,,,Up,0.879,0.853,2,-1.411388108,-1.347370322,0.049319741,FALSE
Purine ribonucleoside monophosphate biosynthesis,,,,,,,,,Down,0.689,0.607,1,-0.733060564,-0.676568831,-0.154406866,FALSE
5-Phosphoribose 1-diphosphate biosynthesis,,,,,,,,,Up,0.773,0.723,1,-1.07540437,-1.0283604,0.058866803,FALSE
RNA Polymerase III Transcription Termination,,,,,,,,,Down,0.24,0.175,1,0.769273799,0.884531598,-0.844665025,FALSE
RNA Polymerase III Transcription,,,,,,,,,Down,0.24,0.175,1,0.769273799,0.884531598,-0.844665025,FALSE
Purine salvage,,,,,,,,,Up,0.383,0.307,1,0.182760865,0.25942692,0.528371039,FALSE
RNA Polymerase III Abortive And Retractive Initiation,,,,,,,,,Down,0.24,0.175,1,0.769273799,0.884531598,-0.844665025,FALSE
TBC/RABGAPs,,,,,,,,,Down,0.403,0.32,2,0.250354573,0.305446588,-0.641253039,FALSE
Nucleotide biosynthesis,,,,,,,,,Down,0.689,0.607,1,-0.733060564,-0.676568831,-0.154406866,FALSE
Nucleotide salvage,,,,,,,,,Up,0.383,0.307,1,0.182760865,0.25942692,0.528371039,FALSE
Chylomicron clearance,,,,,,,,,Up,0.126,0.089,1,1.397480673,1.393607024,1.196347856,FALSE
Alanine metabolism,,,,,,,,,Down,0.072,0.053,1,2.046476569,2.214573058,-1.606918503,FALSE
Loss of function of MECP2 in Rett syndrome,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Pervasive developmental disorders,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
RHOT2 GTPase cycle,,,,,,,,,Down,0.676,0.596,1,-0.772662187,-0.719586183,-0.207887948,FALSE
Biosynthesis of D-series resolvins,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Biosynthesis of DHA-derived SPMs,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Biosynthesis of specialized proresolving mediators (SPMs),,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Biosynthesis of EPA-derived SPMs,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Biosynthesis of protectins,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Biosynthesis of E-series 18(S)-resolvins,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Biosynthesis of aspirin-triggered D-series resolvins,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
Loss of phosphorylation of MECP2 at T308,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Biosynthesis of E-series 18(R)-resolvins,,,,,,,,,Up,0.395,0.33,1,0.109914344,0.1731044,0.396309604,FALSE
NR1H2 and NR1H3-mediated signaling,,,,,,,,,Up,0.236,0.153,2,0.840960964,0.886842442,0.878002609,FALSE
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,,,,,,,,,Up,0.126,0.089,1,1.397480673,1.393607024,1.196347856,FALSE
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,,,,,,,,,Up,0.474,0.396,1,-0.208182272,-0.139422415,0.559657361,FALSE
TYSND1 cleaves peroxisomal proteins,,,,,,,,,Down,0.083,0.047,3,1.785424086,1.936776377,-0.499360027,FALSE
Molybdenum cofactor biosynthesis,,,,,,,,,Down,0.82,0.756,1,-1.086672671,-1.040229827,-0.048918093,FALSE
Activation of RAC1 downstream of NMDARs,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Transcriptional Regulation by NPAS4,,,,,,,,,Down,0.12,0.094,1,1.352728554,1.453750949,-1.121842384,FALSE
Suppression of autophagy,,,,,,,,,Down,0.246,0.179,1,0.706933272,0.715476148,-0.810354341,FALSE
Vitamins B6 activation to pyridoxal phosphate,,,,,,,,,Down,0.103,0.06,1,1.730210334,1.865714409,-1.597640166,FALSE
Disorders of Developmental Biology,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Disorders of Nervous System Development,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
Miro GTPase Cycle,,,,,,,,,Down,0.676,0.596,1,-0.772662187,-0.719586183,-0.207887948,FALSE
Nucleotide salvage defects,,,,,,,,,Up,0.383,0.307,1,0.182760865,0.25942692,0.528371039,FALSE
Defective HPRT1 disrupts guanine and hypoxanthine salvage,,,,,,,,,Up,0.383,0.307,1,0.182760865,0.25942692,0.528371039,FALSE
Diseases of nucleotide metabolism,,,,,,,,,Up,0.383,0.307,1,0.182760865,0.25942692,0.528371039,FALSE
Cobalamin (Cbl) metabolism,,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
Diseases of mitochondrial beta oxidation,,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
Diseases of propionyl-CoA catabolism,,,,,,,,,Down,0.462,0.365,1,-0.120119057,-0.062490766,-0.488410456,FALSE
NPAS4 regulates expression of target genes,,,,,,,,,Down,0.12,0.094,1,1.352728554,1.453750949,-1.121842384,FALSE
NFE2L2 regulating TCA cycle genes,,,,,,,,,Up,0.657,0.58,1,-0.807247087,-0.759881338,0.032236529,FALSE
NFE2L2 regulates pentose phosphate pathway genes,,,,,,,,,Up,0.747,0.676,1,-0.920599834,-0.877108983,0.039772678,FALSE
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,,,,,,,,,Down,0.19,0.162,1,0.726957396,0.183331388,-0.842698848,FALSE
